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SUMMARY
Although the bronchial hyDcr-reactivity to specific and
/
non-specific stimuli in asthma has been well recognised for many 
years, the factors involved in its pathogenesis are still
'7
unresolved. Salter in 1859 first suggested that airways 
hyper-reactivity in astlima resulted from hypersensitivity of 
pulmonary nervous system. More recently, Szentivayni^^ (1968) 
has postulated that the atopic state and bronchial hyper­
reactivity in a,sthma is due to a functional imbalance between 
the alpha and beta adrenergic receptors and results from 
diminished beta receptor function. The theme of work presented 
in this thesis is to examine the autonomic mechanisms in patients 
with extrinsic asthma and in particular the role of alpha 
adrenergic activity in the control of bronchomotor tone both in 
normal subjects and asthmatic patients.
In sixteen patients with extrinsic bronchial asthma alpha 
stimulation in presence of beta blockade caused a significant 
bronchoconstriction both in the central and ueripheral airways 
whereas in ten normal subjects alpha stimulation or beta blockade 
had no effect on the bronchial calibre. The bronchoconstriction 
caused by pharmacological stimulation of alpha receptors could be 
inhibited by pretreatment of these patients with alpha receptor 
blocking drugs, phenoxybenzamine and thymoxamine. The results 
of this investigation confirm the presence of alpha receptors in 
human airways and that the stimulation of these receptors can 
cause bronchoconstriction in asthmatic patients. Further, it is 
shovm that thymoxamine can effectively inhibit histamine, allergen
18
a.nd exercise induced bronchoconstriction whereas it had no effect
in methacholine and Prostaglandin alpha induced broncho-
/
constriction. It is suggested that inhibitory effect of 
thymoxamine in histamine, allergen and exercise provoked asthma 
is mediated by increase in the intracellular levels of cyclic Aî-TP 
which prevents the effect of some of the pharmacological mediators 
released in the type I reaction on the bronchial smooth muscle.
On the other hand, methacholine and Prostaglandin a,lpha are' 
now known to cause bronchial smooth muscle contraction through 
stimulation of cholinergic receptors which are unaffected by 
alpha receptor blocking drugs. Further, it is shown that 
thymoxamine and phentolamine when administered with isoprenaline 
cause significantly greater bronchodilatation compared to 
bronchodilatation achieved with isoprenaline alone. This 
observation may have, therapeutic significance in the management 
of patients with chronic labile airways obstruction and 
especially in those patients in whom beta a,gonists alone fall to 
produce significant bronchodilatation.
In Part II of this thesis biochemical studies of 
leucocyte adenyl cyclase and lymphocyte guanyl cyclase activities 
in normal and asthmatic patients are described. It is now well 
recognised that the membrane bound enzyme, adenyl cyclase-cyclic 
AMP system, mediates beta adrenergic responses and thab guanyl 
cyclase-cyclic GMP system is activated by cholinergic and 
possibly alpha receptor stimulation. The presence of both these 
enzyme activities on the peripheral leucocytes has paved the way 
for more fundamental and basic research to study autonomic
19
mochanisms in asthma. Conflicting results had been reported
previously on the leucocyte adenyl cyclase response to isoorenaline
107in patients with asthma. Logsdon et al observed diminished
leucocyte adenyl cyclase activity in all patients they had
examined whereas Gillespie et al^^^ failed to show any significant
difference in the leucocyte adenyl cyclase activity of normals or
109asthmatic patients. Parker and. Smith , in more detailed 
studies, have reported diminished adenyl cyclase activity in 
patients with acute asthma whereas in padients in remission the 
activity of this enzyme was normal. In none of these studies 
was there any objective assessment of degree of airways 
obstruction or detailed account of the clinical state of the 
patients.
In this carefully conducted investigation it is shown 
that the basal leucocyte adenyl cyclase activity is increased 
in patients with acute asthma and the response of this enzyme 
system to isoprenaline is inversely related to the basal 
levels. These observations indicate that adenyl cyclase activity 
in acute asthma is maximally stimulated by endogenous factors and 
further stimulation becomes increasingly difficult. In contrast, 
the basal adenyl cyclase activity in patients in remission is low 
and the response to .isoorenaline does not differ significantly 
from normal subjects. The adenyl cyclase stimulation to 
isoprenaline in asthmatic patients did not relate to the total 
circulating reagins nor to airways response induced by beta 
blockade and allergen challenge. These observations together 
with the failure to produce histamine hyoer-reactivity in normal
20
subjects suggest that diminished beta receptor function is not
the cause of atopic state or bronchial hyper-reactivity in asthma
45as postulated by Szentivayni . In presence of beta receptor 
function in asthmatic patients the minor alpha receptor 
stimulating properties of adrenaline may become dominant causing 
bronchoconstriction through stimulation of alpha receptors in 
the airways. This phenomenon may explain the adrenaline 
fastness and adrenaline reversal commonly observed in status 
asthmaticus.
The possibility of enhanced cholinergic mechanisms in 
asthmatic patients has also been postulated. In contrast to my 
expectations, the lymphocyte guanyl cyclase response to 
cholinergic and alpha stimulation was depressed in the asthmatic 
group as a who1e and no distinction in this activity could be made 
on the basis of clinical state of the disease as was possible in 
the adenyl cyclase study. It appears that guanyl cyclase-cyclic 
GMP abnormality in asthma may be a primary defect which in turn 
modifies adenyl cyclase activity. Alpha and cholinergic 
stimulation both cause bronchoconstriction in Man, and this 
response is grossly exaggerated in asthmatic patients. In guanyl 
cyclase studies, aloha and cholinergic stimulation have been shown 
to cause a significant increase in cyclic GMP formation 
lymphocytes of normal subjects. Assuming that similar increase 
in cyclic GMP also occurs in the bronchial smooth muscle of these 
subjects, the high levels of cyclic GNP formed may lead to 
inhibition of cyclic AIT phosphodiesterase preventing hydrolysis 
of cyclic AÏ4P and thereby maintaining relaxation of bronchial
21
smooth muscle. In contrast, alpha and cholinergic stimulation
does not produce a significant increase in cyclic GMP in
asthmatic patients and this prohahly has an effect opposite to
178that observed in normal subjects' . It is possible that in
asthmatic patients we are observing an increased hydrolysis of
cyclic AMP through stimulation of cyclic phosphodiesterase due
10?to low concentration of cyclic GMP as reported by Beavo et al '? 
103 resulting in bronohoconstriction. Such a phenomenon in mast
cells would also explain increased mediator release following
?9alpha and cholinergic stimulation as already reported" ,
22
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CHAPTER I 
INTRODUCTION
1.0 BRONCHI AT,. ACTTINA AND DEHEL0PÎPIÏÏT3 IN ALLERGY AHH ANAPTrfLAXIE
1.1 Historical
A numLer of ancient Creek vrritings as early as the
fifth century B.C. described symptoms resembling asthma,
Areteus^ in the second century A«D. gave a granhio
description of asthma. In none of these early references,
however, was there any sharp distinction between various
forms of dyspnoea.
The first Renaissance physician to write about asthma
was Ceralomo Gordano (15OI - 157^ A.D.). He was called
from Italy to Edinburgh to treat John Hamilton, Archbishon
of St. Andrews. Gordano observed the Arohbishon for six
weeks before diagnosing asthma. His treatment included
diet, exercise and nurging to decrease the secretions of
mucous in the throat and substitution of a bed of unsnun
silk for one of feathers. Hanpily for Gordano, John
Hamilton recovered, but only lived long enough to be
2
hanged by the Scottish Reformers .
In 1607 Joannes Baptista van Helmont^ described
nervous or spasmodic dyspnoea as a distinct entity and
later Thomas Hillis (l68l)^ clearly emphasised the
5spasmodic nature of asthma. Sir John Eloyer in I698 
published his classic treatise on asthma and assigned 
the cause of asthma to a "contracture of muscular fibres 
of bronchi".
24
The concept of hyper-sensitivity to hair dnst was 
first suggested by Robert Bree and described in
detail in his book "Disordered Respiration". It remained, 
however, for Salter (l859) to place this concept of 
hyper-sensitivity on more firm clinical grounds. He 
suggested that the asthmatic attack was caused by spastic 
contraction of the circular muscle around the small 
bronchi and it was due to excitoraotory or reflex action. 
Salter by his perfect logic and clinical observations also 
suggested that the bronchi of asthmatic patients were 
hyper-sensitive and factors such as fog, cold air, emotion 
and exercise could cause bronchospasm in these patients.
He said, "I believe it possible that asthma is sometimes 
produced by particular materials admixed with blood in the 
lungs, and that therefore it is so far humoral, but that 
these particular materials - whether absorbed unchanged, 
as alcohol, ethers and saline solutions, or the result of 
healthy digestion, or of perverted digestion - have nothing 
particular in them, but the essence of the disease in these 
cases, as well as in others, consists of a morbid 
sensitiveness and irritability of the pulmonary nervous 
system". In aetiological factors he stressed heredity, 
which he was able to trace in 4 0 - % of his patients. Since 
the muscular spasm did not explain all the clinical and 
experimental phenomena in asthma, the concept of 
obstruction of small bronchi from within was elaborated 
by other prominent nineteenth century physicians like 
Laennoc, Ramadge and Trousseau.
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1.2 Allergy and .Anaohylaxis
8In 1839 Francois Magendie reported first definite
'  ^ work on anaphylaxis in dogs and he observed that dogs died
suddenly if injected repeatedly with egg albumin. Flexner
■ (1894)^  confirmed these results. Hericourt and Richet
(1898 - 1903)^^ performed many experiments on induced
hyper-sensitiveness in animals and Portier and Richet
(1902) ■ termed this phenomenon as anaphylaxis, Otto
(1907)^ ^ demonstrated that anaphylaxis in guinea nigs
depended on an antibody and he showed that it was possible
to passively sensitise animals by transference of serum
from a sensitised animal.
13In 1906 Von Pirquet'' coined the term "allergy" 
indicating an altered reaction or abnormal response and 
he originally used the term to designate the state of 
heightened sensitiveness to tuberculin but subsequently it 
included hyper-sensitiveness represented by hay fever and 
asthma. Coca (l923)^^ recognising the need for a term 
which would distinguish such clinical manifestations from 
other types of hyper-sensitiveness pronosed the term 
"atopy".
The first definite suggestion that human
hyper-sensitiveness - hey fever - was related to anaphylaxis
in animals was made by Wolff-Sisner (l906)^^ and in 1910
Keltzer^^ and Karl Kossler independently suggested that
asthma was a phenomenon of local anaphylaxis in the lungs,
3 7In 1912 Schloss reported food sensitiveness in a child, 
demonstrated by skin tests, and from this point on, the use
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of skin tests for diagnosis of sensitivity to foods and
.other substances developed rapidly.
1.3 Atopy and Reaginic Antibody 
/ 18
j Prausnitz and îCustner in 1921 first demonstrated
• the existence of a specific factor in the serum of an 
atopic subjects (Kustner, who was sensitive to fish) by 
passive transfer to the skin of a normal unsensitised 
person (Prausnitz). This specific antibody-like factor 
could not be shown by precipitation, complement fixation 
or by passive anaphylaxis in guinea pigs. This heat-labile 
antibody like substance, found especially in the sera of 
atopic persons, was called reagin by Coca.
The investigations to find other and better means of 
measuring human reagins and to isolate and. characterise 
them has been an exciting development in recent years.
The chief advances concerning atopy were the identification 
by Ishizaka (1966)^ '^  of the Immunoglobulin E (igE) as the 
elusive reaginic antibody and the development of its 
quantitative measurement by Johansson and his colleagues
(1967)^ °.
Immunoglobulin E is a normal constituent of humau 
serum which is present at l/dOOOOth concentration of 
Immunoglobulin G. It has the capacity to sensitise cells 
for long periods of time for subsequent triggering action 
of antigen. Atopic subjects have six times as much TgE 
as normal subjects, and in allergic asthma 63^ of patients
have raised IgE compared with 5/' non-atopic or intrinsic
20 21 asthma . Ishizaka " has further shown that tho IgE
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/production occurs in the mucosal lymnhoid cells and this 
may explain why atopic subjects are readily sensitised by 
this route, and may also throw light on possibility of 
local TgS sensitisation, without serological and skin
sensitivity, in some subjects at present regarded as
I
 ^ non-atopic or intrinsic.
The clinical characterisation of an individual as an 
atopic person depends on the presence of several features 
including characteristic symptomatology, the existence of 
skin sensitivity of immediate weal and flare tyne, and a 
family history of atopic disease, Eosinophilia is common 
to all atopic disorders, and the level of circulating
2 2
eosinophils parallels the severity of patients’ symptoms
The familial clustering of atonic diseases suggests that an
23atopic tendency may be inherited . The genetic 
predisposition does not seem to determine the organ or 
tissue which is involved. Similarly, there is a great 
variability in the allergens to which an atopic person 
will develon sensitivity.
1.4 Diseases of Reayin-Fediated Hyper-Sonsitivity
■Reagin-mediated hyner-sensitivity is also termed the 
immediate hyper-sensitivity or the type I allergic
2  A
reaction . The classical diseases of the tyne I allergy 
are seasonal and perennial allergic rhinitis and asthma, 
anaphylaxis, certain cases of urticaria and angioedema, 
atonic dermatitis, certain cases of food and drug reactions 
and bee sting hyner-sensitivity.
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The changes characteristic of the type I allergic 
.reaction are initiated hy the interaction of a specific 
antigen with homologous IgE antibody bound to the tissue
/ 25I mast cells or circulating basonhils The tissue changes
• include increase in vascular permeability, smooth muscle 
contraction, mucous gland hyper-secretion, 1eueotaxis and 
especially eosinophilotaxis, and irritation of sensory 
nerve endings. These tissue changes in the reagin-mediated 
allergic reaction can be accounted for by one or more of 
pharmacologically active substances (chemical mediators) 
released during the reaction.
1.5 Ghemioal Mediators Released in the Tyne I Allergio Reaction 
in Man
The presence of histamine in the mast cells^^ and its 
release from the mast cell granules during the
27reagin-mediated reaction was first demonstrated by Mota
28and later confirmed by Austen and Humphrey , Histamine
and slow reacting substance of anaphylaxis (SaR.G.-A.) are
also released from passively sensitised human lung on
29exposure to antigen . Although the formation of 
bradykinin in allergic human lung has not been demonstrated, 
this substance is of interest as it is found in the nasal 
and bronchial secretions of natients with hay fever or 
asthma^^. In addition bradykinin forming enzyme is
31 32released in g^uinea nigs during ananhylaotic reaction ’
Serotonin (5 hydroxytryntamine) although a major mediator
29of anaphylaxis in certain animal species is probably not
33important in allergic reaction in Man' .
29
A recent addition to the ranks of chemical mediators
is an eosinophilic chemotactic factor of anaphylaxis
and Prostaglandin aloha^^. Prostaglandin 
alpha is found in human lung and is released in natients
with asthma during bronchial challenge with anpronriate
. . 3-6antigen" .
Acetylcholine, tho cholinergic neurotransmitter,
although not released during allergic reaction,, has also
been considered an important mediator in asthma because of
its profound effect on bronchial smooth muscle, in asthmatic 
37patients
1.6 Bronchial Hyner-Reactivity to Chemical Mediators in Asthma
Weiss, Robb and Blumgart^^ in 1.929 first reported that
asthmatic patients developed bronchospasm following an
administration of a small dose of histamine which did not
39affect normal subjects. Curry investigated this
phenomenon of bronchial hyper-reactivity to histamine and
37acetylcholine in asthma and Tiffeneau was first to 
quantitatively measure bronchial hyuer-reactivity to 
acetylcholine and histamine in asthmatic natients. In 
recent years, with the discovery of new chemical mediators 
released in the type I allergic reaction, the bronchial 
hyper-reactivity in asthmatic natients has been ■
*2demonstrated to bradykinin^^ and Prostaglandin F^ alnha"^ *^ ’
This bronchial hyper-reactivity has been renorted to 
remain constant in individual natients and is known to 
persist for many years even in the absence of active 
asthma^^' Tho cause of bronchial hyner-rerotivity is
30
still uncertain. The beta adrenergic theory put forward 
â 5
 ^ by Szentivayni oniswers many facets of atopy and bronchial 
hyper-reactivity in asthma.
2.0 DEFINITION OF ASTHMA
Bronchial asthma should he considered as intermittent 
/ reversible obstructive lung disecse and differs from chronic 
I bronchitis and emphysema where airways obstruction is 
.chronic and largely irreversible. Asthmatic patients 
comnlain of wheezing, dyspnoea or tightness in the chest and 
cough productive of thick tenacious sputum. Adequa/te 
therapy with bronchodilator drugs or corticosteroids 
reverses the airways obstruction in these patients. It was 
previously thought that lung structure and gas exchange 
function is normal in asthmatic patients in symptom-free 
periods, however, recent studies have demonstrated 
persistent ventilation-perfusion abnormalities, mild 
hypoxaemia and significant degree of peripheral airways 
obstruction in asymptomatic patients.
On clinical grounds, skin testing together with the 
measurement of IgE, two main types of asthma can be broadly 
defined. First is the extrinsic or atopic asthma which 
begins early in life and is often associated with atopic 
eczema or allergic rhinitis. A patient with extrinsic 
asthma is symptomatic on exposure to a specific allergen, 
has positive skin tests and bronchial challenge reactions 
and frequently the serum IgE level is elevated. Second 
type is the perennial or intrinsic asthma vdiich usually 
begins later in life and is often associated with nasal 
polyps. In a patient with intrinsic asthma no allergic 
aetiology can be detected by any currently available 
techniques and the serum IgF level is not elevated.
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Respiratory tract infections predispose to asthmatic attacks 
in both types but more frequently in the intrinsic yroup*
The family history of allergic diathesis tends to be more 
common among the extrinsic group.
Except for the partial separation of extrinsic and
intrinsic groups on the basis of serum IgE levels and skin
tests, there are at present no other immunological or
biochemical parameters useful in classifying asthma or in
understanding its underlying pathogenic mechanism.
Bronchial hyper-reactivity and variability of airway
calibre is the hallmark of asthma. In recent years,
evidence has accummulated that the imbalance of autonomic
45neural control of the airways gives rise to the airways 
hyper-reactivity in asthma.
The autonomic mechanisms in asthma form the main theme 
of this thesis and hence a short historical review, 
together with the present concept of biochemical nature of 
autonomic receptors and their role in bronchial asthma, is 
described in the following section.
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3 .0  IHIE A.ÜTO.NOMia TTERV0TT3 SY3T1M ATOPY AND ABT^MA
3.1 Autonomic Receptors
The two divisions of the autonomic nervous system are
quite distinct in many of their anatomical and physiological
characteristics, • The neurohumoral transmitter of all 
preganglionic autonomic fibres, all postganglionic 
parasympathetic fibres and a few postganglionic sympathetic 
fibres is acetylcholine, whereas the neurohumoral 
transmitter in the majority of the sympathetic 
postganglionic fibres is noradrenaline. '
As early as 1905? Langley^^ suggested that most 
substances then thought to act upon nerve endings acted 
instead upon "the receptive substance" of the cells of 
the organs innervated. A year later Dale referred to this 
concept to explain his observation that ergot alkaloids 
prevented the excitation actions of a.drenaline but had no 
effect on its inhibitory actions. The adjectives 
"adrenergic" and "cholinergic" were introduced by Dale"^ "^  
(1933) to designate nerve fibres that release the 
sympathetic transmitter and acetylcholine respectively.
The receptor concept was not accepted generally at the time 
because of the difficulty in explaining the diverse effects 
of sympathetic stimulation to a single transmitter on one 
kind of receptor. It was thought for some years that two 
mediators (Sympathin E and Sympathin I, both derived from a 
single substance "Sympathin") must be involved"^ .^ The 
proper explanation that two tyres of receptors, only one of 
which WQ.8 blocked by Dale's ergot preparation, rather than
3^
two mediators was put forward by Ahlquist"^ ’^ in 3.948*
Alilquist’s main conclusions were based on a detailed 
comparison of the effectiveness of five sympathetic amines 
in cats, dogs, rats and rabbits* He found that various 
responses fell into two categories* For one noradrenaline 
was the most effective compound, and isoprenaline the lea^ stg 
whereas for the other isoprenaline was the most effective, 
with noradrenaline the least. Ahlquist suggested that 
these two types of responses reflected the actions mediated 
by two distinct receptors which he designated as the alpha 
and beta receptors. Soon after Ahlquist's paper it was 
shown that adrenergic bloclcing drugs abolished only the 
actions mediated by alpha receptors but subsequent 
development of agents such as dichloroisoproterenol and 
propranolol that block actions of beta receptors with 
comparable selectivity further confirmed Alilquist’s 
conclusion.
The possibility that there may be more than one kind of
beta receptor is both of theoretical and practical
50importance. Lands aud his associates who compared the 
effectiveness of 15 sympathomimetic amines in causing 
bronchodilatation, vasodepression, cardiac stimulation and 
increased lipolysis. The relative potencies of the various 
compounds were such that the effects on the heart ond 
lipolysis were mediated by a recentor (type B-l) of a kind 
somewhat different to the tyne (b~2) involved in both 
3)ronchodilatation and vasodepression.
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Although the adrenergic and cholinergic receptors have
/ had these names for many years we are only just beginning to
get acquainted with their fundamental nature.
3*8 Adenyl Cyclase - Cyclic MiP System
It has recently been shown thad the membrane bound
adenyl cyclase is the second messenger and a. mediator of
actions of many hojf'mones and neurohormones including 
51cadecholamines , According to this concent a hormone, 
the first messenger, reacts with a receptor in a  target cell 
membrane, resulting in the activation of membrane bound 
adenyl cyclase. In presence of Mg^ "* ions, the activated 
adenyl cyclase catalyses the formation of a cyclic 
nucleotide from adenosine triphosphate. This cyclic 
nucleotide, adenosine 3’5* monophosphate (cyclic AMP) is a 
nucleotide of adenylic acid with phosphate groups 
diesterified ad Carbons 3' and 5' of the ribose moiety. 
Cyclic AMP is the intracellular messenger and is of central
I Rp_
importance in the regulation of cellular function 
Cyclic AMP is hydrolysed by cyclic phosphodiesterase, 
specific for mononucleotide 3*5’ bonds, to an inactive 
nucleotide, 5’ AMP. The beta adrenergic responses of 
catecholamines are mediated through activation of adenyl 
cyclase and increase in cyclic AMP levels.
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3.3 Adenosine Triphosphatase (ATPase)
Althoug‘h the exact 'biochemical nature of the alnha
53receptor is still uncertain, Lelleau pronosed on the
theoretical ground that mem'brane "bound adenosine
triphosphatase (ATPase) would renresent an ideal enz^ nne for
alpha adrenergic modulation. This hypothesis is supported
by the o'bservation that divalent cationic dependent ATPase
activity in cell preparations can he stimulated hy alpha
adrenergic agonist and inliihited hy alpha receptor blocking 
54 55drugs ’ . A  recent advance has been the finding that
alpha receptor activation causes changes in the ionic
56permeability of the cell membranes of several tissues ,
It is likely that ionic selectivity of permeability caused 
by alpha receptor activation may vary between tissues. In 
the longitudinal muscle of the intestine mainly ions are 
concerned, so that the membrane potential rises and 
electrical activity is inhibited and in other smooth muscle 
cells e.g. arteries and veins depolarisation occurs. It 
has been suggested, however, that alpha receptor stimulation
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may initiate contraction in certain smooth muscles hy
releasing Oa"*"^ ions from an intracellular store, possibly
57in the sarcoplasmic reticulum , .
An important but unsettled question is whether changes 
in cyclic AMP underlie alnha recentor mediated responses. 
One possibility which has been suggested is that aJpha 
effects may result from a fall in the levels of cyclic AMP, 
and some evidence to support this suggestion has been .
, .58, 59reported  ^ ' .
3.4 Guanyl Cycla.se - Cyclic OMP System
It is now generally accepted that .cholinergic and vagal 
responses are mediated by activation of guanyl cyclase and 
the formation of guanosine 3*5' monophosphate (c^mlic GMP) 
which is the intracellular messenger^^^ . There is also 
evidence that guanyl cyclase is also activated by alpha 
adrenergic stimulation^"^. Several substances such as 
acetylcholine, bradykinin, prostaglandin and insulin
63are also known to increase cyclic GMP formation . Cyclic 
GMP, like cyclic AI-*'P, is hydrolysed in the cell by cyclic 
phosohodiesterase which may have varying affinities for 
respective cyclic nucleotides^"^ ^ . The intracellular
concentration of cyclic GMP and cyclic AMP is, therefore, 
a balance between the hormono.1 'driving forces causing their 
formation and the rate of hydrolysis by phosphodiesterases 
within the cell. Guanyl cyclase activity has been
demonstrated in many tissues including human lung and
, , 6 6lymphocytes
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3.5 Autonomic Imbalance in Asthma
Salter (l859) was first to suggest that spasmodic
contraction of the muscle of bronchi was due to "a morbid
sensitiveness and irritability of the-pulmonary nervous
system". Eppinger and Hess^ "^  in 1909 suggested that
asthma was a result of parasympathetic over-activity and
Pottenger (1928)^^ felt that in addition to the vagus
overtone, there was also a deficiency in certain
sympathotonic glands such as adrenals and thyroid, and
that specific and certain non-specific stimuli only acted
as precipitating factors in disorganised neurocellular
mechanisms. Gudehus ( 1933)^^ and Handa ( 1934)'^ ^
regarded bronchial asthma as a vagus neurosis of resoiratory
organs and believed that endocrine glands played a
dominant role. The concept of autonomic imbalance in
asthma was not generally accepted then because of failure
or minimal effect of atropine or vagus section in the
71treatment of asthma
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3.6 The Beta Adrenergic Theory of Atopic Abnormality in Asthma
 ^ Over the past three decades the interest in the
autonomic nervous control of the airways in asthma has
been revived. The significant advance in our present
knowledge of autonomic nervous system in asthma has been
to produce an experimental animal counterpart of atopic
state. A meaningful analogy to the bronchial
hyper-reactivity in asthma has been the finding that
certain strains of mice aud rats when sensitised with
Bordetella pertussis vaccine acquire hyper-sensitivity to
72 73histamine, serotonin and bradykinin '^ and also to less 
specific stimuli such as cold air, changes in atmospheric 
pressure and respiratory irritants^f. These animals also 
show a reduced beta receptor sensitivity to catecholamines 
and a reversal of normal adrenergic activity. In addition,
there is a marked eosinophilia and an enhanced antibody
73 . ■formation ; these antibodies exhibit many of the features
peculiar to atopic reagins and are thought to represent its
animal counterpart. Subsequently, it has been shown that
a similar state can be produced in experimental animals
following beta adrenergic blockade with
45dichloroisoproterenol
In Man, it has long been known that asthmatic patients 
are somehow more tolerant to adrenaline than normal 
subjects and this impression has gained experimental 
support by observation of reduced beta adrenergic 
responsiveness to catecholamines in asthmatic subjects^^’ 
This' beta receptor resistance in asthmatic Patients is
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78reported .to increase with the severity of asthma <. In
status asthmaticus, the majority of patients become "fast"
to adrenaline and this adrenaline fastness cannot be
explained by tachyphylaxis as bronchial préparations under
experimental conditions do not develop tachyphylaxis on
79repeated exposure to sympathomimetic amines .
’Based on these observations in animal experiments and 
45Man, Ssentivayni postulated that asthma is not an 
immunological disease 'but a unique pattern of bronchial 
hyper-reactivity to a broad spectrum of stimuli and results 
from the reduced functioning of the beta adrenergic 
receptor system a.nd that the adrenergic neurotransmitters 
are released in the face of relatively unavailable beta 
effector system. The resultant adrenergic imbalance 
deprives the bronchial tree from its normal counter- 
regulatory control. This hypothesis is supported by 
observation in patients with hay fever and allergic rhinitis 
without previous history of asthma who develop bronchial 
hyper-reactiVity to methacholine and antigen inhalation 
following beta adrenergic blockade with propranolol^^.
In addition, beta adrenergic blockade with propranolol has 
also been shoim to precipitate bronchospasm in asthmatic 
patients^^. According to Szentivoyni^^, in asthma the 
reduced beta receptor activity would be primarily relegated 
to the lung rendering this organ thp s.o called "target 
organ", whereas deficient beta function in other tissues 
could result, for exa.mple, in atopic dermatitis or allergic 
rhinitis.
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Although Szentivàyni put forwEird a Unitarian concept 
to explain bronchial hyper-reactivity and atopic state in 
asthma,, his conclusions are mainly based on observations 
in animal experiments. These observations are important,
. however, the inferences derived have to be regarded with 
caution firstly because of species differences and secondly
f
because of failure to produce chronic unrelievable
asthmatic state in animals. In o,ddition, pharmacological f h
blockade in non-atopic subjects has failed to induce
82bronchial hyper-reactivity in these - subjects , Further,
: Ssentivayni without much experimental evidence ventured to
postulate that sympathetic imbalance in patients with
asthma may result from increased alpha adrenergic activity
of the airways. In 1968 when he put forward his hypothesis
there was some evidence of presence of alpha adrenergic
receptors in animal airways, however the existence of such
receptors and their function in human bronchial tree was
still in doubt.
3*7 Alpha Receotors in Ma.mmalian Bronchial Tree
Dixon and Ransom ,(l912)^  ^showed that stimulation of
the cervical sympathetic fibres in cat could be followed
either by bronchodilatation or bronchoconstriction
depending upon the strength and the frequency of electrical
stimulus used; they identified certain fine nerve fibres
with a high threshold of excitability which were
constrictor in function. Hebb (l94l)^ '^  described
bronchoconstriction after stimulation of stellate ganglion.
83More recently, Castro de la Fata et al ' showed that the
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bronchial smooth-mnsc’i e in dogs contained alpha receotors
which could be stimulated to cause bronchoconstriction.
86Takagi et al have also reported both alpha and beta
adrenergic receptors in guinea pig tracheo-bronchial tree
87and these observations have been confirmed . The 
existence of sympathetic bronchoconstriotor receptors in 
human airways has been more doubtful until Kerr et al^^ 
in 1970 reported that histamine induced bronchoconstriction 
in patients with asthma, could be inhibited by aloha 
receptor blocking drugs, phenoxybenzamine and phentolamine. 
This was probably the first indirect evidence of the 
presence of alpha receptors in the human airways. Recently 
Prime et al (l972)^^ and Simons son et al ( 1972)"^  ^have 
shorn that 8,1 pha- receptor stimulation can cause 
bronchoconstriction in Man, however the significance of 
alpha adrenergic activity in human a.irways, and especially 
in patients with asthma, has not yet been fully 
investigated.
3.8 Cyclic AMP, Cyclic Gf-'P and the Type I Alleryic Reaction 
The capacity of adrenaline to suppress the antigen 
induced wheal-o,nd~flare reaction in an allergic subject 
and histamine release from sensitised guinea nig lung was
91 92described forty years ago , but the mechanism was not
appreciated until Sutherland described cyclic AMP formation
93following beta stimulation. Groth and his associates
reported that adrenaline reduces the amount of histamine
released from guinea pig heart by anaphylactic challenge.
94Gubseouently, Lichtenstein and Margolis found that
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adrenaline acting through beta receptors inhibited the 
release of histamine from peripheral blood leucocytes of
allergic subjects when incubated with ragweed antigen.
95 96Assein and Schild Ishizaka et al and Orange, Austen
97and Austen extended these studies to human lung. These 
workers found an inverse relationship between the tissue 
levels of cyclic AÎ4P and the amount of histamine and 
S*R*3«-A. released. Beta agonists, Prostaglandin and 
methy1-xanthines and histamine itself increased 
intracellular levels of cyclic AMP and inhibited mediator 
release. Alpha stimulation, with phenylephrine or with 
adrenaline in the presence of pi'opranolol, reduced the 
level of cyclic AMP and increased the amount of mediator 
release .
Conversely, cholinergic agonists and 8 bromocyclic
guanosine monophosphate enhanced histamine- release, though
98they had no effect on levels of cyclic AMP'
Thus, in mast cells, as in airways, it appears that
the balance between cholinergic and beta adrenergic, as
well as the balance between alpha and beta adrenergic
activities, may play a critical homoestatic role.
3.9 Cyclic AMP, Cyclic GMP and the Bronchial Smooth Muscle
Catecholamines stimulate intracellular formation of
cyclic AMP in bronchial smooth muscle and cause 
99relaxation . Phosphodiesterase inhibitors act by 
preventing the hydrolysis of intracellular cyclic AT"'P.
The methyl-xanthines are the best known compounds with this 
property and asthma is frequently treated with Theonhyllino
44
^  100 compounds
Several substances such as acetylcholine, bradykinin 
and prostaglandin alpha, which cause bronchoconstriction 
in Man, are known to increase cyclic GMP forma/tion^^^.
The suggestion that cyclic GMP may be increased in tissues 
of asthmatics, thus facilitating bronchoconstriction and 
mediator release was made by Poison et who have shovm
that maninula.tions producing an asthma-like condition in 
rodents are associated with an increase in the levels of 
cyclic GMP in their lungs.
Lewis et al^^ have sho^m that the effect of cyclic GMP 
on smooth muscle function is dose dependents low 
concentrâtion producing tracheal smooth muscle contraction 
whereas higher concentration produces a dose dependent 
relaxation. This action of cyclic GMP can be explained by 
the influence of cyclic GMP on cyclic AMP nhosnhodiesterase; 
in low concentration cyclic GMP stimulates cyclic 
phosuhodiesterase, whereas in higher concentrations it 
inhibits cyclic AI'T hydrolysis^^^' .
It is possible to consider that at least in certain 
cells the concentrations of cyclic AMP and cyclic GMP may 
reflect the balance of beta adrenergic and cholinergic 
division of autonomic nervous system. The importance of 
such a relationship in asthma is evident. It has been 
suggested that cyclic AMP and cyclic GMP have a sort of 
recinrocal or Yin-Yang relationship in cell function^ '^^ '. 
Such a rolationshin may have a significant importance in 
the regulation of bronchomotor tone and chemicol mediator
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release in asthma.
3.10 Leucocyte Adenyl Cyclase Activity in Asthma
In addition to the above observations, an attempt has
been made to study the cyclic nucleotide metabolism in the
leucocytes of patients with asthma in relation to the
activity of the disease. It is believed that the
biochemical abnormality in asthma is not localised to
target organs but is generalised (table l), and therefore
studies on isolated viable leucocytes may provide a
99meaningful information
In 1970 Scott^ "^  ^renorted the presence of adenyl cyclase
activity on the human leucocytes and this has promuted
/ \ 99Smith and Parker (1970) to examine the adenyl cyclase 
system in intact leucocytes and its stimulation by 
isoprenaline in patients with asthma. Contrasting results 
have been reported on the leucocyte adenyl cyclase activity
107in asthma. Logsdon et al found that almost all their
patients had a diminished leucocyte adenyl cyclase activity,
whereas Gillespie et al^^^ were unable to demonstrate any
difference in leucocyte adenyl cyclase activity in asthmatic
99. 109patients and normal subjects. Smith and Parker ' 
renorted a diminished adenyl cyclase activity in natients 
with acute asthma but they could not demonstrate a 
significant difference in the leucocyte adenyl cyclase 
activity in natients in remission and normal subjects.
It still remains uncertain whether, in fact, the 
deficiency of beta receptor function or tho adenyl cyclase 
activity is the underlying cause of bronchial hyner-
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reactivity. If so, whether this defect is acquired or 
■inherited and does the adenyl cyclase activity vary with 
the degree of airways obstruction.
3.li Leucocyte ATPase Activity in Asthma
I 54. 55Coffey and his colleagues have shovm that
membrane bound divalent cationic dependent ATPase is 
activated by alnha stimulation and inhibited by alnha 
blocking drug, phentolamine. These workers^^'^ recently 
reported that and Ga’”’' dependent ATPase activities
were significantly increased in the leucocytes of asthmatic 
patients compared with sex-age matched normal subjects, 
ATPase activity in asthmatic patients could be significantly 
reduced by steroid therany. In addition, they have 
proposed that the adrenergic imbalance in asthma is 
associated with reduced adenyl cyclase activity and enhanced 
ATPase activity. This in turn facilitates mediator 
release in the tyne I allergic reaction and ad so increases 
bronchomotor tone in asthmatic natients.
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4.0 BRONCHIAL SrOOTÏÏ HUSOLB A70D AIRWAYS OBSTRUCTION tn AST^ RAA
4.1 An ato my of Bronchial Smooth Muscle
, Diseases associated with airways obstruction are
extremely common and are a major cause of morbidity a,nd 
mortality. It is important to know the structural 
arrangement of the bronchial muscle to understand the 
natho-nhysiology of obstructive airwavys disease. Varniers- 
(1779)^^^ was first to describe the ability of normal 
bronchi to contre,ct. Reisseins (l882)^ '^^  made an 
anatomical study of the bronchial musculature and described 
the bronchial smooth muscle. He pointed out that airways 
smooth muscle was so arranged thot it allows easy 
adaptation of rhythmic changes in airwa,ys dimensions which 
form an integral part of breathing. Toldt (l888)^ '^  ^gave 
one of the earliest and more detailed descriptions of the 
anatomy of bronchial musculature. He outlined that the 
muscle fibres in the bronchi are arranged in lattice-like 
form (gittorforrnige) , and dispelled earlier doscrintions of 
its forming a completely closed muscular tube^ '^"^  ^
Miller (1921)^ "^  ^confirmed Toldt’s descrintion and suggested 
that the muscle bands formed a network as 'geodesic', that 
is lying along the shortest mural uathway between any two 
points. He claimed that these geodesic bands prevent 
tangential motion and provide the greatest amount of 
strength, and at the same time allow the greatest amount of 
extension and contraction of the airways.
The present prevalent view is that the bronchial smooth 
muscle extends from the trachea down to the alveolar
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117duc-bs . In the bronchioles and alveolar ducts the muscle
' is thicker relative to the diameter of the lumen than in
the larger airways"^^^ Thus changes in
bronchomotor tone affect the diameter of" the small airways
more than that of large ones because of the greater muscle
mass of the small airways. The alveolar ducts contain
smooth muscle fibres arranged in rings and spirals around
the mouths of alveoli and the sphincter-like appearance of
the smooth muscle around the atria has been described by 
119 121, 122
various workers '  ^ ‘ , The - narrowing due to
muscle contraction at such a strategic site would be of 
functional significance and would lead to air-traoning,
4•2 Physiological Effects of Bronchoconstriction
The precise Physiological function of the airway smooth 
muscle remains undetermined. Radford and Lefooe (l955) 
suggested that airway smooth muscle does not contribute 
significantly in modifying lung recoil but indicated that 
bronchoconstriction might result in a decrease of effective 
lung volumes by closing off bronchial segments. Olsen et 
al (1967)^^^ found that constriction of bronchial smooth 
muscle increased both the circumferential and the 
longitudinal tensions in bronchi and they claimed that 
bronchoconstriction led to a; decrease in bronchial 
compliance with the result that the airways became less 
distensible and also less compressible. It would seem to 
■ .. indicate that in the constricted state a greater compressing 
force is necessary to close the airway than in the relaxed 
state. Olsen attributed this to the presence of
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cartilaginous plaques in the airway wall which are pulled
into an overlapping position when bronchi are narrowed, thus
increasing the rigidity of the airways. In bronchioles,
where cartilage is-absent, increase in the smooth muscle
tone could increase collapsibility and protect against 
12Sclosure * It is known that the stability of a nine is
related to the ratio of the thickness of its wall to its
internal diameters the greater this ratio the less
collapsible the pipe is. Hence, although it is quite
possible that maximal constriction of bronchial smooth
1?6muscle might lead to critical closure of the airways , a
smaller muscle tone might well help in improving airway
stability without producing complete obstruction in the
normal airways. Widdicombe and Nadel (1963)^^^ suggested
that smooth muscle tone may normally help to adjust the dead
space and airways resistance to values at which the
mechanical work of breathing is minimal.
4.3 Physiological Effects of bronchoconstriction in Asthma
For more'than 30 years aerosol of histamine and
cholinergic agonists have been known to cause vigorous
bronchoconstriction in patients with asthma. Normal
persons respond with slight transient bronchoconstriction
detectable with sensitive techniques but response of
patients with asthma is 100 to .1000 fold greater. Although
this airways hyper-reactivity in asthma was long recognised
37by clinicians, it was Tiffeneau who first measured 
Physiologically the airways response to inhaled 
acetylcholine in asthmatic patients. He demonstrated that
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asthmatic patients develop significant fall in Forced 
Expiratory Volume in 1 second (fW^) by inhaling small 
quantities of acetylcholine which failed to produce a 
similar fall in FJïïV,^ in normal subjects. In asthmatic 
patients this threshold of excitability can be reduced 
further by allergic reactions, bronchopulmonary infection, 
psychic trauma and inhaled irritants that stimulate a 
bronchoconstrictor response. In recent years, acute 
provocation tests in asymptomatic patients with asthma have 
been used to examine some of the functional abnormalities 
which occur during a spontaneous asthmatic episode. Cade 
et al^^ measured plethysmographic lung volumes, airways 
resistance, static elastic properties, dynamic compliance, 
together with standard spirometric lung volumes and gas 
mixing in young asymptomatic asthmatics before and after 
raethacholine inhalation. The results of their study 
suggested that both the large and small airways respond to 
provocation with methacholine. The larger airways apnear 
to respond faster than the smaller airways and the response 
of the smaller airways appears to be more prolonged.
It is now known that changes in airways resistance
128reflect changes in the large airways whereas FEV^ is 
determined mainly by the elastic recoil of the lung and the
resistance of the airways upstream from the equal nressure
IpA 129
points . In addition, Bouhuys and Woestijne have
suggested that reduction in maximum expiratory flow rate
with little change in airways resistance indicates
peripheral airways obstruction whereas a marked change in
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airways resistance with little effect on maximum expiratory 
flow rate and indicates obstruction in the central
airways. These authors reported two types of physiological 
responses in cotton workers following inhalation of cotton 
dust? one group (the "flow-rate" responders) there was a 
reduction in maximum expiratory flow rate and FEV^ with 
little change in airways resistance, whereas in the other 
group (the "conductance" responders) there was a rise in 
airways resistance hut little change in maximum expiratory 
flow rate or FEV^. Further, it was suggested that the 
difference in the site of airways obstruction induced by 
cotton dust may be due to an anatomical variation in the 
autonomic innervation in the bronchial tree.
The bronchial smooth muscle cells in patients with 
severe asthma show changes of hypertrophy and hyperplasia 
which extend from central airways to the terminal 
bronchioles^^^* i31j 132, 1^3^ The physiological effect 
of bronchial smooth muscle contraction due to various 
pharmacological mediators will depend on the site of 
contraction in these patients. The smooth muscle 
contraction occurring predominantly in the peripheral 
airways will give rise reductions in flow rates, F3T7^ , 
together with airways closure resulting in air-tranning, 
increase in static lung volumes and a diffusion defect.
On the other hand, smooth muscle contraction in the large 
airways will lead to an increase in airways resistance 
without affecting the elastic properties of lungs or lung 
mechanics. Because the effect is different depending on
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the site of constriction the methods that determine the
site are important.
The obstruction in the peripheral airways is difficult
to assess clinically and physiologically and this zone is
12Sconsidered a 'quiet' or 'silent' zone where disease 
process may smoulder on undetected. In recent years, 
measurements of closing volume^^^* and frequency
dependent complianoe^^^ have been described for early 
detection of peripheral, airways obstruction. The site of 
obstruction in asthma is not known,, although there is some 
evidence that in remission considerable obstruction may
1 -) "7 T T Q
affect peripheral airways ' whereas during an acute
attack the central airways are affected. If one imagines
that a division into "flow-rate" and "conductance"
129responders, as suggested by Bouhuys exists in asthmatic
patients, then' the patients whose airways constrict more 
readily at the peripheral may be at a greater risk of 
morbidity than a patient who is a "conductance" responder.
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5 • 0 STATEMENT QT'' THE
The review of literature supports the hypothesis that
/
the glycaemic, lactate, peripheral vasodilatation and
eosinopenic responses to adrenaline administration are
diminished in patients with asthma whereas cardiac and
free fatty acid mobilization responses are not (table I ).
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In light of Lands classification of beta adrenergic 
receptors, it is apnarent that beta-2 responses are the ones 
chiefly impaired in these patients. It still remains 
uncertain whether the diminished beta receptor function or 
the adenyl cyclase activity is the underlying cause of 
bronchial hyper-reactivity. If so, whether this defect is 
acquired or inherited and does the diminished adenyl 
cyclase activity vary with the severity of airways 
obstruction or is drug induced.
The other question which still remains unresolved is 
the presence of alpha adrenergic receptors in human airways 
and their role in the control of bronchomotor tone. There 
is a vast amount of literature on the presence of alpha 
adrenergic receptors in smooth muscles of blood vessels and 
their function in control of blood pressure. However, in 
the most recent editions of Physiology and Pharmacology 
textbooks^^^' there is a delightful blank so far as
alpha receptors arc concerned in the bronchial smooth 
muscle. The main theme of the first part of this thesis is
PART I (physiological)
(a) To find more direct evidence of the presence of aloha 
adrenergic receptors in the human lung and their role
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in the control of bronchomotor tone in normal subjects 
and asthmatic natients.
(b) In addition, to study the effect of alpha adrenergic 
blocking drugs on (i) histamine, (ii) methacholine, 
(iii) Prostaglandin alpha, (iv) allergen, and
(v) exercise induced bronchoconstriction in patients 
with extrinsic asthma, and
(c) to assess the theraneutic significance of aloha 
receptor blocking drugs in the management of asthma,
(d) The place sodium cromoglyoate in management of 
extrinsic bronchial asthma is now well established. 
Although it has been shown to be effective in 
preventing mast cell degranulation in the tyoe I 
allergic reaction^^^ and inhibiting both the 
allergen^^^' and exercise induced^^ broncho­
constriction the mechanism of its action is still 
uncertain. There is some suggestion that sodium 
cromoglyoate is a cyclic nhosnhodiestorase inhibitor ■ 
and may act by increasing the intracellular levels of 
cyclic  ^ The effect of sodium
cromoglyoate has been studied in Prostaglandin
alpha and post-exercise bronchoconstriction to comnare 
its effect to aloha receptor blocking drugs.
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Site of Bronchoconstriction
It has been reported that nervously mediated
bronchoconstriction may operate at a different site in the
airways from humoral bronchoconstriction^^^^
Histamine or a histamine releaser (48/80) injected into the
right atrium has been shown to cause constriction of
peripheral airways and alveolar ducts without affecting
the calibre of the larger conducting airways, Vagally
mediated bronchoconstriction, on the other hand, causes
bronchoconstriction in the larger airvrays, there being
little effect in the peripheral airways^^^^ Bouhuys
129and Woestijne have postulated that individual variations 
in airways response to histamine and hemp dust in cotton 
workers is principally determined by variations of 
sympathetic tone. According to this hypothesis a subject 
with peripheral airways bronchoconstriction or 'flow-re,te 
response' may have relatively few sympathetic fibres in 
peripheral airways so that the beta adrenergic activity 
might be insufficient to counteract the bronchoconstrictive 
effect of histamine or hemp dust in these airways. 
Conversely, in a subject with conductance response, the 
sympathetic distribution might be predominantly to smaller 
airways. This raises a question whether asthmatic 
patients show such differing airways responses following 
various provocation tests, i.e. beta blockade with 
propranolol or inhalation of histamine, methacholine, 
Prostaglandin alpha or allergen challenge. To answer 
this question airways resistance and are measured
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simultaneously during various provocation tests in patients 
with asthma and the sequence of these changes assessed.
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PART II (Biochemical)
•Leucocyte Adenyl Cyclase Activity in Asthma 
j There have "been conflicting reports on the leucocyte
adenyl cyclase activity in patients with asthma^^^' 108, 309^  
These differences are probably arising from patient 
selection and failure to assess the severity of airways 
obstruction at the time of leucocyte adenyl cyclase assay.
A more detailed physiological and clinical assessment of 
patients to relate the leucocyte activity to the activity 
of asthma is required to elucidate the differences. The
aim of Part II of the project is to study in detail
(a) the leucocyte adenyl cyclase activity in patients 
, with extrinsic asthma in relation to their symptoms
and the degree of airways obstruction. In addition,
(b) the effect of alpha receptor blocking drugs, 
phentolamine and thymoxarnine, on isoprenaline 
stimulation of the leucocyte adenyl cyclase activity, 
and also
(c) Ouabain, a K*** Na'*' activated ATPase inhibitor, on
isoprenaline stimulation of the leucocyte adenyl
cyclase activity.
Lymphocyte Guanyl Cyclase Activity in Asthma
101Although Poison et al ' have suggested that enhanced 
guanyl cyclase activity may increase mediator release and 
bronchoconstriction in asthma, studies of cyclic GkP in 
asthmatic patients are lacking. It has recently been 
reported that guanyl cyclase activity is present in various 
tissues including human lung and lymphocytes. In the
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preliminary time-course experiments it was established 
I that the lymphocyte guanyl cyclase activity measured was 
membrane bound. To investigate the proposed hypothesis
(a) lymphocyte guanyl cyclase activity and the response 
to alpha and cholinergic stimulation in asthmatic 
patients and normal subjects is investigated.
(b) In addition, the effect of alpha receptor blocking 
drug, thymoxarnine, on guanyl cyclase activity is also 
studied.
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CHAPTER II 
METHODS
PART I (physiological Experiments)
6.0 PATIENTS AND NORMAL SUBJECTS 
Patients
Forty patients, aged between 11 - 43? with extrinsic 
bronchial asthma and reversible airways obstruction have 
been studied. These patients had nositive skin tests to 
inhalant allergens such as house dust, house dust mite 
(bermatophagoids pteronyssinus), grass pollens or feathers, 
a blood eosinophil count of over 500 cells/cu.mm. and an 
IgS level above 100 ng./ml. Sixteen patients had 
associated atopic diseases such as eczema, allergic rhinitis 
or hay fever, and in twelve patients there was a.family 
history of atopic diseases. Detailed clinical data on 
ten of these patients, selected- one from each section, is 
presented in the Appendix.
Some of the natients were on daily maintenance therapy 
with bronchodilators, sodium cromoglyoate or corticosteroids 
either given orally or as aerosol (beclamethasone 
dipropionate), All therapy was discontinued for at least 
24 hours before each experiment.
Hormal Subjects ,
Twenty two normal subjects, aged between 19 - 43 years, 
have also been studied as a control,group. These subjects 
were volunteers, they had no resniratory disease, and no 
personal or family history of bronchial asthma or atonic 
disease.
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Informed Consent
The procedure of experiments was explained to all
!
patients and normal subjects, and an informed consent was 
obtained in each case. In the study of exercise induced 
asthma, which is more common in children, I have included 
patients v/ho are below 18 years of age. In these patients, 
the procedure involved was explained to their Parents and 
informed consents were obtained from them.
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7.0 AIHEATS MECHANICS
7.1 Measurement of FEV. and Airways Resistance
A number of methods of quantitatively expressing the 
rate of delivery of the forced vital capacity are used in 
assessing air flow obstruction in asthma. The most popular 
is to measure the volume expired in the first second (FEV^) 
with a spirometer and kymograph. Forced Expiratory Volume ■ 
in 1 second (FEV^) is a much more sensitive index of 
severity of airways obstruction than vital capacity. In 
subjects with good motivation, the readings obtained are 
reproducible and. show less than lOfc variability.
I used a dry air wedge spirometer manufactured by 
Vitalograph Limited, Buckingham, England. This spirometer 
is portable and is easy to operate. The tracing obtained 
on a calibrated chart is clear and can be kept for future 
reference. The calibration of the spirometer is checked 
periodically using one litre plastic syringe.
The forced expiratory manoeuvre was explained and 
demonstrated, to each participant. Only after ascertaining 
that the subject fully understood the procedure, and that 
he had good motivation, was he included in any of the 
experiments described. Three tracings of FEV^ were 
recorded at each step of the experiment and the highest 
value of FEV^ was taken as the result for the event. The 
vitalograph chart is calibrated at Ambient Temperature 
Saturated water vapour pressure (ATPS) and therefore 
requires only the temperature correction to convert the 
FEV^ at Body Temperature Saturated water vauour pressure
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(dtps).
The resistance of the airways to the air flow through 
them depends on the radius, length and number of airways.
The body plethysmography affords a good technique for 
measuring airways_resistance (Raw) and thoracic gas volume 
(Vtg). ' The principle and design of a constant volume body 
piethysrnograph has been described in detail by Dubois and
148, 149his colleagues ^
The body plethysmograph (Pig. l) which I used is a 
constant volume type and was constructed by the Denartment 
of Regional Physics and Bio-Engineering, Greater Glasgow 
Health Board. It is a 65O litre airtight wooden box with 
a perspex window. The flow rate is measured by a Fleish 
pneumotachograph (range 0 - 50 litre) and a micromanometer 
pressure transducer (Greer Mercury Electronics (Scotland) 
Limited? range - 10 mm. H^O). Pressure changes within the 
box are measured by a similar micronanometer (range - 3 mm. 
HgO), and both signals are amplified and disulayed on the Y 
and X axis of a Lanscope ÎÜe II oscilloscope. Pressure on 
the mouth side of the shutter is measured by a third Greer 
pressure transducer (range - 30 cm. H^O) and recorded oh 
the Y axis of the same scope spot.
A subject sits in the body plethysmograph and as soon 
as the door is closed the pressure within the box rauidly 
rises as the air inside is warmed and humidified by the 
subject. During this initial neriod the box is vented 
periodically to the room outside by means of a solenoid 
ouerated valve until the pressure drift with the door closed
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fifi. 1. Constant volume body plethysmograph.
is so slight that it does not interfere with the 
measurements. The subject then apnlies a nasal clip and 
pants shallowly through the pneumotachograph at 
approximately two cycles per second and a flow rate of 0,5 
litre per second. During the panting manoeuvre the slope 
of the line generated on the oscilloscope is o.ir flow 
divided by box pressure. This is rapidly aligned by a 
moving graticule on the oscilloscope face. The angular 
movement of the graticule is integrated so that the tangent 
for a given angle can be read directly on a visual display 
(tan @^). This modification simplifies the test procedure 
and numerous estimations can be carried out in a short 
period. A foot switch is then operated to occlude the 
pneumotachograph while the subject is panting, and also to 
alter the signal on the Y axis from air flow to mouth 
pressure. The slope now displaced on the oscilloscope is 
mouth pressure divided by box pressure and the tangent of 
this angle is road by the same technioue (tan 0 ). Raw
C
can be calculated by dividing the flow rate by mouth
pressure, i.e. the mouth pressure ( ^g). The
tan 0-^
resistance of pneumotachograph at a flow rate of 0.5 litre 
per second is- O.48 litres/cm.H^O sec. and this value is 
subtracted from the total resistance to give Raw of the 
subjects. The thoracic gas volume (Vtg) is calculated 
from the mouth pressure measurement (tan 6^) as outlined 
by Dubois et al (1956)^^^.
The result of Raw is expressed as Specific Airways 
Conductonce (sOaw) which is derived by dividing the
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reciprocal of Raw by the thoracic gas volume at which Raw
is measured (SGaw = 1 ). This index is useful in
/ Raw X  Vtg
comparing individp.al subjects of differing size and is now
/ generally accepted as a standard method of expressing
airways resistance.
■ The technique of panting was demonstrated by a trained
technician to eanh subject on his first attendance. He
was asked to practice panting until satisfactory and
reproducible slopes were recorded. A mean of four
recordings was taken to give 8Gaw for each step of the
experiment. The calibration of signals on the
oscilloscope were checked daily. The calibration factors
of the body .plethysmograph are as followss
Flow t 2 0 0  litres/mill. = 10 cm. deflection on Y
axis of oscilloscope (Pressure range -
10 mm. HgO).
Mouth Pressure: 200 mm. H^O - 10 cm. deflection Y axis
(Pressure ronge - 30 cm. H^O).
Box Pressure t 50 ml. injected at 2 cycles/sec. = 3 0 cm.
deflection X axis (Pressure range - 3 mm.
HgO).
7.2 Methods of Nébulisation
Drugs given by inhalation were nebulised with a 
Wright's nebuliser using compressed air at a flow rate of 
8 litres per minute and cylinder pressure not less than 
10 lbs. per so. in. A Wright's nebuliser has a capacity of 
15 ml. and 8 - l6 ml. of water can be nebulised per hour.
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As this volume varies between nebuliscrs, the rate of 
nébulisation of the three nebulisers used during this study 
were calibrated and the time taken to nebulise 1 ml. of 
normal saline was marked on each. A short vinyl tubing 
connected the nebuliser to a face mask (polymask or Hudson 
mask). ■ The length of the tubing was kept short so that a 
subject could hold the nebuliser in front of his face and 
this also avoided excessive condensation of the aerosol 
along the length of the tubing.
The subject wore a-comfortable mask and was asked to 
breathe deeply and evenly through a widely open mouth.
The volume of drug nebulised was calculated from the 
difference in the volume of drug before and after 
nébulisation. By this method it is only possible to 
measure the amount of drug nebulised. The exact amcunt 
of drug going into the lung is difficult to assess as this 
has been known to vary greatly, and even with the best of 
techniques the amount reaching the lungs does not exceed 
10/?. Some amount of drug is also absorbed from 
buccopharyngeal mucosa and from gastrointestinal tract. 
Sodium cromoglyoate and nhenoxybenzamine were administered 
through a spinhaler (Fisons Pharmaceutical Limited).
7,3 Drugs Used
Histamine dihydrochloride and methacholine chloride 
were obtained in powder form and dissolved in distilled 
water to give a concentration of 200 ugm, per ml. and 
2*5 mgm. per ml. respectively. These solutions were made 
UP fresh before the experiments.
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stock drugs used were Oo5f- phenyleobrino hydrocbloride 
.solution (’.Roots Pure Drug Company Limited, U*K.) , 
Propranolol (l.G.I, Limited, U.K.), 1.5/ thjnnoxamine 
hydrochloride (W. R. Warner & Company Limited), 
phonoxyhenzamine powder (Smith, Kline & French La’boratories 
Limited), 0,5/- phentolamine (CIBA Laboratories Limited), 
sodium cromoglyoate (Fisons Pharmaceutical Limited), 0.06/ 
adropine sulphate (Antigen Limited, Ireland), Prostaglandin 
Fg alpha (Armour Pharmaceutical Company Limited), allergen 
inhalation test solutions (Bencard Division, Beecham 
Research Laboratories Limited, U*K.) and 1/ Isoprenaline 
solution (BeP.C.). Prostaglandin F^ alpha was diluted 
to give a final concentration of 50 ugm, per ml., and the 
antigen solution was diluted in water to give a 
concentration of 500 protein nitrogen units (pnu) per ml.
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8.0 ALPHA REOEPTOHE IN ASTHMA
8.1 ResDonse to Phenylenhrine After Blockade of Aloha end Beta/  —      —  —        -----
Adrenergic Receptors
•.lun Jtisi'ii n IIM I III I ii "■•f'»
Six patients, aged between 15 ~ 23 years, with 
extrinsic bronchial asthma and five normal subjects, aged 
between 19 - 26 years, were investigated. After recording
the baseline and 8Gaw each subject inhaled 5 mgm, of
phenylephrine hydro chloride solution (0.5/) through a 
Wright's nebuliser. PEV^ and 8Gaw measurements were 
repeated 5 minutes after the end of inhalation. All 
subjects were then given propranolol orally. Normal 
subjects received 120 mgm. while asthmatic patients
received 20 - 30 mgm. PEV^ and 8Gaw were recorded 45 and
60 minutes after propranolol administration. At 60 minutes 
phenylephrine■inhalation was repeated and thereafter the 
PEV^ and 8Gaw were recorded at 2, 5 S'Hd 10 minutes.
Asthmatic patients inhaled 80 ugm. of isoprenaline aerosol 
at the end of the test and PEV^ and 8Gaw were recorded 10 
minutes later.
The procedure described above was repeated in the six 
asthmatic patients. At the time they were given 
propranolol each patient inhaled 10 mgm. of phenoxybenzamine 
hydrochloride dispensed in a capsule with 20 mgm. of lactose 
from a spinhaler. In four patients the test was repeated 
after inhalation of 15 mgm. of thymoxarnine through a 
Wright's nebuliser. Thymoxarnine was not tolerated by two 
further patients because of its bitter taste and throat 
irrita-tion.
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The effect of 5 nigm. of phenylephrine hydrochloride 
on FEV^ and SGaw after prior beta blockade with 5 mgm. o.f 
nroDranolol was studied in ten more patients with extrinsic 
asthma. After recording the baseline PEV^ and 8Gaw,
5 mgm. of propranolol was given intravenously to each 
patient and FEV^ and 8Gaw measured at 5? 10, I5 and 20 
minutes. At 20 minutes, 5 mgm. of phenylephrine 
hydrochloride was given by inhalation and thereafter the 
FEV.j^  and SGaw were recorded at 2, 4, 6 and 8 minutes. 
Asthmatic subjects inhaled 80 ugm. of isoprenaline aerosol 
at the end of the test and FEV^ and 8Gaw were rocorded 10 
minutes later. Similar procedure was carried out in five 
normal subjects 3)ut these subjects received 10 mgm. of 
propranolol intravenously.
8.2 Response to Phenylephrine After Prior Beta and Oholiner,gic 
Blockade
It has been suggested that propranolol induced
bronchoconstriction in asthmo.tic patients may be mediated
] 23
through vagal over-activity' '. Under such a situation 
it can be argued that the bronchoconstriction induced by 
phenylephrine in presence of beta blockade is due to a 
non-specific effect of this drug on irritant cholinergic 
receptors in the airways, and not due to its specific alpha 
receptor activity. To clarify this further, six patients 
with extrinsic bronchial asthma were investigated. The 
test procedure was similar to the one described in the 
previous experiment. After establishing the baseline 
8 G aw, each subject inhaled 1.2 mgm. of atropine an.lphato
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from 0, Wright's nebuliser. 8 G aw was measured at 2, 5 ard
10 minutes. At 10 minutes, each patient received p mgm.
of propranolol intravenously and the test procedure
thereafter has been described above.
• 3/ ■Thymoxarnine in Histamine Induced Bronchoconstriction
In 1970, I reported that histamine induced
bronchoconstriction can be inhibited by alpha receptor
blocking drugs, phentolamine and phenoxybenzamine.
However, both these drugs have additional effects and
criticism was raised at the time that the observed effects
could have resulted from antihistaminic and atronine-like
activities of phentolamine and phenoxybenzamine.
In recent years a new alpha receptor blocking drug,
thymoxarnine, has been introduced in clinical practice.
The pharmacology of thymoxarnine was described by
Birmingham and Szolcsayni (1965)^^^ and its relation to
phentolamine by Brownlee (1966)^^^ . It is the most
specific alpha receptor blocking drug and is without the
mixed action seen with other alnha receptor blocking drugs,
such as phenoxybenzamine and phentolamine. Our
observations of alpha receptor blockade on histamine induced
bronchoconstriction have been confirmed by others using 
15? 153thymoxarnine . To confirm these observations eight
patients with extrinsic bronchial asthma, aged between 
15 - 30 years, were investigated.
Hist am i ne te s t
After establishing the baseline FEV^, each subject 
inhaled normal saline for 2 minutes through a '■Iright's
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nebuliser, FE37^  was recorded at 5 and 10 minutes after 
placebo inhalation. At 10 minutes, each patient inhaled
I
200 ugm. of histamine dihydrochloride through a Wright's 
nebuliser. PEV^ wan reoord.ed at 2 minutes after 
inhalation and thereafter at regular intervals for 30 
minutes.
The test Procedure described above was repeated in the 
eight asthmatic patients. On this occasion, each patient 
inhaled 15 mgm. of thymoxarnine hydrochloride (1.5"^'^ solution) 
through a Wright's nebuliser instead of normal saline.
8.4 Thymoxarnine in Methacholine Induced Bronchoconstriction 
Although acetylcholine, the cholinergic neuro­
transmitter, is not released during, allergic reaction, it
37has profound effects on the airvjays of asthmatic patients
45According to Szentivayni bronchial hypor-reactivity to 
chemical mediators and acetylcholine results from a 
functional imbalance between the alpha and beta adrenergic 
receptors in the airways. In order to assess the role of 
alpha receptors on the bronchial hyper-reactivity to 
cholinergic agents, I studied eight patients, aged between 
15 " 30 years, with extrinsic asthma.
Methacholine inhalation test
The procedure for this test was exactly the same as 
for the histamine inhalation test. Instead of histamine 
the patient inhaled 800 ugm. of methacholine chloride 
(2.57- solution) through a Wright's nebuliser. The test 
procedure was repeated in the eight patients after 
inhalation of 15 vngm. of tlp/Tfioxamine hydrochloride through
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a Wrightnehuliser. îï’SV^ was measured to assess the 
effects.
8.5 Thytnoxamine. Atrouine and Sodium Orornoglyoate in
Prostaglandin aloha Induced 'Bronchoconstriction
In recent years there has been a.n increasing interest
in the role of nrostaglandin a.lnha in the pathogenesis of
asthma. Prostaglandin F^ is released from mammalian
lungs during anaphylactic reaction and by various chemical
15 3 54and mechanical stimuli'^? . Prostaglandin F^ aloha is a
potent bronchoconstrictor to which patients with asthma are
• exquisitely sensitive. Recent biochemical work has
suggested that the effect of prostaglandin F^ alpha may be
mediated through guanyl cyclase system, which is known to
be activated by cholinergic agents^^^ and also by alpha
6?receptor stimulation In light of these observations,
I studied the effect of prostaglandin F^ aloha by inhalation 
on FW^ and SO aw in six patients, aged between 15 - 37 years, 
with extrinsic bronchial asthma, and tested the effect of 
thymoxamine, atrooine and sodium cromoglycate (sCfl) on 
prostaglandin F^ alpha induced bronchoconstriction in these 
patients.
Procedure
After establishing the baseline FEV^ and SGaw, each 
patient inhaled 0*5 ml. of prostaglandin F^ alpha (50 ugm. 
per ml.) solution through a Wright's nebuliser. FFV^ and 
SGaw measurements were recorded 2 minutes after the 
inhalation, and thereafter at 5 minute intervals for 25 
minutes.
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The test procedure was repeated three times in all
’2patients. Ten minutes before the prostaglandin alnha/
inhalation, each received 1.2 mgm. of atropine sulphate or 
40 mgm. of sodium cromoglycate or I5 mgm, of thymoxamine 
hydrochloride. Atropine sulphate and thymoxamine were 
given by inhalation through a Wright's nebuliser and sodium 
cromoglycate was inhaled using a spinhaler.
8.6 Thymoxamine in Allergen Induced Bronchoconstriction
It ha.s recently been shown that alpha receptor 
stimulation enhances histamine relea.se from sensitised human 
leucocytes in the type I allergic reaction. To extend 
this experimental observation to in vivo situation, I 
studied the effect of thymoxamine given intravenously and 
by inhalation on allergen induced bronchoconstriction in 
ten patients, aged between 18 - 46 years, with extrinsic 
bronchial asthma.
Allergen inhalation test
Standard solutions of house dust or pollen extract 
(500 protein nitrogen units per ml.) were used. After 
recording the baseline SGaw, each patient received 2 ml. of 
sterile normal saline intravenously. Five minutes later 
he inhaled an appropriate allergen solution through a 
Wright's nebuliser until he developed symptoms of airways 
obstruction, SGaw was recorded 5 minutes after the 
inhalation and thereafter at regular intervals for 60 
minutes. On s, different day (allowing ah'least three days 
between tests), the allergen inhalation tost was repeated 
in each patient after intravenous administration of
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thymoxamine (O.l mgm. per kg. body weight). In two 
patients (ho. 3 and 10 - Ta.ble Kt.V'/rt) 9 allergen challenge was
/
repeated after inhalation of 15 mgm. of thymoxamine (l.5r) 
through a Wright's nebuliser. In one patient (ho. lO) the 
dose of allergen inhaled after thymoxamine was doubled.
8.7 Thymoxamine in Post-Exercise bronchoconstriction
Exercise induced bronchoconstriction is a well
■ 155recognised phenomenon in bronchial asthma and in some 
patients exercise may act as the predominant or even the 
only precipitating stimulus of bronchoconstriction. The 
mechanism of exercise asthma still remains uncertain.
One possibility is that noradrenaline, a powerful alpha 
receotor agonist, released during strenuous exercise may 
give rise to alpha stimulation and lead to broncho­
constriction.
To test this hypothesis, thirteen patients, aged 
between 11 - 23 years, with extrinsic bronchial asthma who 
developed post-exercise bronchoconstriction were studied.
Ill addition, the effect of sodium cromoglycate was compared 
with that of thymoxamine.
Exercise test
It has recently been reported that high efficiency 
negative work, namely running at near maximal work loads 
for 8 minutes, proves as a more potent stimulus for 
bronchoconstriction than other patterns of exercise 
tests^^^. Using this method, exercise tests were carried 
out in symptom-free periods. Each test consisted of
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steady state exercise of running on an inclined treadmill 
.(10°) for up to 8 minutes. The speed of the treadmill was 
adjusted so that the patient’s pulse rate at the end of 
exercise was at least I80 per minute. was recorded
at 2 minutes after exercise and thereafter at regular 
intervals for the next 30 minutes.
In these thirteen patients, the test was repeated 
after inhalation of saline, thymoxamine and sodium 
cromoglycate. The order of drug treatment was randomised. 
In the control test, the patient inhaled normal saline 
through a Fright's nebuliser. The exercise test was 
repeated in each patient on different days after inhalation 
of 15 mgm. of thymoxamine hydrochloride solution (1.5^  
solution) or 40 mgm. of sodium cromoglycate through a 
spinhaler 15 minutes before exercise.
Alpha Receptor Blocking Drugs Alone and in combination with 
Isoprenaline on the SGaw
In vitro biochemical studies (discussed in Part II), 
it was noted that diminished beta recentor function in the 
leucocytes could be restored towards normal by alpha 
receptor blocking drugs, thymoxamine and phentolamine,
To investigate the therapeutic implication of this 
biochemical observation, I studied the effect of alnha 
receptor blocking drugs, thymoxamine and phentolamine, in 
ten patients, aged between 17 - 43 years, with extrinsic 
bronchial asthma. Each patient inhaled normal saline,
15 mgm. of thymoxamine (1.55)9 0*5 ml. of isoprenaline
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(ly) or a mixture of 0.5 ml. of isoprenaline and 1 ml « of 
thymoxamine through_a Fright's nebuliser. The order of 
inhalations was randomised. SGaw was measured before the 
inhalations and at 5 minute intervals for 30 minutes after 
each, treatment. In three patients, who developed 
bronchospasm after thymoxamine administration, the test was 
repeated after inhalation of 5 mgm. of phentolamine (0.5/^ ).
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9.0 PHYSIOLOGICAL Eli'FEGTS OF BRONGTIOCONSTRICTIOH
9.1 The Site of Bronchoconstriction and the Relationshin of
Res no rise to Initial Bronchomotor Tone
It is known that airways resistance predominantly
reflects changes in large airways whereas FFV^ is determined
mainly hy the elastic recoil of the lung and the resistance
129of the peripheral airways' . To study the effects of 
histamine, methacholine, allergen challenge, propranolol 
and prostaglandin F^ alnha on the airways of asthmatic 
patients FFV^ and SGaw were measured simultaneously after 
various nrovocation tests. The dose .of hronchoactive agent 
used and procedure of inhalation has been described in the 
previous section. The number of patients studied in each 
group is as followss 
ho. of Patients Age range Bronchoactive agent Dose
16 15 *” 37 years Histamine dihydrochloride 200 ugm.
15 15 “ 37 years Methacholine chloride 8OO ugm.
15 15 - 44 years House dust or grass
pollen 150 unu
12 15 -* 30 years Pronranolol 5 mgm. IV
7 15 - 23 years Prostaglandin F^ alnha 8-ugm.
(pnu s Protein nitrogen units)
Analysis of data
1. The mean percentage fall in FSV^ and SGaw ind.uced by 
each agent was plotted against-time to assess time 
sequence of airways responses.
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To investigate whether the absolute fall in and
SGaw had any relationship to the baseline and
SGaw, the changes were plotted against baseline values 
and correlation factors calculated. To do this the 
results of 65 tests with various agents were nooled.
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CHAPTER III 
RESULTS 
Physiological Experiments
10.0 ALPHA RECEPTORS IN ASTHMA
10.1 Response to Phenylephrine After Prior Blockade of Alnha and
Beta Receptors
This investigation was designed to study the effect of 
alpha stimulation on the airways of patients with extrinsic 
bronchial asthma and normal subjects. The mean results 
are given in tables II and III. In six patients, first 
phenylephrine produced a significant bronchodilatation and 
an increase in the mean FEV^ and SGaw by lOfS and 
respectively (p<.005). Following oral propranolol, the 
mean FEV^ fell by l8*^  and the mean SGaw by 51/^ at 60 minutes
(p<.05). Phenylephrine inhalation repeated at 60 minutes
produced bronchoconstriction and a further fall in the mean 
FE\r^  by l ' ] f and the mean SGaw by 195'. The fall in FEV^ 
and SGaw observed at 2, 5 und 10 minutes remained significant 
throughout the test as compared to readings at 60 minutes 
before the second phenylephrine inhalation (P<.005 and 
<■,001). Isoprenaline inhalation at the end of the 
investigation increased the mean FEV^ by 2 2 %  and the mean 
SGaw by l?ÿ, however, the mean FSV^ was still 12/ and the 
mean SGaw below the baseline recordings (Figs. 2 and 3)* 
In five normal subjects the mean FEV^ did not change 
significantly after inhalation of phenylephrine nor was 
there any significant change in FEV^ and SGaw uroduced by 
beta adrenergic blockade Qp^.lO). In each subject, after
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3.20 of propranolol, repeat inhalation had little
effect on or SGaw (tables IV and V, Fig. 4)»
As in the control experiment, the first inhalation of 
phenylephrine produced hronchodilatation and an increase in 
the mean FFV^ and. SGaw hy 9 %  and 295' respectively. After 
pronranolol administration and phonoxyhensamine or 
thymoxamine the mean FEV^ fell hy lO^ i and the mean SGaw hy 
19a’ 5,t 60 minutes. The mean fall in FSV.j^  and SGaw effected 
by pronranolol, phenoxyben%amine or thymoxamine was smaller 
than that observed when pronranolol was given alone.
However, the difference in the results was not statistically 
significant (p>.10). Phenylephrine inhalation reneated at 
60 minutes produced bronchodilatation and an increase in the 
mean FSV^ by 8f5 and the mean SGaw by 14a* The resnonse to 
phenylephrine in the presence of alpha and beta blockade 
was significant compared to the effect of phenylephrine in 
the presence of beta blockade alone. Isonrenaline 
inhalation at the end of the test increased the mean FTT/^  
by 5a and the mean SGaw by 225 * The mean FEV^ was 35 ond 
the mean SGaw 175 above baseline recordings (Figs. 2 and 3, 
tables VI and VIl).
Additional exneriments
The effect of alpha stimulation on the FEV^ and SGaw 
was studied in a further 10 patients with extrinsic asthma 
and 5 normal subjects. The results of this investigation 
are given in tables VIII and IX.
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Beta adrenergic blockade with 3 nigm. of pronranolol 
given intravenously produced a significant fall in the moan 
FEVj and SGaw in 10 patients with extrinsic asthma (P< .OO5 
and <.00l), the fall in the mean FEV^ and SGaw being 20% and 
41^ resnectively at 20 minutes after pronranolol
administration. Phenylephrine inhalation at 20 minutes/
produced bronchoconstriction and a further fall in the mean
FEV^ by 155 and the mean SGaw by 275' (Pig* 5? P< .001).
Isoprenaline inhalation at the end of the investigation
increased the mean FEV^ by 15a and the mean SGaw by 28f-,
however, the mean FEl/^ was still 19/ and the mean SGaw 31f
below the baseline readings.
In the 5 normal subjects 10 mgm. of pronranolol given
intravenously failed to cause a significant change in the
mean FEV^ and SGaw, and phenylephrine by inhalation at 20
minutes also failed to cause a significant change in both
the FEV^ and SGaw (table X, Pig. 6).
10.2 Response to Phenylephrine After Prior Blockade of Beta and
Cholinergic Receptors
There is a possibility that bronchoconstriction caused
by phenylephrine in the previous investigation could have
resulted from stimulation of irritant cholinergic receotor 
1R8in the airways . To rule out this possibility airways 
response to Phenylephrine after prior beta and cholinergic 
blockade was studied in six patients with extrinsic bronchial 
asthma.
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Fig. 6. Effect of phenylephrine inhalation on the mean FEV.
and SGaw after prior "beta adrenergic blockade in 
5 normal subjects.
The results of this investigation are given in table
XI. In six patients, atropine by inhalation produced, a
/
significant bronchodilatation and an increase in the meau 
SGaw by 53/'- at 10 minutes. After propranolol 
administration, the mean SGaw fell by lO^ o at 20 minutes. 
Phenylephrine inhalation in the presence of beta and 
cholinergic blockade caused bronchoconstriction and a fall 
in the mean SGaw by 33G. The fall in SGaw observed at 2, 
4, 6 and 8 minutes remained highly significant throughout 
the test as compared to readings at 20 minutes before 
phenylephrine inhalation (p < .001). Isoprenaline 
inhalation at the end of the investigation increased the 
mean SGaw by 41^ (Pig. 7)®
10.3 Thymoxcimine in Histamine Induced bronchoconstriction
The results of this investigation are given in table
XII. Histamine dihydrochloride given by.inhalation 
caused a significant fall in the mean PEV^ in 10 patients 
with extrinsic asthma. The maximal fall in PP7^ was 40y'- 
and occurred at 2 minutes after the inhalation,
’n o ^Thereafter there was a gradual restitution in the PW.
in the following 30 minutes. In presence of aloha 
blockade with thymoxamine, histamine inhalation produced a 
smaller fall in PEV^ as compared to the fall in P:P/^  
produced by histamine alone. The maximal fall in 
was 208' at 2 minutes and thereafter there was gradual 
restitution in the PEV^ in the following 30 minutes 
(pig, 8). The inhibiting effect of thymoxamine on 
histamine induced fall in the PEV. was statistically
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significant (P <.05)« The results of this investigation 
.suggest that alpha 'blockade can inhibit histamine induced 
' ^ "bronchoconstriction in patients with asthma.
10.4 Thymoxamine in Methacholine Induced Bronchoconstriction
I The results of this investigation are given in table
XIII. In eight patients, 800 ugm. of methacholine chloride, 
a powerful cholinergic agonist, produced a significant fall 
in the mean The maximal fall in the mean P13V^  was
41 A' and occurred at 2 minutes (Pig. 9)» The fall in 
was highly significant (P < .OOl), ■ In the following 30 
■ minutes there was a gradual restitution in the PE'V'^ .
In these eight patients, thymoxamine given by 
inhalation did not produce a significant change in the mean 
PEV^ and methacholine inhalation 10 minutes later oroduoed 
a maximal fall in the mean of 47^-^ at 2 minutes.
There was no significant difference between the meocimal 
fall in PPV^ produced "by methacholine alone and that 
produced by methacholine after pre-treatment with 
thymoxamine (p >  .10). These results suggest that 
thymoxamine had no effect on methacholine induced broncho­
constriction (pig. 9)*
10.5 Thvmoxamine, Atropine and Sodium Gromoglycate in 
Prostaglandin P^ Aloha Induced Bronchoconstriction
The detailed results of changes in PEV^ and SGaw 
produced by prostaglandin P^ alpha and the effect of 
various drug treatments in six patients are -given in tables 
X I V  and XV. Prostaglandin Pp aloha inhalation nrcduced 
maximal fall in the mean P'tV^  and SOaw of 32^ ' and 93'
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respectively which occurred at 5 minutes after inhalation. 
The falls in and SGaw were highly significant (p <...01
and P < .001). In 25 minutes thereafter there was a 
gradual restitution in both the PEV^ and SOaw (Figs. 10 
and 11).
In these six patients atropine sulnhate by inhalation 
increased the mean FEV^ and 80aw by 9/^ and 679^ respectively 
and the bronchodilatation produced by atropine wa,s 
significant (P < .025). Prostaglandin inhalation 10 
minutes later produced ‘a fall in the mean FEV^ and 80aw of 
10> and 20^ 6 respectively. There was a statistically 
significant difference between the maximal falls in FEV^ 
and SOaw produced by prostaglandin.Fg alpha alone and that 
produced by prostaglandin alpha after pre-treatment with 
atropine (p < .05). These results suggest that prior 
inhalation of atropine sulphate partially inhibited the 
bronchoconstriction induced by prostaglandin aloha.
Sodium cromoglycate and thymoxamine inhalations did not 
produce a significant change in the mean FlTf^  and SOaw. 
Further, both these drugs failed to inhibit prostaglandin 
F g alpha induced bronchoconstriction (P >■ .10, tables. XIV 
and XV, Pigs. 10 and ll).
10.6 Thymoxamine in Allervcn Induced Bronchoconstriction
The results of this investigation are given in table 
XVI. In ten patients with extrinsic bronchial asthma, 
allergen inhalation produced a significant fall in the 
mean SGaw (P < .01). The maximal fall in the mean oGaw
84
was 59y: at 15 minutes and thereafter there was a gradual 
restitution in the oGaw (Fig. 12).
Following intravenous thymoxamine, a smaller fall in 
the mean SGaw was observed. The maximal fall in the mean 
SGaw was 35^  ^at 25 minutes. The inhibition obtained with 
thymoxamine was statistically significant (p < .025). The 
effect of intravenous thymoxamine on allergen induced 
bronchoconstriction varied greatly in individual 'oatients.
In six patients (Nos. 1, 2, 3? 5 ; 7 and 10, tables in the 
Appendix) the allergen provoked bronchosnasm was completely 
or partially inhibited whereas in four patients (Nos. 4, 6,
8 and 9? tables XLVI and XLVIl) thymoxamine had no effect 
in this respect,
Thymoxamine given by inhalation also inhibited allergen 
provoked bronchoconstriction in tvro patients (Nos. 3 and 10, 
tables XLVI and XLVIl) and in one of these patients this 
protection was maintained even when the dose of allergen 
inhaled was doubled (Figs. 13 and 14)»
Thymoxamine given intravenously did not cause a 
significant fall in blood pressure in any of the Patients 
and none complained of any side-ef■^ects.
10.7 TlNPiioxamine and Sodium Gromovlycate in Post-Exercise 
bronchoconstriction
The results are given in table XVII. In thirteen
patients the maximal fall in the mean FFV^ after treadmill 
exercise was 359 and occurred at 5 minutes. Thereafter 
there was a gradual restitution in FEV^ over the next 25
85
minutes (Fig. l6). The fall in FSV^ was highly 
significant (P < . 00l).
When the patients were nre-treated with thymoxamine, 
the maximal fall in the mean FEV^ was 5f and occurred 5 
minutes after exercise. Thereafter the FSV^ returned to 
the baseline value over the next 25 minutes. The fall in 
mean FEV^ was statistically significant (P < .05).
Hov;ever, when the falls in FEV^ induced by exercise in the 
control test and after thymoxamine treatment were compared, 
the inhibitory effect of thymoxamine on post-exercise 
bronchoconstriction was found to be highly significant 
(P < .01, Fig, 16).
When the exercise test was repeated after inhalation of 
sodium cromoglycate, the maximal fall in mean FEV^ was 10^ 
and occurred 5 minutes after exercise. Thereafter the 
mean FSV^ returned to the baseline value over the next 25 
minutes. The fall in mean FEV^ at 5 minutes was 
significant (P < .025). However, when the falls in FEV^ 
induced by exercise in the control test and after sodium 
cromoglycate treatment were compared, the inhibitory effect 
of sodium cromoglycate on post-exercise bronchoconstriction 
was found to be highly significant (P < .01).
The inhibitory effect of thymoxamine and sodium 
cromoglycate on nost-exercise bronchoconstriction in 
patients with bronchial asthma was comparable aud no 
statistical difference was found between the two drug 
treatments (t test = 0.3? P  ^,10, Fig. I6).
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10.8 Aloha Receptor 'Blocking Drugs Alone and in combination with 
ISQprenaline on SGaw
The results of this investigation are given in table 
XVIII. Saline inhalation did not cause a significant
. change in SOaw. The maximal increase in the mean SOaw 
WQ.S 459 after thymoxamine or phentolamine inhalation, 
however, this increase was significantly less than the 
increase in mean SGaw achieved with isoprenaline, 122f^ .
When isoprenaline and thymoxamine were administered 
together the mean SGaw increased by 200^  ^from the baseline 
value of SGaw (Figs. 17 and l8). There was a higlily 
significant difference between the bronchodilatation 
achieved with isoprenaline alone and that achieved with 
isoprenaline plus thymoxamine or phentolamine (P < .OOl), 
The results of this investigation supnort the biochemical 
work reported in Part II that alpha receptor blocking drugs 
potentiate the effect of beta receptor stimulants.
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11.0 HITSIOLO.GICAT. EFFECTS OF ERQNCHOGOWSTRICTTOF
11.1 Site of Bronchoconstriction
As summarised in the method section, 65 provocation
tests with different bronchoactive agents were carried out.
The time-response relationship of fall in FEV^ and SGaw to
these agents are given in figures 19, 20, 21 and 22, The
• maximal fall in FEV'^  and SGaw and the recovery in both
these assessments thereafter occurred simultaneously. . Tn
these 65 provocation tests, no differentiation into 'flow'
129or 'conductance* responders as proposed by Bouhuys et al 
could be made. These results suggest that broncho­
constriction induced by histamine, methacholine, allergen 
challenge, beta blockade and prostaglandin F^ alnha occurs 
simultaneously in the central and peripheral airways.
11.2 Relationship of Response to Initial Bronohomotor Tone
On combining the results of the fall in SGaw nroduced
by histamine, methacholine, allergen challenge, beta
blockade and prostaglandin Fg alpha in the 65 provocation
tests (tables XIX - XXIII) and relating the change to the
baseline value of SGaw, a significant correlation was
observed (r = 0.76, t test = 9.21, P < .001, Fig. 23)'.
The uatient who had the highest baseline SGaw had the
greatest fall in SGaw following any of the provocation
manoeuvres. These results are in accord with Starling's
1S9law of heart muscle and can be derived mathematically 
(Page 162).
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On the other hand, the fall in produced hy
histamine, methacholine, allergen challenge, beta blockade 
and prostaglandin alpha did not relate to baseline value 
of FEV (r = 0,02, t test = 0.08, P ^  .10, Fig. 24).
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Table XIX
Maximum fall in FEV^ and SG-aVir produced by histamine 
iniiralation in 16 patients with asthma
J'lllfc-acOlHjW
No. Age Sex F. SG-aw
Baseline Change Baseline Change
1 . 18 F 2.40 1.00 0.087 0.066
2. 1 23 M 3.70 1,05 0.090 0.050
3. 20 M 3.05 1.45 0.079 0,065
•4. 37 M 1.30 0.45 0.01(4 0.013
5. 15 M 3.20 1.20 0.068 0.038
6. 19 M 3.30 1.30 0.083 0.055
7. 21 F 2.70 1.65 0.092 0.071
8. 22 M 2.60 1.60 0.093 0.066
9. ■ 30 F 2.6o 0.25 0.207 0.160
10. 33 M ; 2.25 0.85 0.188 0.074
11. 31 . M 3.20 0.40 0.179 0.082
1 2 . 19 F 2.65 1.15 0.103 0.085
13. 29 M 2.40 0.95 0.082 0.061
14. 28 M . 2.70 0.75 0.054 0.031
15. 21 M ■ 4.40 1.70 0.185 0.154
1 6 . 33 M , 3.00 1.80 0.065 0.043
Mean 2.%. 1.10 0.106 0.070
8EM 0.17 0.12 0.013 0.009
1.  f «1 .wate w  Jjam -mm*
Table XX
Maximum fall in and SGaw produced by methacholine
inhaJation in 15 patients with asthma
No. Age Sex
»A«nr ccftMtMnM «m  i,^ -vwrTia»r<7Wxn*. m
FEV SGaw
<WLKzu»
Baseline Change Baseline Change
1. 18 F 2.50 1.55 0.115 0.050
2. 23 M 3.85 . 1.65 0.188 0.160
3. 20 M 3.15 1.95 0.113 0.069
4. 17 M 2.70 0.85 0.108 0,064
■ 5. • 15 M 2.90 1.70 0.312 0.161
6« 20 M 3.70 2.70 0.123 0.045
7. 21 P 2.70 1.50 0.136 0.108
8. 33 F 2.25 0.45 0.141 0,099
9. 31 M 3.25 1.40 0.167 0.141
10. 30 M 3.70 1.45 0.053 0.037
11. 28 M 3.05 0.85 0.075 0.052
12. 21 M 2.50 1.15 0.103 0.03!,.
13. 20 M 4.75 0.30 0.308 0.176
14. 33 F 2.40 1.20 0.220 ■ 0.159
15. 37 M 1.90 1 .10 0.116 0.060
■i j / j  mmi
M ean 
SEM
3.02
0.19
itaiirti'-gi.t'.iygwmna.aCTjiwmw
1.32
0.15
0.152
0.020
0.094
0.013
/
Table XXI
Maximum fall in FEV^ and SGaw produced by 
allergen challenge in 1.5 patients with asthma
No. Age
f W. I'l,
»pW«*I eWItUAW w;e Iww««*e »
Sex FEV^ SGaw
1 . 20 M
Baseline
4.70
Change
0.70
Baseline
0.235
Change
0.154
2. 1 23 M 4.20 0.80 0.189 0.108
3. i 21 F 2.75 1.55 0.14A* 0.115
4. 19 F 3.50 0.60 0.213 0.117
5. 15 M 2.40 0.60 0.077 0.052
6. 37 F 1.90 0.30 0.109 0.059
7* 19 F 2.30 0.60 0.132 0.044
8. 23 F 2.90 1.50 0.227 0.167
9. • 19 M 2.90 1.85 0.066 0.055
10. 27 M 2.45 1.3P 0.105 0.091
11., 30 M 3.35 0.95 0.082 0.063
1 2. 39 M 1.70 0.70 0.085 0.063
13. 20 M 2.75 1.95 0.062 0.047
14. 21 M 2.60 0.90 0.098 0.051
15. 18 F ■ 2.20 1.10 0.076 0.048
rnWHB'rt’i «-o.™,-™,-
Mean
SEÎVÎ
' 2.84 
0.21
1.02
0.13
0.127
0.016
0.082
0.010
Clinical details of Patient No. 8 (Mrs. J, H.) given in Appendix, Page 15!^ *
Table XXIII
Ma:x/imura fall in PEV. and SG-aw produced by 5 mgm. of nropranolol
II given intravenously in 12 patients with asthma
| l."l H" 1 M l . " M l *  :' 1 iHlW.' H«n
Ho. Age Sex PPV^ SG-aw
Baseline Change Baseline Chang 0
1. 19 M 3.15 0.25 0.122 0.039
2. 21 P 3.20 0.60 0.189 0.062
3. 20 M 3.40 0.45 0.100 0.044
4. 15 M 3.05 1.05 -, 0.165 0.102
5. 23 M 4.20 2.05 0.212 0.149
6. 19 P 2.80 0.70 0.104 0.050
7. 30 M ' 3.00 0.55 0.098 0.036
8. 19 P 3.30 0.25 0.153 O.OW-
9. 31 M 2.60 0.90 0,126 0.086
10. 21 P 2.30 0.80 0.133 0.072
11. 27 P 2.40 . 0.10 0.201 0.083
12. 20 . M 4.80 0.60 0.312 U.I44
M ean 3.18 0.69 0.160 0.076
S M 0.21 0.15 0.018 0.011
Table XXIII
Majcimum fall in FEV.^  and SGaw produced by 
Prostaglandin in 7 patients with asthma
'1. "Tfi
No. \
i
Age Sex PEV^ S&aw
Baseline Change Baseline Change
1. 15 M 3.20 1.95 0.134 0.044
2. 30 M 3.20 1.65 0.068 0.048
3. 21 P 3.00 0.95 0.212 0.143
4. 33 M ■ 2.80 1.78 0.128 0.093
5. . 28 M 2.60 0.63 0.084 0.051
6. 21 M 4. 25 1.00 0.215 0.143
7. 23 M 4.80 1 .10 0.282 0.191
Mean 3.41 1,29 0.160 0.102
s m 0.31
—iM. Ill— ao> i m # , W T # n n i # . w o w & l K , i . i n a
0.19 0.030 0.022
I Histamine dlHCl 
W 200 ugm by inhalation Minutes
% Change 0 10 20
0“
-10-
-5 0 -
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SGaw
-7 0
Fig. 19. Effect of histamine inhalation on the mean FEV^ and 
SGaw in l6 patients with asthma.
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Fig. 20. Effect of methacholine inhalation on the mean T^ EV^  and 
GGaw in 15 natients with asthma.
PROPRANOLOL 
5mgm IV.
CHANGE
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•40“
FEV,
SGaw
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Pigo 21. Effect of intravenous propranolol (5 mgm.) on the mean 
EEV^ . and SGaw in 12 patients with asthma.
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10 20 30
TIME (minsl
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Fig. 22. Effect of allergen challenge cn the mean and SGaw
in 15 patients with asthma.
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Fig. 23» Relationshin "between the "baseline values of SGaw and
the changes in SGaw produced "by histamine, methacholine 
allergen challenge, propranolol and prostaglandin. 
in 65 provocation tests.
(r = 0.76, student's t = 9*21, P <' .001, y = O.986 x +
0.003).
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Relationship "between the "baseline vaines of FE'V
FEV^ (ml)
1 'andthe changes in F!GV. produced "by histamine, methacholine , 
allergen, pronranolol and prostaglandin Fg in 65 
provocation tests.
(r = 0.02, student’s t ~ O.O8, F > .10).
CHAPTER IV 
DISCUSSION■
12.0 ROLE OF ALPHA RECEPTORS IN ASTHMA
12.1 Airways Response R(^ ba Blockade
A small dose of propranolol given orally or
intravenously produced a significant fall both in the PEV^
and SGaw in asthmatic patients, whereas a large dose of
propranolol did not affect the PEV^ and SGaw significantly
in normal subjects. These observations are in agreement
with similar results reported previously^^'
Statistically, asthmatic patients and normal subjects
157belong to two different populations .
The control of bronchomotor tone is complex. It is
. directly under the autonomic neural influence through the
vagus and sympathetic nerve supply and in addition to these
are humoral factors which include histamine, 5 hydroxy- 
tryptamine, S„R.S.-A*, prostaglandins and possibly other 
influences yet unknown. The extent to which all or some 
of these factors are active in, a given subject at any one 
time is bound to vary and more so in asthmatic patients.
In most mammalian species vagal stimulation has been 
known to cause bronchoconstriction and prevention of these 
responses by atropine indicate that they are mediated by 
cholinergic fibres. Pharmacologically it has been shown 
that parasympathomimetic agents, such as acetylcholine and 
methacholine, cause an increase in resistance to air flow 
and it has therefore been inferred that the vagal
90
stimulation also causes bronchoconstriotion in Man as in
other m a m m a l ^  In most animals and in Man there is
some resting bronchomotor tone in eupnoa under normal
conditions, mediated through the vagus nerves. Vagotomy,
vagal cooling and atropine administration have been shovm
to increase the diameter of larger airways and increase
117anatomical dead space
The effect of sympathetic nerve stimulation on lung 
mechanics is less certain than that of vagus, but generally 
it is thought to cause 'relaxation of bronchial calibre and 
decrease in resistance to air flow. Indirect 
pharmacological evidence on action of sympathetic nervous 
system on bronchi comes from use of adrenaline and 
isoprenaline in both animals and Man^ '^ .^ From the action 
of isoprenaline it appears that sympathomimetic broncho- 
dilatation depends on adrenergic beta stimulation. The 
existence of resting beta receptor adrenergic hroneho- 
dilator activity in normal man is doubtful^^^^ as both
beta stimulation or beta blockade has failed to cause a 
significant change in the bronchial calibre in normal 
subjects^^^ ^ and the effect of propranolol in normal
subjects reported here would support this hypothesis.
The presence of alpha receptors in mammalian lungs 
with bronchoconstrict or activity has been postulated^^ ’
86, 87  ^ Pharmacologically, alpha receptor stimulation in
presence of beta blockade has been reported to cause 
bronchoconstriction in Man^^’ However, in normal
91
subjects alpha receptor stimulation does not cause
157bronchoconstriction" and it is unlikely that alpha 
adrenergic activity in the airways plays a significant role 
in the control of bronchomotor tone in these subjects.
Thus, it can be postulated that in normal subjects the 
mechanisms operating through alpha and beta adrenergic 
receptorsp receptors at parasympathetic nerve endings and 
receptors for humoral mediators such as histamine, 5 
hydroxytryptamine, bradykinin, prostaglandins and possibly 
through other receptors yet to be defined are so balanced 
that the combined effect of these mechanisms favours 
brone h odilatation.
In contrast, patients with asthma, develop marked 
bronchoconstriction following beta blockade with 
propranolol. This suggests that there is an increased 
beta adrenergic activity at rest, the reduction of which 
by pharmacological blockade^^, infection or possibly other 
means can unmask an underlying state of bronchoconstri ction. 
However ; it is not known whether this enhanced activity is 
due to sympathetic nervous tone, or to circulating 
catecholamines. It has been suggested that the cholinergic
and alpha adrenergic activities are also possibly increased
S7,
165in asthmatic patients and both cholinergic and alpha
stimulation has been shown to increase bronchomotor tone' 
and also to enhance mediator release in the type I 
allergic reaction'^^. Thus, the balance between the beta
receptor activity (bronchodilator) and the cholinergic and
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alpha activities' (hronchoconstriotor) in asthmatic patients 
is much more subtle compared to normal subjects and any . 
change in balance greatly alters the bronchial calibre.
It is likely that beta blockade with propranolol in 
asthmatic patients results in unopposed vagal or alpha 
adrenergic over-activity or both favouring broncho- 
constriction. The failure of atropine to abolish 
completely the rise in airways resistance following 
propranolol a,dministration^"^^ would suggest that alpha 
adrenergic activity in presence of beta blockade may be 
partly responsible for bronchoconstriction. Further, 
alpha receptor blockade has been shown to modify proprauolol 
induced bronchoconstrict ion in asthmatic patients^^"^ ^ 
suggesting an increased alpha adrenergic activity in 
presence of beta blockade.
In ad.dition, the distribution of autonomic influence in
the central and peripheral airways in asthmatic patients is
also important because of varying physiological responses
to site of bronchoconstriction. Vagal1y mediated
bronchoconstriction has been reported to cause selective
bronchoconstriction in larger airways, there being little
change in calibre of peripheral airways^''^'^"
Histamine, on the other hand, has been shovm to cause
constriction of peripheral airways and alveolar ducts
without affecting the calibre of the larger conducting 
117airways . These variations in site of bronchoconstriction 
has been attributed to variations in sympathetic tone of the
93
129airways " . Propranolol administration to asthmatic
patients produced a significant fall both in the and
SGavj suggesting that airways' obstruction occurred
simultaneously in the peripheral and central airways.
These results suggest that beta blockade in asthmatic
patients causes bronchoconstriction in the central and
peripheral airways and similar observations have been
reported following alpha receptor and cholinergic
]  157
stimulation in asthmatic patients . These observations 
therefore suggest that balance of autonomic influences 
mediated through alpha, beta and cholinergic receptors in 
asthmatic patients does not vs.ry in the central and 
peripheral airways as has been proposed in normal subjects
129^
12.2 Beta Blockade Theory of Bronchisil Bypor-Reactivity
A 5
Szentivayni in 1968 '■ put forward an miitarian 
hypothesis to explain bronchial hyper-reactivity and atonic 
state in asthma. He proposed that increased irritability 
of the bronchial tree in asthma results from diminished 
beta receptor response to catecholamines and a relative in 
alpha adrenergic activity. Although his hypothesis has 
provided a great impetus to re-examine autonomic imbalance 
in asthma, most of his conclusions were derived from animal 
experiments. Mice given pertussis vaccine became hyper-
73sensitive to histamine and other mediators of anaphylaxis  ^
f 4 j 75^  In addition, this was associated with eosinophilia, 
diminished response to beta stimulation and an enhanced
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response to alpha stimulation'^ '^ ’ .
In contrast to observations in animal exooriments, Eaid 
82and Beall have failed to induce methacholine or histamine
I hyoer-sensitivitv in normal subjects after beta adrenergic
.blockade with nropranolol. Zaid and Beall’s observations
were confirmed by me in five normal subjects. In these
subjects 10 mgm. of propranolol given intravenously did not
cause a significant change in either the PEV^ or SGaw and
200 ugm. of histamine dihydrochloride by inhalation in the
presence of beta blockade also failed to affect the bronchial
calibre significantly in these subjects (Figs, 25 and 26),
These observations suggest that bronchial hyoer-reactivity
akin to that observed in asthmatic patients cannot be
induced experimentally in normal subjects after beta
blockade. Undoubtedly the observations in animal
experiments are important, the inferences derived have to
be reganded with caution because of soecies differences and
failure to reproduce chronic unrelievable asthmatic state
in animals. Further, Szentivayni ventured to propose that
this autonomic imbalance could result in relative increase
in alpha adrenergic activity of the airways when the
existence of such receptors in the human airways was still
in doubt and their function yet uncertain.
The diminished beta receptor responses observed in
asthmatic patients are related to the severity of asthma.
78Inoue (1967) reported that diminished metabolic responses 
to adrenaline administration increased with the severity of
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% Change
+ 5
-H
— 5-
Pig. 25
Histamine diHCl 
200 ugm by inhalation SGaw
b FEV.
Minutes
Effect of histamine inhalation on the mea-n FEV_ and 
SGaw in 7 normal subjects. Histamine failed to 
cause a significant change in the PEV^ and SGaw in 
these natients.
Tables XLI and XLTI.
% Change [ Propranolol 
10 mgm I. y,
0 / 10
Histamine diHCl 
200 ugm by inhalation
>*© SGaw
Minutes0 FEV.
-5
Pig. 26. Effect of histamine on the mean PEV.| and SGaw after
prior beta blockade in 5 no-rmal subjects. Pronranolol 
failed to cause any change in both the FEV^ and SGaw 
and histamine by inhalation also failed to affect 
bronchial calibre significantly in these subjects. 
Tables XLIII and XLTV.
asthma whereas asthmatic patients in remission could not he 
distinguished from normal subjects in this respect*^^’ 109» 
168, 169  ^ is probably true that the diminished beta
receptor observed in natients with acute asthma may reflect 
a failing counter-regulatory mechanism rather than be
*3 69considered the cause of asthma' . Further, the
biochemical observations suggest that the beta receptor 
system is maximally stimulated and further stimulation 
becomes increasingly difficulf*’^ ^. Secondly, an increased 
rate of metabolism of catecholamines to 3 methoxy
1 70derivatives which are weak beta-adrenergic blockers' may 
also result in diminished response to sympathomimetic 
amines in these patients. The latter possibility still 
remains to be investigated.
12.3 Response to Phenylenhrine After Blockade of Alnha and Beta 
Adrenergic Rocentors
Although the presence of excitatory alpha adrenergic 
receptors in the respiratory tract of various animal snecies 
has been demonstrated^'^’ the existence of such
receptors in human bronchi has been more doubtful. In 
1970? we^^ reported that histamine induced broncho- 
constriction in asthmatic patients could be inhibited by 
alpha receptor blocking drugs, phenoxybenzamine and 
phentolamine, suggesting that there are alpha adrenergic 
receptors in the human bronchial tree. However, it has 
been suggested that the effect we had observed was unlikely 
to be wholly due to alpha receptor blocking properties of 
phenoxybenzamine and phentolamine as both’these agents are
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knoxm to have additional effects which include atropine-like
and antihistaminic actions. About this time a more
selective alpha receptor blocking drug, thymoxamine, became
available for clinical use. Unlike phenoxybenzamine and
phentolamine, thymoxamine is devoid of additional effects
and is highly specific in its alpha blocking actions in 
151isolated organs . Our observations have been confirmed 
both by Prime et al and Caddie et al using 
thymoxamine0 At least this was the first indirect evidence 
of the presence of alpha adrenergic receptors in human 
airways.
In an attempt to find more direct evidence of the
presence of alpha receptors in human a.irways, the effect of
phenylephrine inhalation after prior beta and alpha
blockade was studied in patients with bronchial asthma and
normal subjects. Phenylephrine is a powerful alpha
receptor stimulant with little effect on the beta receptor.
A direct action on the receptor accounts for a greater cart
of its effects, only a small part being due to its ability
173to release noradrenaline' '. In l6 patients with extrinsic 
bronchial asthma, phenyleplirine given by inhalation in the 
presence of beta bloclcade, caused a significant fall in 
both the and SGaw (Pigs. 2, 3 and 5) whereas
phenylephrine had no effect on the airway calibre of ten 
normal subjects (Pigs. 4 and 6). These observations in 
asthmatics provide a more direct evidence of the presence of 
alpha adrenergic receptors in the human bronchial tree and
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that stimulation of these receptors can cause 'broncho-
constriction in pa.tients with asthma. But unlike Prime and
■ 89
his colleagues , I have been unable to demonstrate aluha
adrenergic activity in the airways of normal subjects. In
six asthmatic patients, the phenylephrine effect could be
comuletely inhibited by alpha receptor blocking drugs,
phenoxybenzamine and thymoxamine, suggesting that the
effect of Phenylephrine was specifically on the alpha
adrenergic receptors (Figs. 2 and 3)-
However, it has been suggested that beta adrenergic
blockade in patients with asthma may lead unopposed
parasympathetic activity which in turn causes bronoho-
constriction^^^. If this is so, a possibility arises
that the phenylephrine induced bronchoconstriction in
presence of beta blockade could have resulted from
stimulation of ’irritant' cholinergic receptors in the 
158airways , The effect of phenylephrine after 
pre-treatment with atropine was studied in six patients 
with asthma.
12,4 Response to Phenylephrine After Blockade of Beta and 
Cholinergic Receptors
In six patients, atropine given by inhalation produced 
a significant bronchodilatation and rise in SGaw 
suggesting resting bronchomotor tone mediated by 
cholinergic activity as suggested by Widdicombe and 
Sterling (l970)^^^. In presence of cholinergic blockade 
with atropine, propranolol induced bronchoconstriction was
• 98
partially inhibited. Further, Phenylephrine inhalation
in presence of beta and cholinergic blocka.de produced a •
significant fall in SGaw (Fig. 7)* The result of this
investigation further suggests that the Phenylephrine
effects in patients with asthma is mediated specifically
through alpha adrenergic receptors and cannot be due to a
158non-specific effect on 'irritant' cholinergic receptohs , .
12.5 Thymoxamine in Histamine Induced Bronchoconstriction 
In a previous study, we had reported that alpha 
receptor blocking drugs, phenoxybenzamine and Phontolamine, 
could inhibit histamine induced bronchoconstriction.
However, both these drugs have additional effects and it is 
difficult to assess whether the inhibition observed was 
wholly due to alpha receptor blocking property of these
352 153drugs. Bianco et al'-^  and Gaddie et al have confirmed
our findings using thymoxamine which is more specific in
its alpha receptor blocking action and is devoid of
additional effects seen with phenoxybenzamine and 
151phentolamine . I confirmed our observation using
thymoxamine in eight patients with astlima (Fig. 8).
Thymoxamine administered by inhalation effectively inhibited
histamine induced fall in the in eight Patients with
extrinsic asthma.
The effect of histamine on bronchial smooth muscle is
complex. It may act directly or by a.delayed reflex 
3 72action . Although it is well established thot patients 
with extrinsic asthma are hyoer-sensitive to inhaled or
99
intravenously administered hist a m i n e t h e
mechanism by which this hypor-sensitivity is produced still
remains uncertain. One possibility is that this may be the
sequelae of diminished beta recentor responsiveness,
The alpha and beta adrenergic receptors are believed to
control ionised calcium concentration in the environment of
contractile protein of myofibrils^^^’ and histamine
175response of smooth muscle is dependent on calcium ions 
In addition, it has recently been shown the ionotronio and 
relaxing effect of cyclic AMP on cardiac muscle is mediated 
by modulation of rate of Ga*”' binding with sarcoplasmic
] 76
reticulum # It can therefore be postulated that beta
receptor agonists by increasing the Ca^  ^  binding in the
sarcoplasmic reticulum of bronchial smooth muscle fibrils
cause relaxation whereas alnha receptor agonists may have a 
]  7 7
reverse effect ‘ .
Alpha receptor blocking drugs which are known to
1 1 *  n - T 5~ i e >  I ' 1 0 7 , 1 6 8  ,  ^ ■ { " ' • 1'enhance cyclic A i - P formation ^ may increase Ga
binding in the sarcoplasmic reticulum of bronchial smooth
muscle and thus inhibit the histamine effect on the
bronchial smooth muscle in asthmatic patients.
12.6 Thvmoxamine ip Methacholine Induced Bronchoconstriction
Although acetylcholine5 the cholinergic neuro-
transmitter, is not released in the reagin-mediated
allergic reaction, it might be considered a mediator because
37of its profound effects on bronchial physioloay . In 
addition, cholinergic agonists have been shoiTn to enhance
98histamine release from human lung
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Thymoxamine as expected failed to inhibit methacholine
•induced fall in FEV^ in eight natients with asthma (Fig. 9).
It is now established that cholinergic agonists, like
acetylcholine and methacholine, activate guanyl cyclase
• and lead to an increase in cyclic GHP formation^^. Guanyl
cyclase-cyclic GMP is the second messenger system for
cholinergic responses. Cyclic GMP formation is not
178influenced by thymoxamine in asthmatic patients (Part XI 
of this thesis) and therefore it is unlikely for thymoxamine 
to have any effect on methacholine induced broncho- 
constriction. Atronine which inhibits cyclic GFP 
formation effectively inhibits methacholine induced broncho- 
constriction in asthmadic patients and normal subjects 
(personal observations).
12.7 Thymoxamine, Atronine and Sodium Grornoglycate in
Prostaglandin F„ Alnha Induced Bronchoconstriction
Prostaglandin F^ alpha is a potent bronchoconstrictor 
in Man. The presence of prostaglandin F^ alpha in human 
lung and its release during type I allergic reaction and in
/19 1 79
response to various chemical and mechanical stimuli'^ ”"’
has led some workers to postulate that locally formed
prostaglandin F^ alpha may play an important part in
pathogenesis of bronchial asthma^*^’ In addition,
179Paterson et al have also su.ggested that prostaglandin F^ 
alpha may be involved in exercise induced asthma.
In six patients with a.sthma atropine inhalation 
partially inhibited prostaglandin F^ adpha induced fall in
101
the FEV.|^ and SGaw whereas thymoxamine and sodium
oromoglycate had no effect in this respect (Figs. 10 and
11). The failure of sodium cromoglycate to inhibit
prostaglandin F^ alpha induced bronchoconstriction together
with the observed ions of its inhibitory effect in
allergen^^^ and exercise provoked asthma'^would suggest
that the release of prostaglandin F^ alnha locally in the
lung may not be a, primary factor in the pathogenesis of
asthma. In addition, indomethacin administration which
markedly reduces the total body production of prostaglandin
Fg alpha does not completely inhibit allergen provoked
asthma in Man or anaphylactic reaction in guinea pigs^'^^’
181
The studies of cyclic nucleotide systems suggest that 
the effects of prostaglandin F^ alnha like cholinergic 
agonists is mediated through guanyl cyclase-cyclic 
The partial inhibition of prostaglandin F^ alnha induced 
bronchoconstriction by atropine as observed in this 
investigation is consistent with this hypothesis. Although 
there is evidence that alpha stimulation increases cyclic
GMP formation^^, it is unlikely that prostaglandin F^ alnha
acts on the alnha receptors in the lung as thymoxamine 
failed to alter prostaglandin F^ alpha induced broncho­
constriction in asthmatic patients (Figs. 10 and ll). The 
evidence so far suggests that prostaglandin F^ alpha 
together with other chemical mediators, such as histamine, 
bradykinin, serotonin and S.RaSe-A, is released during the
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type I allergic 'reaction. Prostaglandin F_ a.lnho is ac
very potent ’bronchoconstrictor to which asthmatic natien.ts 
are exouisitely sensitive and it may act hy stimulating 
cholinergic recentors. It would bo wrong to consider 
prostaglandin alnha as the main factor in pathogenesis 
of asthma until we further clarify the cause of airways 
hyper-reactivity which seems to be the primary defect in 
asthma.
12.8 Thymoxamine in Allergen Induced Bronchoconstriction
In ten padients with asthma, allergen induced broncho­
constriction was inhibited by thymoxamine given 
intravenously (Fig. 12). In two of these natients the 
thymoxamine by inhalation also inhibited allergen provoked 
bronchoconstriction and in one patient this protection was 
maintained even when the dose of allergen inhaled wo.s 
doubled (Figs. 13 and 14).
3 82Lichtenstein and be Bernado ' IiEive shovm that cyclic 
AMP inhibits mediator release and tliat the adenyl cyclase 
system is involved in the first stage of the type I 
allergic reaction which is not calcium dependent. There 
are tvro possibilities for the observed effects in this 
investigation. Firstly, that thymoxamine acts by 
increasing cyclic AFP^^^’ and thereby prevents the
release of pharmacologically active substance from mast 
cells following allergen challenge or that thymoxamine does 
not inhibit mediator release but alters the bronchial smooth 
muscle response to these mediators, by altering the .
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bronchomotor tone. It is now known tho.t reagin-mediated 
.allergic reaction releases significant quantities of 
prostaglandin alpha in addition to histamine, ShR.S.-Aa,
I 29I bradykinin and 5 hydro.xytryotamine " . The variable
I  ■ responses recorded after allergen challenge in presence of
/ alpha blockade with thymoxamine could be accounted for by
the failure of thymoxamine to inhibit the effect of
183prostaglandin alpha on the airways suggesting that 
the dominant effect is on the bronchomotor tone rather than 
the mediator release.
12.9 Thymoxamine and Sodium Cromoglycate in Post-Exercise 
Br 0no hoconstriction
A significant inhibition of post-exercise broncho­
constriction was observed in 12 out of 13 patients 
following thymoxamine inhalation, and in the same 12 
patients a statistically comparable inhibition was also 
obtained with sodium oromoglycate (Fig. 16). However, in 
one patient neither drug had any effect on post-exercise 
bronchoconstriction. Further, atropine sulphate given by 
inhalation also failed to inhibit exercise induced broncho- 
spasm in this oatient. These results contrast with the 
observations of Sly et al^^^ who fotled to inhibit nost- 
exercise bronchoconstriction using phentolamine.
Phentolamine is a short acting drug and it may produce 
inadequate and transient blockade when given intravenously
A wide variety of humoral mediators have been suggested 
as the cause of exercise induced asthma. Histamine levels
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have "been found to he normal or unrelated to the degree of 
•post-exercise hronohoconstriction^^^^’ Further,
antihistaminic drugs have failed to inhibit post-exercise
/ bronchoconstrict ion"'""'’’ The role of serotonin as a/  188
33bronchoconstrictor in Man is disputed and its antagonist,
methysergide, does not alter exercise r e s p o n s e , Local
1T9prostaglandin release has been suggested and the 
demonstration of this release in guinea pig lungs in 
response to minor mechanical stimuli would sunnort this
154
view • . However sodium oromoglycate does not inhibit
prostaglandin F^ alnha induced bronchoconstriction in
3 83asthmatic patients' The effect of sodium oromoglycate
on prostaglandin F^ alnha, induced bronchoconstriction, 
together with the observation of its beneficial effect in 
exercise asthma^ "^ ,^ would suggest that the release of 
prostaglandin F^ alplia locally in the lung may not be the 
primary factor in exercise induced bronchosnasm.
Noradrenaline and adrenaline are released during
, . 190, 191 J I , . M „strenuous exercise ’ , and this release of
catecliola.mines is grea.tly enhanced by prior beta blockade
192with propranolol or oxnrenolol . A similar enhanced 
release of catecholamines ma,y also occur in astlimatic 
natients who show diminished beta resnonsiveness to 
catecholamines. The ol^servations of this investigation 
suggest that increased alnha adrenergic activity in the 
presence of diminished beta receptor responsiveness could 
be the mechanism of post-exercise bronchoconstriction in
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these subjects. Tn addition, the report by Jones^ '^  ^that 
' a proportion of normal subjects develop post-exercise 
bronchoconstriction in the presence of prior beta blockade 
with pronranolol would further suggest that alpha 
adrenergic stimulation could be the cause of post-exercise 
bronchoconstriction in these subjects.
It has recently been suggested that sodium oromoglycate 
acts by inhibition of cyclic phosphodiesterase and leads to 
an increase in the levels of cyclic 145^  %-{;
possible that like alpha receptor blocking drugs which 
increase cyclic AMP formation on stimulation with 
isoprenaline^^"^’ (reported in Part II of the thesis),
sodium oromoglycate may also increase cyclic AMP level via 
inhibition of cyclic phosphodiesterase. The increase in 
cyclic AMP levels may modify the bronchomotor tone and 
alter the response to exercise in asthmatic patients.
12.10 Alpha Receptor Blocking Drugs Alone and in Combination with 
with Isoprenaline on SGaw
In ten patients with asthma, thymoxamine or phentolamine 
increased SGaw by 45^ '> this improvement was, however, 
significantly less than that achieved with isoprenaline 
alone. Ph.en isoprenaline and thymoxamine or phentolamine 
were administered together the mean SGaw increased by 200ft 
from the baseline value of SGsiw. There was a highly 
significant difference between the bronchodilatation 
' achieved with isoprenaline alone and that achieved with
isoprenaline plus thymoxamine or nhentolamine (Pias. 17 and 
18).
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The above observations are supported by the biochemical 
studies on the leucocyte adenyl cyclase activity in 
asthmatic patients^ '*^  ^ (reported in Part IT). In acute 
asthma, the leucocyte adenyl cyclase activity shows 
diminished resnonsiveness to stimulation with isoprenaline 
This abnormal adenyl cyclase response in acute168, 169
asthma can be restored towards normal by alnha recentor 
blocking d r u g s t h y m o x a m i n e  and phentolamine.
Thus, in the airways, as in leucocytesit annears 
that the balance between alpha, and beta adrenergic receotors 
may play a critical role in the control of cell function.
In bronchial smooth muscle alpha receptor blockade restores 
the balance in favour of beta adrenergic recentors and hence 
the bronchodilator resnonse to catecholamines* The use of 
alpha receptor blocking drugs may be another line of attack 
of this distressing disease as well as a means of better 
understanding of the mechanism which underlie bronchial 
hyper-reactivity in asthma.
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13.0 Pï-n'SIOLOaiGAL 0? IBRONGHOCONSTRIGTION
13.1 Si'be of Airways Obstruction
It has "been renorted that nervously mediated broncho-
constriction may ooerate at a different site in the airways
from humoral bronchoconstriotion^^^’ Histamine, on
the other hand, has been reported to cause constriction of
peripheral airways and alveolar ducts without affecting the
calibre of larger conducting airways, Vagally mediated
bronchoconstriction, on the other hand, causes broncho-
constriction in the larger airways there being little
effect in the peripheral airways^^^. Bouhuys and 
129Woestijne have postulated that individual variations in 
airways response to histamine and hemp dust in cotton 
workers is principally determined by variation of 
sympathetic tone. According to this hypothesis a subject 
with peripheral airways obstruction demonstrated by fall in 
PEV^ and flow rate ('flow rate response') may ha.ve 
relatively few symuathetic fibres in periuheral airways so 
that the beta adrenergic activity might be insufficient to 
counteract the bronchoconstriction effect of histamine or 
hemp dust in these airways. Conversely, in a subject with 
conductance response (fall in SCaw) the sympathetic 
distribution might be predominantly to smaller airways,
To explore a similar possibility in patients with asthma, 
the airways responses as assessed by PEV^ (perinheral 
airways) and SGaw (larger airways) during various 
provocation tests were analysed.
108
In 65 provocation tests, there was a good time 
 ^relationship between the maximal fall in and SGaw
produced by histamine, methacholine, propranolol
prostaglandin P^ alpha and allergen challenge (Pigs. 19 - 
22), These results suggest that the airways obstruction 
occurs simultaneously in the central and peripheral airways 
in these patients, and it is difficult to demonstrate 
different sites of airways obstruction as has been shown in
194dogs following vagal stimulation and as suggested in Pan
129by Bouhuys and Woestijne . Although the balance betw^ een 
sympathetic and parasympathetic divisions of autonomic
194nervous system in the airways may vary in dogs’ and also
129, 195in normal subjects '' , the observations reported here
suggest that the diminished beta receptor function may be 
present in both the central and peripheral airways in 
asthmatic patients and this would explain marked broncho- 
constrictor response to various agents at both these sites,
13.2 Relationship of Response to Initial ’Bronchomotor Tone
The change in SGaw produced by histamine, methacholine, 
propranolol, prostaglandin Pg aloha and allergen challenge 
depends on the baseline (initial) SGaw (Pig. 23). The 
greatest change in SGaw was elicited when the baseline SGaw 
was highest, i.e. maximum bronchoconstriction in response 
to any of the above agents occurred when the airways were 
maximally dilated. In contrast, the change in PPV^ did 
not relate to the baseline value of P'W^. This lack of 
correlation between the change in PEV^ and the baseline
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as reported here and p r e v i o u s m a y  he due to
collapse and the closure of the peripheral airways durip.v
forced expiration manoeuvres. The collapse and closure of
the peripheral airways is accentuated during maximal
expiratory effort and remains a major cause of flow 
196limitations , Further, the PBV^ is determined by the
properties of upstream segment of airway which contributes
a small proportion to the total airways resistance.
Airways closure causes air trapping, leads to chonges in
lung volumes and accounts for the disparity in the results
of lung volumes measured by body plethysmography and helium
197dilution method during spontaneous asthma' ' . On the
other hand, the airways conductance is the measurement of
airways obstruction in the central airways which do not
collapse readily. The changes in SGaw may therefore
provide a better assessment of the change in bronchomotor
tone during provocation tests. The results of this
investigation are in accord with in vitro studies on the
guinea pig tracheal smooth muscle in which it has been
shown that the muscle contraction is dependent on the
87 198inherent tone of the muscle . Astin ' has shown that 
patients with chronic bronchitis who had highest initial 
airways resistance had the greatest increase in airways 
resistance after nronranolol administration whereas in this 
study asthmatic patients who had the lowest airways 
resistance (highest SGaw) had the greatest increases in 
airways resistance after propranolol administration.
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The differing airways response to beta blockade in patients 
•with asthma and chronic bronchitis may be due to underlying 
inherent differences in the bronchial reactivity and this 
may be of considerable clinical importance in classifying 
• patients with obstructive airways disease.
13»3 Airways Closure
199Recently Dolfuss et al described a simple test using
133Xe to determine the lung volume at which ventilation 
ceases in the dependent lung sones as a result of airways 
closure. The volume termed the closing volume increases 
' linearly with age in adults^^^. Other workers have
described closing volume in disease and as a simple test 
to detect air flow obstruction in peripheral airways of 
less than 1 mm. in diameter^^^' 3^5^
The closing volume, using single breath nitrogen
201test , was measured in eight patients with asymptomatic 
extrinsic bronchial asthma and. ten normal subjects. The 
procedure and results are not included in' the method and 
results seotionsof this thesis; however, the data of this 
Investigation is given in the Appendix (tables LIII - LVi). 
The closing volume was significantly increased in asthmatic 
patients as compared to the closing volume observed in 
normal subjects. The closing volume in asthmatic patients 
decreased to normal values following salbutamol inhalation 
whereas propranolol caused a significant increase in the 
closing volume in these patients. The results of this 
investigation suggest that changes in the smooth muscle tone
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in the terminal bronchioles, which is largely dependent on 
the sympathetic nervous activity of the airways, can 
significantly affect airways closure in natients with 
bronchial asthma.
Recently there has been a renewed interest in the
130
observation of Huber and Koessler that bronchial smooth 
muscle in asthmatic patients show changes of hypertrophy and
133hyperplasia. Hossain “ noted a three fold increase in the
number of smooth muscle cells and the absolute volume of
muscle in necropsy specimens of bronchi of patients with
asthma compared with that found in a normal airway. This
change of hypertrophy and hyperplasia extend from the
central airways to the terminal bronchioles. The increase
202in closing volume reported here and previously suggests 
that bronchial smooth muscle contraction in terminal 
bronchioles with peripheral airways obstruction is present 
in many patients with asthma in remission. The influence 
of bronchomotor tone on airways closure may be more 
pronounced in asthmatic subjects because of an increase in 
absolute muscle volume and the bronchial hyper-reactivity 
to adrenergic activity. The cause of the hypertrophy and 
hyperplasia of bronchial smooth muscle cells in asthma is 
unknown. If these changes result from a latent airways 
obstruction in asymptomatic patients then an early detection 
and treatment may help in breaking the vicious cycle which 
leads to chronic muscular changes and chronic asthma.
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P A R T .  II
Biochemical
14.ci
CHAPTER V 
METHODS
PART II (Biochemical Experiments)
ADEHYh CYCLASE ADD GUAHTT, CTGLASE SYSTEMS IE ASTHMA 
14^1 • Patients and Control Subjects
Fourteen out-patients, aged from 1'/ to 42 years, were
/
studied. They were further divided into two groups.
The first consisted of seven patients ivith active asthma as 
assessed by a history of daily wheezing, breathlessness on 
moderate exercise, clinical and spirometric evidence of 
airways obstruction, and the amount of bronchodilator and 
steroid therapy required for the relief of symptoms. The 
second group consisted of seven asthmatic natients in 
remission. Ten healthy adults, aged from 19 to 45 years, 
were studied as a control group. All therapy in asthmatic 
patients was discontinued for at least 24 hours before the 
experiments. Samples of venous blood were collected 
between 9 and 10 a.m. to avoid circadian variations.
Blood films from each patient and control subject were made 
for differential leucocyte count. The FEV^  ^was measured 
in asthmatic patients within a few minutes of blood 
collection.
14.2  Leucocyte Adenyl Cyclase Assay 
Reagents
The reagents used were as follows: adenosine
triphosphate (ATP), adenosine diphosphate (AD?), 5' 
adenosine monophosnhate (5'*“AFP), 3’~5* cyclic adenosine
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monophosphate (dyclic AMP), adenosine, adenine, human serum 
albumin, theophylline, Ouabain, octahydrate, BL isoprenaline 
hydrochloride (all nurchased from Sigma Chemical Gomnany), 
phentolamine mesylate (Ciba Laboratories Limited), 
thymoxamine hydrochloride (w.. R. Warner & Company, 
Eastleigh), and ^H~adenino (15 Ci/mmol) (Radio Chemical 
Centre, Amersham). The scintillation grade chemicals
naphthalene, 2, 5^üiphonyloxazole (PPO), toluene, 1, 4- 
dioxan, and 2-etho%yethano1 and also the Whatman 3MM 
ohromatogranhy paper were purchased from BI)H Chemicals 
Limited.
^ a^^tion of leucocytes
Leucocytes were prepared from 40 ml. of whole blood
according to the dextran sedimentation technique as
1 07
described by Logsdon et al (l972)‘ , and the cells were
resuspended in a buffered culture medium (table XXIV) so 
that 2 ml. of a suspension contained between I50 and 
200 X 10^ cells. The cell count was carried out in a 
Weubauer's Chamber.
Adenyl cyclase assay
Leucocyte adenyl cyclase assay was performed by the 
following modification of the intact cell method described 
by Humes et al (1969)^^^» Two ml. of a suspension of the 
leucocytes in the buffered culture medium described were 
incubated with shaking at 37°C. for two hours with 
^H-adenine (lu Ci/5 x 10^ cells) in a siliconised conical 
centrifuge tube. After incubation the cells were
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centrifuged at I50 grn. for five minutes and the supernatant 
fluid removed. The cells were then washed three times with 
fresh culture medium to remove as completely a.s possible 
the extracellular labelled adenine and were resuspended in 
a fresh medium to give a concentration of about 10 x 10^ 
cells/ml., 0.5 ml. quantities of which were then added to 
siliconised tubes and once again incubated in a shaking 
metabolic water bath at 37*^ 0. for I5 minutes to allow 
temperature equilibration to occur. Then O.5 ml. of a 
solution of 20 mmol, theophylline/l. dissolved in buffered 
culture medium was added to the cell suspension. The 
various drug treatments were carried out by adding 
appropriate agents at the same time as theophylline.
These drug treatments are given in table XXV. The cells 
were incubated for a further five minutes and the reaction 
was terminated by boiling the reaction tubes for three 
minutes. A non-radioactive carrier solution, 0.1 ml. 
containing 5 mmol/l. each of 3’~5* cyclic AfP, ATP, A'OP,
5'-AMP, adenosine and adenine, was then added and after 
thorough mixing the tubes were centrifuged. All 
incubations were performed in duplicate and the use of All 
rhesus-nositive serum helned to nrevent aggregation of 
cells. Aliquots of 40 ml. of the protein free sunernatant 
solution were spotted on a Whatman 3MM paper and subjected 
to chromatography for I4 hours in a solvent system 
consisting of IM ammonium acetate (pH 7*5^) and ethanol 
(30:75) which effectively senarates 3’-™5‘ cyclic AMP from
115
107other nucleotides and ourine bases . The Rf values of 
these nucleotides and purine bases are given in table XXVI. 
After drying the chromatogram the positions of the soots 
were located under ultraviolet light and identified by 
means of markers in addition to mobilities. The areas 
corresponding to 3'"-5' cyclic AMP, adenine plus adenosine, 
and ATP plus ABP plus 5*“AMP were cut out with scissors and 
placed in separate vials. The nucleotides and purine 
bases were eluted from the paper with 1 ml, of 10 mM TRIS 
HGl (pH 7*40) and 15 ml. of a scintillation fluid, 
constituents of which are given in table XXVII. The vials 
were then counted in a Beckman scintillation counter with a 
counting efficiency of 30% for H^.
14*3 Analysis of Bata
Following the procedure devised by Logsdon et al 
(1972)^^^ adenyl cyclase activity was calculated as the 
ratio of cyclic Al^IP to the total activity found in ATP, 
ABP, 5'“AMP, cyclic AMP, adenosine, and adenine expressed 
as percentage. This method avoids differences in the 
uptake of adenine by the cells in different sample 
tubes. The percentage of cyclic AlP formed in the control 
tubes containing only theophylline was taken as the control 
for each experiment. The neroentage cyclic Aî':F formed 
after each drug treatment was then divided by the control 
value for that experiment so that each drug treatment was 
exoressed as a percentage of the control value, thus making 
possible comnarison between the various treatments in each
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experiment and between experiments. Results from separate 
 ^ experiments were pooled and group means calculated plus or
/
minus the standard error of the mean. Students t test was 
used to determine the significance of drug effects.
14,4 Lymphocyte Ouanyl Cyclase Assay 
Patients and control subjeots
Twelve patients, aged from I4 to 44 years, with 
extrinsic bronchial asthma were studied. They were 
further divided into two groups; six patients with active 
asthma and six patients were in remission- The criteria 
for dividing these patients have already been described.
Ten healthy adults, aged from 19 to /|5 years, were studied 
as a control group. All therapy in asthmatic patients was 
discontinued for at least 24 hours before the exneriments. 
Samples of venous blood were collected, between 8.30 and 
9.30 a.m. to avoid circadian variations. The FEV^ was 
measured in asthmatic patients within a few minutes of blood 
collection.
Reagents
Reagents used were guanosine trinhosnhate (gtP), 
guanosine dichosphate (gBP), 5'-guanosine rnonophosuhate 
(5'-GMP), 3’5.* cyclic guanosine monouhosphate (cyclic GMP), 
guanosine, guanine, human albumin, DL uropranolol 
hydrochloride, ï,~noradrenaline (all purchased from Sigma 
Chemical Comoany), acetylcholine (Cal Biochem), th\atîOxamine 
hydrochloride ('L R. Warner & Gonroany) , Ficoll (Pharmacia 
Fine Chemicals, Sweden), hypaque 459 (Hinthrop Laboratories,
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3Surrey),, H-,guanine, 1 Gi/rnmol (Radio Chemical Centre, 
Amersham). The scintillation grade chemicals, 2, 5- 
diphenyloxazole (PPO), toluene, 1-4 dioxan, and 2 
ethoxyetha.no 1 and also the Whatman 3MM ohroma/bography naner 
were purchased fr.om DDE Chemicals Limited,
Preparation of Ivmnhocytes
Lymphocytes were prepared from 40 ml. of whole blood. 
This volume of blood was carefully layered over an eoual 
volume of ficoll-hypaque and then centrifuged with 400 gm, 
at the interface for 20 minutes as described by Harris et 
al^^^. The red cells and granulocytes were sPun down and 
the lymphocytes appeared as a narrow white layer immediately 
below the supernatant ficoll-hypaque interface. The 
lymphocyte layer was carefully removed and resuspended in 
the buffer solution (pH 7«40), the constituents of which 
are given in table XXIV. After centrifuging this 
suspension for 5 minutes at 70 gm. the supernatant was 
discarded and the procedure was repeated, Finally, the 
lymphocyte pellet was resuspended in 1.5 ml, of buffer 
prior to incubation with ^H-guanine at 37°0, This method 
produced a highly purified preparation of lymphocytes^
Guanyl cyclase assay
The procedure for guanyl cyclase assay was as 
described previously for the leucocyte adenyl cyclase asso.v. 
Briefly, the procedure involved the. incubation of 
lymphocytes with ^H-guanine (l u Gi/5 x 10^ cells) at 37^0- 
for two hours followed by stimulation of the washed,
118
resuspended cells for 3 minutes with the appropriate drugs. 
■The various drug treatments are given in table XX'VIII. The 
reaction was terminated by boiling and 0.1 ml. of non­
radioactive carrier solution containing 5mM each of 3'3* 
cyclic GMP, GTP, GDP, 5' AMP, guanosine and guanine was 
added. Chromatographic separation of nucleotides and 
purine bases after l8 hours of development are given in 
table XXIX. The areas corresponding to 3'5* cyclic GPP, 
guanine plus guanosine and GTP plus GDP plus 5* GPP were 
cut out and placed in separate vials. The nucleotides and 
purine bases were eluted from the paper with 1 ml, of water 
and 15 ml. of scintillation fluid, constituents of which are 
given in table IV. The scintillation counting was done on 
a Packard S,S. scintillation counter with 30% efficiency 
for
Analysis of data
The guanyl cyclase activity was calculated as the ratio 
of cyclic GM? to the total activity found in GTP, GDP,
5* GMP, cyclic GMP, guanosine and guanine expressed as a 
percentage. The method for expressing results has been
•i
described previously'.107, 168
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CHAPTER VI 
RESULTS
^ Biochemical Experiments
15.0 LEUCOCYTE ADETTYL CYCLASE ACTIVITY
15.1 Response to Isoprenaline in Normal Subjects, Asthmatic
Patients in Remission and Patients with Active Asthma
The results of each group of subjects are shovm in 
table XXX together with the statistical evaluation. There 
was a significant difference in the mean percentage value 
of cyclic AUP in the control (or basal) level between 
the active asthmatic group (I.48 - 0.21) and the asthmatic
group in remission (0.64 - 0.08, P < .OO5) but not between
the active asthmatic group and the normal group
(1.15 i 0.26). The difference between the normal group 
and the asthmatics in remission was also not significant 
(P >.10).
In normal subjects isoprenaline at 10 and also 10 
evoked significant increases in leucocyte adenyl cyclase 
activity 61% (P < .02) and 44% (P < .OO5) respectively.
In the asthmatic remission group significant increases in 
leucocyte adenyl cyclase activity were observed, that is 
64%: (P 4, .005) and 93% (P < .001). However, no significant 
increase in enzyme activity was observed in the acute
-6asthmatic group when the cells were stimulated with 10 M 
and 10""^ M isoprenaline.
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In the asthmatic group, when the hasoA or control level 
of adenyl cyclase activity was plotted against the increase 
in activity of enzyme on stimulation with 10 isoprenaline 
(Pigo 26), there was a significant inverse correlation 
between these two. parameters (r - 0.82, t test = 4«79,
P <.00l). These results suggest that in patients with 
acute asthma, the leucocyte adenyl cyclase activity is 
maximally stimulated and further stimulation becomes 
increasingly difficult.
The leucocyte adenyl cyclase response to 10 
isoprenaline (percentage increase over the control value) 
in individual patients did not relate with the changes in 
and SGaw produced by propranolol administration or 
allergen challenge. Further, no correlation was observed 
between the total circulating reagins (igZ) and the control 
adenyl cyclase activity or its responsiveness to 
isoprenaline. The results of this investigation have been 
published and a copy of the paper is included in the 
Appendix^^^.
13.2 Effect of Thynexamine and Phentolamine on the Leucocyte 
Adenyl Cycla.se Response to Isoprenaline
The results of each group of subjects are given in 
table XXXI. Thymoxamine 2 x 10”^M nroduced no increase in 
the three groups examined, but in combination with 
isoprenaline 10"^M the increased activity in all three grouns 
wa,s highly significant. Similarly, phentolamine at 
2 X 10"*^ M alone evoked no change in any group, but in
121
/combination with 10 isoprenaline a highly significant 
increase was obtained in all three groups.
13.3 Effect of ha** Activated ATPase Inhibitor, Ouabain, on the
Leucocyte Adenyl Cyclase Resnonse to Isonrenaline
The results of each group of subjects are given in 
table XXXIIc Ouabain 2 x 10 caused a marginally 
significant increase in ^H-cyclic AMP in the asthmatic 
patients in remission but no change in active asthmatic or 
normal groups. The combination of Ouabain 2 x 10~^M and 
isoprenaline 10 significantly stimulated leucocyte 
adenyl cyclase a,ctivity in all three groups.
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16.0 LYMPHOCYTE C r X j m T Î .  C r C L k S T ,  ACTIVITY
16.1 Response to Propranolol and Pro-pranolol 4 Noradrenaline
Results of this' investigation are summarised in table 
I XXXIV. Propranolol alone at 2 x 10 did not evoke any
I significant difference in cyclic GMP levels in all three
I groups. However, propranolol at 2- x 10“'^H in combination
 ^ with noradrenaline 10 produced a very significant
increase in guanyl cyclase activity in normals, 94^
(p < .001), but no significant increase in either the active 
asthmatic group or asthmatic patients in remission.
16.2 Response to Acetylcholine, Thymoxamine and Thvmoxamine +
' Acetylcholine
Results of this investigation are given in table XXXV.
Acetylcholine alone at 10 '^M produced a significant increase
in the lymphocyte guanyl cyclase activity in normal group,
4 l f o (p < .02), but no significant change in either the
remission group or patients with active asthma,
~4Thymoxamine alone at 2 x 10 M produced a significant 
increase in the enzyme activity in the normal group,
(p < .01) and also in the remission group, 21^ (p < .02), 
but no significant change in the active group. Thymoxamine 
at 2 X 10"^M in combination with acetylcholine lO^^M 
produced a highly significant increase in the guanyl 
cyclase activity in the normal group, 104^ (P < .001), but 
no significant change in either the remission group or 
patients with active asthma.
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'CHAPTÏÏR VII 
DISCUSSION
17.0 LT^TCOCTTN ADNUYL GYCT.ASN ACTIVITY
17.1 Response of Tieuoocyte Adenyl Cyclase to IsoDpenalino
The increase in leucocyte cyclic ANF in the active 
or "acute" asthmatic group on stimulation with lO" 
isoprenaline was not significant (l2.4f) and was associated 
with a mean FBV^ of 56/ for the groun. This contrasts 
with the 93'^/' increase in ]^î cyclic AMP in the remission 
group with a mean PEV^ of 67f'> (tahle XXXVl). These 
. findings are in agreement with the clinical division of the 
patients into those suffering from active or "acute" asthma 
and from asthma in remission. These results are in accord
109with the observations of Parker and Smith' who found not 
only was there a diminished responsiveness of leucocyte 
adenyl cyclase to isoprenaline stimulation associated with a 
more severe degree o f  airways obstruction but, in addition, 
two of their asthmatic patients showed a waxing and waning 
in this activity with remission and exacerbations of the
107illness. The results of Logsdon et al who found most 
of their asthmatic patients had reduced responsiveness^ to 
isoprenaline, and those of Uillespie et al^^^, who found 
that most of their asthmatic patients showed no difference 
from normals in this respect, are difficult to explain, but 
it should be noted that these authors did not report 
measurements of airways obstruction in their patients.
The significant differences in the control values of 
adenyl cyclase activity in active asthmatic group and those
124
Log % Increase in 
Leucocyte Adenyl Cyclase A ctiv ity  
on Stimulation w ith  iso
Fig. 2 1
0  5 0 100 1-50 200 2*50
BASAL ADENYL CYCLASE ACTIVITY
Relationship between the control (basal) leucocyte 
adenyl cyclase activity and log^^ ner cent increase in 
this activity in response to ’ 10 M isoprenaline
in patients with asthma.
(r = 0.82, student's t = 4.79, F < .001),
Individual data published (Patel, Alston and Kerr, 
1974)169.
in remission suggest that in active asthma the leucocyte 
adenyl cyclase may he almost maximally stimulated by 
circulating endogenous catecholamines and that further 
stimulation with sympathomimetic amines becomes increasingly 
.difficult, resulting in adrenaline fast state (Pigc 27).
This diminished beta receptor resnonsiveness in acute asthma
I
is generalised and may also explain the diminished metabolic 
responses to adrenaline administration in some patients with 
asthma.
It is difficult to postulate whether the diminished beta
receptor responsiveness observed in some patients with
asthma is an inherent abnormality or whether it results from
the severity of the disease. The presence of this
abnormality in patients with acute asthma and inverse
relationship of enzyme activity to the basal levels of
adenyl cyclase activity suggests that this enzyme system is
maximally stimulated by endogenous factors under the stress
of the disease and further stimulation becomes increasingly
difficult. In addition, increased metabolisation of
catecholamines to 3 methoxyadrenaline and 3 methoxy-
170noradrenaline, which are weak beta blockers , could also 
account for diminished beta responsiveness in these uatients 
and this possibility still remains to be investigated,
17.2 Effect of Aloha Blocking Drugs and Ouabain on the Leucocyte 
Adenyl Cyclase kesoonse to Isoorenaline
In Part I of this thesis the presence of alpha receotors 
with bronchoconstriotor activity ha,s been demonstrated in
12'
human lung. The effect of alpha recentor blocking drugs
.was therefore studied in the experimental system. It is
clear that phentolamine and thymoxamine both restore the
responsiveness of leucocyte adenyl cyclase activity to
isoprenaline towards normal in acute asthmatic groups.
Moreover, Ouabain, a potent inhibitor of Fa"^  and K*''
205
activated ATPase  ^ also restores the adenyl cyclase 
responsiveness to isoprenaline towards normal in acute 
asthmatic grouns. The similarity of the action of Ouabain 
to that of the alpha blocking drugs supnorts the view that 
there is increased alpha receptor activity in acute asthma, 
and that the membrane bound enzyme Na*' activated ATPase 
is closely associated with alpha receptor activity^^^.
Coffey et al^^^ have demonstrated with broken cell 
preparations that there is increased ATPase activity in 
the leucocytes of asthmatic children, and that, this activity 
can be reduced towards iiormsd. by treatment with 
hydrocortisone, and also that latter restores the 
responsiveness of the cells to isoprenaline stimulation.
This increased ATPase activity in leucocytes of asthmatic 
patients cannot be attributed to treatment with broncho- 
dilator drugs since these drugs show no effect on the
leucocyte ATPase activity of normal subjects treated with
. 110 
sympathomimetic amines
The above observations would imply that the therapeutic 
approach to patients with acute asthma would be to stimulate 
their adenyl cyclase cyclic AMP system through the combined
126
use of beta adrenergic agonist and aloha recentor blocking 
drugs and indeed such an approach is feasible in management 
of patients with resistant airways obstruction^^^ (pigs. 1? 
and 18).
17*3 Relationship of Leucocyte Adenyl Cycleso Activity and
Airways Response to Beta Blockade and Alleryen Chal‘J en.^
In 13 patients the leucocyte adenyl cyclase response to 
isoprenaline (percentage increase over the control value) in 
individual patients did not correlate with the changes in 
and SGaw produced by propranolol administration or 
allergen challenge. Further, no correlation was observed 
between the total circulating reagins (igk) and the control 
adenyl cyclase activity or its responsiveness to 
isoprenaline.
However, when the basal or control level of adenyl 
cyclase activity was plotted against the percentage increase 
in the activity of enzyme on stimulation with 10“’'^P 
isoprenaline (Fig. 27) there was a significant inverse 
correlation between the two parameters. The individual 
data of this investigation was published in Clinical 
Allergy^^^ and the reprint of the paner is included in. the 
Appendix.
Assuming that the beta adreno-receptor dysfunction in 
asthma is generalised and also reflected in the Peripheral 
leucocytes, the results of this investigation suggest that 
■ the phenomenon of bronchial hyper-reactivity and IgF
production may not be related to diminished beta recentor
127
function. In normal subjects beta receptor blockade does 
not induce histamine or methacholine hyper-reactivity 
(Figs. 24 and 25) whereas in certain animal species beta 
adrenergic blockade with dichloroisoproterenol has been 
shovm to induce histamine hyper-sensitivity and a state 
resembling atopy in these animals^^. Undoubtedly the 
observations in animal experiments are important, their 
significance in the aetiology of bronchial asthma has to be 
regarded with caution because of species differences and 
failure to reproduce chronic unrelievable asthmatic state in 
animals. The diminished beta receptor function in patients 
with acute asthma may reflect a failing counter-regula.tcry 
mechanism rather than be considered the cause of asthma.
In vitro experiments it has been showm tha,t beta 
stimulation is associated with inhibition of mediator
193release from mast cells and leucocytes " and with broncho- 
dilatation. Patients with acute asthma being defective in 
response to beta stimulation are prone to enhanced 
immunological induced release of chemical mediators and 
subsequent bronchoconstriction. Both alpha adrenergic and 
cholinergic mechanisms have recently been implicated in both
98enhanced mediator release and bronchoconstrictive 
178mechanisms . In so far as these mechanisms appear to be 
enhanced in their activity in asthma, it seems reasonable 
to speculate that the enzyme systems mediating these 
influences will be found to be increased in their activity. 
The alpha adrenergic ATPase relationship has been proposed
1-28
by Belleau^^ and evidence to support this hypothesis has
5/1 55
been put forward by Coffey et al ’ . Similarly,
cholinergic cyclic GMP relationship has been observed in a 
number of tissues including lymphocytes and lung^^. The 
cyclic GMP has been proposed to have an opposing influence 
to the cyclic . It may be that the beta adrenergic
defect observed in the cells of asthmatic patients may well 
result from more primary imbalances in the membrane ATPase 
and guanyl cyclase cyclic GMP system. The effect of alpha 
receptor blocking drugs and Na* K*" activated ATPase 
inhibitor, Ouabain, would support this hypothesis. However 
to confirm that guanyl cyclase activity is also increased 
in patients with asthma the lymphocyte guanyl cyclase 
response to alpha and cholinergic stimulation was studied 
in patients with asthma and normal subjects..
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18.0 T77;IPHQ0Y.TT'1 GÜAHTL CYCLASE ACTIVITY
18.1 Guanyl Cyclase Response to Aloha and Cholinergic Stimulation 
and thEffect of Thymoxamine on this Response
The early work on the distribution and sub—cellular
location of guanyl cyclase indicates that in most tissues
studied it occurred mainly in the membrane-free cytoplasm
of the cell in contrast with adenyl cyclase which is present
207 208mainly in the plasma membrane ^ . However, Rudl.and et
209al . have recently demonstrated that stimulation of guanyl 
cyclase activity by fibroblast growth factor (f of) in 
BMjB/c 3 TB cells in tissue culture was due almost entirely 
to an enzyme activity located on the plasma membrane 
fraction. Since the concern was to explore cell receptor 
activities a method which measured plasma membrane guanyl 
cyclase activity seemed more likely to give significant 
results. Figure 28 shows that stimulation of lymphocytes 
with noradrenaline in presence of propranolol produced a 
considerable stimulation of guanyl cyclase activity which 
reached maximum between 5 and 10 minutes and returned 
towards baseline by about 15 minutes. This time course 
activity experiment is comnarable in the degree of 
stimulation and duration of effect to the stimulation of 
membrane bound leucocyte adenyl cyclase activity with 
isoprenaline^^^. Further, addition of phosnhodiesterase 
inhibitor, theophylline, to the medium increased the basal 
level of lymphocyte guanyl cyclase activity in both the 
normal and asthmatic subjects without altering the overall
130
pattern of response. These observations suggest that the 
lymphocyte guanyl cyclase activity measured was membrane 
bound.
It has been suggested that guanyl cyclase is activated
by acetylcholine^^’ and also by alpha stimulation^^.
In normal subjects alpha stimulation with noradrenaline +
propranolol and cholinergic stimulation with acetylcholine
produced a very significant increase in cyclic GMP formation,
Unexuectedly, thymoxamine also produced a significant
although a lesser increase in cyclic GMP production in the
normal subjects which makes it difficult to explain action
of alpha receptor blocking drugs on this basis. However, 
210
Illiano et al in their studies on isolated fat cells 
found that cholinergic agonist, atropine, also caused a 
slight increase in cyclic GMP formation. In contrast, the 
only significant stimulatory drug effect on cyclic GMP 
production in asthma patients' cells was observed with 
thymoxamine in the remission group. Acetylcholine alone 
and in combination with thymoxamine and alpha stimulation 
with noradrenaline did not evoke a significant increase in 
cyclic GMP formation in either the active asthmatic group 
or patients in remission. These observations are the 
reverse of what might have been expected as it has been 
reported with experimental animals that increased levels of 
cyclic GMP are associated with a more severe degree of 
anaphylaxis^^^. However, Lewis et al^^ have shora that 
the effect of cyclic GMP on smooth muscle function is dose
131
dependent? low concentrations producing tracheal smooth 
muscle contraction whereas higher concentrations produce a
/
dose dependent relaxation. This effect of cyclic GMP on
smooth muscle can he explained by the influence of cyclic
GMP on cyclic ATT? phosphodiesterase as suggested by Beavo 
]02 103et al' ’ . Using particulate preparations of cyclic
phosphodiesterase from various tissues it has been shown
that low concentrations of cyclic GMP stimulated hydrolysis
of cyclic #iP whereas with higher concentrations of cyclic
GMP there was an inhibition of cyclic AI'IP hydrolysis
(Pig, 29)' Similar findings have been renorted for rat 
211lymphocytes ' . , and concentration of cyclic GMP required to
demonstrate this phenomenon is within the physiological 
103range
The lymphocyte guanyl cyclase activity in normal 
subjects and patients with asthma, can be explained in light 
of the relationship of cyclic GMP to cyclic AMP, In normal 
subjects alpha adrenergic and cholinergic stimulation cause 
a significant rise in cyclic GMP levels which may lead to 
inhibition of cyclic phosphodiesterase Preventing 
hydrolysis of cyclic AÎ4P and thereby maintaining relaxation 
of bronchial smooth muscle. On the other hand, in acute 
asthma alpha and cholinergic stimulation does not produce a 
significant rise in cyclic GMP level. In this situation, 
a low intracellular concentration of cyclic GMP increases 
the hydrosis of cyclic AMP through stimulation of cyclic 
m P  phosphodiesterase resulting in increased bronchomotor
132
tone and bronchoconstriction (Pig, 30). The high basal 
levels of adenyl cyclase activity^^^’ 169^ and the 
responsiveness to isoprenaline stimulation of adenyl cyclase 
in acute asthma supports this hypothesis. Asthmatic 
, patients in remission demonstrate cyclic GMP responses 
midway between those found in normal subjects and active 
asthma. The factors depressing cyclic GMP response in 
acute asthma and confirmation that cyclic phosphodiesterase 
activity is increased requires further investigation.
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% Guanyl Cyclase
Pig. 2 8 .
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Minutes
The noradrenaline (lO K) stimulation of guanyl cyclase
in lymnhocy-tes of normal subjects in the presence of 
propranolol (2 x 10“‘4m ) expressed as a function of time
(± sem).
3H"Cyclic AMP 
Hydrolysed ;iimole-R 
30 min ^
Supernale
03
Initial (cyclic AMP) - 1 pM
0 2
0-1 Particles
100101001
Cyclic GMP (pM)
P ig . 29 Effect of increasing concentrations of Cyclic GMP on the hydrolysis 
of 3H-cyclic AMP by rat liver supernatant and (particulate fractions
(Beavo, Hardmhn & Sutherland, 1970)
RELATIONSHIP of CYCLIC 3'5'AMP and 3'5'GMP
adrenergic receptor adrenergic or cholinergic receptor (?)
ATP
adrenaline & isoprenaline
adenyl cyclase
3’5’ cyclic AMP
phosphodiesterase
5’ AMP
GTP
noradrenaline &
/  acetylcholine
/
Guanyl cyclase 
3’5’ cyclic GMP
phosphodiesterase
5’ GMP
Fig. 30, The proposed relationshin of cyclic GFP to cyclic /IMP 
in control of 'bronchomotor tone. Activation of 
guanyl cyclase hy acetylcholine or noradrenaline 
increases the concentration of cyclic GMP. high 
■concentration of cyclic GMP inhibits cyclic AMP 
phosnhodiesterase preventing the hydrolysis of cyclic 
AMP to 5* AMP, thus maintaining normal bronchomotor 
tone. In asthma, the low.levels of cyclic GMP 
stimulate cyclic AMP phosphodiesterase and promote the 
hydrolysis of cyclic AMP to 5' AMP thus increasing 
bronchomotor tone.
CORRELATION RETWEEN PHYSIOLOGICAL ANO BIOGHELIICAL 
OBSERVATIONS
In Man pharmacological stimulation of beta adrenergic '
receptors in the airways causes bronchodilatation whereas
117cholinergic stimulation induces bronchoconstriction ' .
In .addition, observations renorted here confirm the 
presence of alpha adrenergic recentors in the human 
airways which when stimulated cause bronchoconstriction^'^'^.
It may therefore be postulated that the state of 
bronchomotor tone in an individual depends on the balance 
between bronchodilator beta adrenergic and bronchoconstriotor 
cholinergic and alpha adrenergic activities. In non­
asthmatic subjects, the balance of different autonomic 
divisions is so adjusted that pharmacological stimulation 
or blockade of any division does not change the bronchial 
calibre significantly. This balanced autonomic control 
of the airways in normals may also explain an attenuated 
or absence of response to pharmacologically active 
substances such as histamine, bradykinin, ,
acetylcholine and prostaglandins on the airways of these
subjectd^’ 39, 42, 157,
In contrast, the patients with asthma show a great 
variability in bronchomotor tone, an abnormality which, has 
been recognised for many years and considered to be the 
hallmark of asthma. Furthermore, pharmacological 
stimulation of the beta adrenergic receptors in the airways 
causes marked bronchodilatation whereas cholinervic 
stimulation causes bronchoconstriction in these nationts.
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In addition, the investigations reported in Part I of this 
thesis confirm that alpha adrenergic receptors stimulation 
in asthmatic patients can cause significant broncho- 
constriction in both the central and peripheral airways.
In contrast to normal subjects, the balance between the 
broncliodilator beta adrenergic and bronchoconstrictor 
alpha adrenergic and cholinergic activities in the airways 
is more critical in asthmatic subjects end a change in any
one division greatly influences the bronchial calibre.
89 90Although Prime et al and Simonsson et al have
demonstrated more directly the presence of alpha adrenergic
receptors in human airways, its role in control of
bronchomotor tone had not been investigated. Unlike Prime 
89
et al , I was unable to demonstrate bronchoconstrictor
alpha adrenergic activity in normal subjects even after
beta adrenergic blockade with large doses of propranolol.
This observation would indicate that alpha adrenergic
117activity, like beta and cholinergic activities ,
contributes little in the control of bronchomotor tone in
normal subjects. In contrast, asthmatic natients develoo
significant bronchoconstriction following alpha stimulation
with phenyleuhrine. In patients with acute asthma, there
is diminished beta receptor responsiveness to 
76 77catecholamines ’ which increases with severity of 
78asthma . In such a situation, the minor alpha recentor 
stimulating properties of catecholamines may become 
dominant and cause bronchoconstriction by stimulating 
alpha receptors. This phenomenon may well explain the
139
adrenaline fastness or reversal commonly seen in status 
asthmaticus.
In various provocation tests, alpha blockade with
21 /
thymoxamine effectively inhibited histamine, exercise 
215and allergen induced bronchospasm whereas it had no
195effect on prostaglandin alpha ' or mechacholine induced 
bronchoconstriction. The inhibitory effect of thymoxamine 
in histamine, allergen or exercise induced broncho­
constriction may be mediated by ability of alpha receptor 
blocking drugs to restore beta receptor responsiveness to 
cat echo lamine 8^ "^^  ^ 168^ Although the overall inhibition 
of histamine, allergen or exercise induced broncho­
constriction was statistically significant, there was wide 
individual variation in these patients suggesting inherent 
differences in airways sensitivity to different mediators 
released in the type I reaction. For instance, in a, 
patient in whom thymoxamine effectively blocked allergen 
induced asthma may reflect predominaJice of histamine 
hyper-reactivity which is inhibited by alpha blockade 
whereas in a patient in whom thymoxamine had no effect in 
this respect may reflect predominance of hyner-reactivity
to other suasmogens such as prostaglandin alpha which
195are not inhibited by alpha blockade The failure of
thymoxamine to inhibit methacholine and prostaglandin F ^  
alpha induced bronchoconstriction is easy to explain as 
both these agents have been shown to activate cholinergic 
receptors through guanyl cyclase cyclic GMP. systom^^^
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178which is unaffected hy thymoxamine . In addition, 
inhibition of methacholine and prostaglandin alpha by • 
atropine is consistent with this hypothesis.
It is difficult to postulate whether the autonomic
imbalance in asthma is a local phenomenon relegated to the
lung or is mediated from higher centres. The influence
of emotion and psyche on the bronchomotor tone in Patients
with asthma would suggest that higher centres may be
involved. In addition, differences in metabolic responses
to epinephrine administration in normal subjects and
76 77 78patients with asthma ' ' indicate that the
biochemical abnormality observed in asthma is more 
generalised than previously thoughti
The autonomic receptors have been visualised as 
specialised receptive organs on the cell membrane since 
they were first described by Dale in 1933^^ ° Our 
understanding of the biochemical nature of these receptors 
is just beginning to develop. The presence of enzymatic 
autonomic receptor activities on the membranes of 
peripheral leucocytes has provided a meaningful material 
for more basic and fundamental research into biochemical 
abnormalities in asthma. The leucocyte adenyl cyclase 
(now identified with, beta receptor function) stimulation 
with isoprenaline is diminished, in padients with acute 
asthma whereas response of this enzyme■system in patients 
in remission does not show any significant difference from 
normal subjects^^^' 1 ^ 9 ^  The high basal levels of
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adenyl cyclase activity and its inversely related response
169
. to isoprenaline in acute asthma would seem to reflect
maximal stimulation of this enzyme system hy endogenous
factors so that further stimulation becomes increasingly
difficult. This observation vjould support previously
76 77reported refractoriness to adrenaline administration ’ 
in asthmatic patients which is known to increase with the
78severity of asthma . It is unlikely that the diminished
adenyl cyclase activity in asthma is drug induced as has
212been suggested by Connolly and co-workers In normal
subjects long term oral medication with sympathomimetic
109
amines has failed to produce similar phenomenon , and 
secondly the patients studied in the present investigation 
were off simple bronchodilator drugs and steroids for at 
least .24 hours before the blood samples were collected for 
enzymatic assays. The airways bronchoconstrictor response 
to beta blockade with propranolol in asthmatic patients can 
be explained in light of biochemical observations. In 
patients with asthma, the adenyl cyclase activity is 
increased, and this is required to maintain broncho- 
dilatation and to counteract bronchoconstricting influences 
mediated by cholinergic, alpha adrenergic and possibly local 
hormonal activities. Propranolol vfhich inhibits adenyl 
oyclase^^^ leads to reduction in the beta receptor function 
of the airways and hence bronchoconstriction.
The possibility of enhanced cholinergic mechanisms in 
asthmatic patients has also been postulated^^^ ’ In
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contrast to rny expectation, the lymphocyte guanyl cyclase 
'response, an enzyme system knoT-m to mediate cholinergic^^’ 
and possibly alpha adrenergic responses^^, was depressed 
in asthmatic groun as a whole and no distinction could be 
made on the basis of clinical state of the disease as was 
possible in the adenyl cyclase study. It appears that 
guanyl cyclase cyclic GMP abnormality in asthma may be a 
primary defect which in turn modifies adenyl cyclase 
activity. Alpha and cholinergic stimulation both cause 
bronchoconstriction in Man, and this response is grossly 
exaggerated in asthmatic patients. In guanyl cyclase 
studies, alpha and cholinergic stimulation have been shoivn 
to cause a significant increase in cyclic GMP formation in 
lymphocytes of normal subjects. Assuming that similar 
increase in cyclic GMP also occurs in the bronchial smooth 
muscle of these subjects, the high levels of cyclic GMP 
formed may lead to inhibition of cyclic AMP phospho­
diesterase preventing hydrolysis of cyclic AMP and thereby 
maintaining relaxation of bronchial smooth muscle. This 
observation would explain the absence of bronchoconstrictor 
response on alpha and cholinergic stimulations in normal 
subjects. In contrast, alpha and cholinergic stimulation 
does not produce a significant increase in cyclic GMP 
formation in asthmatic patients and this would have an 
effect opposite to that observed in normal subjects. It 
is possible that in asthmatic patients we are observing an 
increased hydrolysis of cyclic AMP through stimulation of
139
102 101cyclic phoschodiesterase as reported by Beavo et al ^
r e s u l t i n  bronchoconstriotion. Such a phenomenon in
bronchial smooth muscle would explain bronchoconstrictor
response to alpha and cholinergic stimulation and in mast
cells increased mediator release by alpha and cholinergic
98agonists as already reported by Kaliner et a,l
It is my belief that the answer to the pathogenesis of 
bronchial hyper-reactivity and atopy in asthma may lie in 
the relationship of nucleotide enzymatic activities on the 
bronchial and mast cell membranes and further research in 
this field may provide further understanding and better 
management of this disease.
Therapeutic Implications
Biochemical and physiological evidence is presented 
which suggest that alpha receptor blocking drugs potentiate 
the effect of beta agonists. A combined administration of 
thymoxamine and isoprenaline certainly causes greater and 
more prolonged bronchodilatation as compared to broncho- 
dilatation achieved with isoprenaline alone. In addition, 
combined therapy has proven of value in patients with chronic 
labile airways obstruction who had previously failed to 
respond to salbutamol alone. The use of alpha blocking 
drugs may prove a new approach in management of asthma. 
However, the wide clinical application of such a form of 
therapy may be limited at present because of short duration 
of effect and hypotension caused by aloha receotor blocking 
drugs when given intravenously and local irritant effect 
when inhaled.
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Clinical and Lung Function Data 
of 10 Patients with Asthma
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Patient Mo. 1.
Mr.
Age î 18 yearso
/
Occupations Accounts™clerk.
Historys
' This young man gave a history of episodic asthma and hay 
fever since early childhood. There were no seasonal variations in 
his asthma, however, his attacks were mainly nocturnal. There was 
no history of exercise induced asthma.
Family History:
Parents alive.
Two brothers and one sister - sister suffers from asthma. 
Therapy£
Sodium cromoglycate one spincapsule four times a day and one 
Franol tablet at night.
Invest igat ions t
Haemoglobin 97%*
Total W.B.C. count î 7,600/mm^.
Absolute eosinophil counts 694/mm .
Total serum IgE level ■s 343 ng/ml.
Skin tests s House dust ++
Dermatophagoides Fteronyssinus 4-+
Bg Grasses +++
Feathers (mixed) ++
Pulmonary function tests î V.G* 3*80
3.15
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Patient No ■> 2.
Mr. D. 0.
Age t 20 years.
Oooupeitions Welder in shipyard.
Historyg
This patient gave a history of atopic eczema and asthma 
since early childhood. His attacks of asthma were fairly mild 
and there was no seasonal variation. He denied history of exercise 
induced asthma.
Family History;
Two sisters and two brothers - one brother suffers from
asthma.
Therapyg
Sodium cromoglycate one spincapsule four times a day +  
Salbutamol inhaler - 2 puffs when required.
Investigat ionst
Haemoglobin s 108^ o.
Total W«]3*G* count t 7,450/mm^.
Absolute eosinophil counts 864/mm^.
Total serum IgS level s 8O8 ng/ml.
Skin tests £ House dust ++
Dermatophagoides Pteronyssinus + +
Bg Grasses 44+4 
Dog hair 4 
Pulmonary function tests s 2.60
FW^ 1.75
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Patient No. 3°
Mr. A. H.
/
Age î 30 years.
Occupations Lecturer at Technical College.
History;
This patient gave a history of episodic asthma and hay fever 
since early childhood. His attacks of asthma were fairly mild hut 
tended to become more frequent between June and September. There 
was no history of exercise induced asthma.
Family History;
Ho siblings.
Mother suffers from asthma.
Therapy;
Isoprenaline 5 mgm. sublingually.
Required this medication occasionally.
Investigat ions;
Haemoglobin s 98^ 1.
Total W.B.C. count : 5>580/ 3
Absolute eosinophil counts 836/mm^.
Total serum IgF level t 467 ng/ml. 
Skin tests s House dust +4
Dermatophagoides Pteronyssinus 44
Dg Grasses 44
■ Feathers -ve 
Dog hair 4
Pulmonary function tests s V.G. 6.43 (5«60)
F.HF^  3.87
F.R.G. 4.50 (4.25)
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R.V. 2,50 (2.17) 
T.L.O. 8.93 (7.77)
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Patient Ho« 4* .
Miss E, P.
Age s 16 years.
Occupations School girl.
History:
This patient gave a history of recurrent respiratory tract 
infection associated with wheezing in her childhood. In the last 
two to three years her asthma had been fairly mild but her main 
problem was exercise induced bronchospasm which prevented her from 
taking part in physical activities at school.
Family Historys
Two sisters - one suffers from asthma.
Mother also suffers from asthma.
Therapy;
Sodium cromoglycate one spincapsule three times a day + 
Salbutamol 4 mgm. orally - when required,
Inve s t i gat ions :
Haemoglobin s 102/.
Total W.H*C. count î 5>800/mm^.
Absolute eosinophil counts 720/mm/.
Total serum IgE level ; 1,496 ng/ml.
Skin tests s House dust 44
Dermatophagoides Pteronyssinus 44 
Dg Grasses - 
Feathers - .
Pulmonary function tests 2 V.O. 3.80 (3.30)
FEY^ 2.45
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F.R.O'. 2.60 (1.90)
R.V. 1.55 (0.90)
T.L«0. 5-35. (4,30)
D^GO 25.9 (25.0) ml. co/min/mm.Hg
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Patient Wo. 9*
Miss R.
Age^ s 23 years.
Ocoupations Primary school teacher.
I
History;
I^
 This patient gave a history of atopic eczema and episodic
asthma since early childhood. Since moving to Glasgow two years 
ago, her asthmatic attacks were more frequent. There was no 
seasonal variation. She also gave a history of exercise induced 
bronchospasm.
Family Historys
Two brothers - one brother has atopic eczema and asthma. 
Therapy:
Sodium cromoglycate one spincapsule four times a day + 
Salbutamol inhaler 2 puffs when required.
Investigations:
t 94#.
s 7,620/mm^.
Haemoglobin 
Total W.H.C. count
Absolute eosinophil counts 893/mm/. 
Total serum IgE level 't 1,110 ng/ml. 
Skin tests s House dust 4+
Dermatophagoides Pteronyssinus 444
Bg Grasses 4
Pulmonary function tests
Feathers 4 
V.G. 4.40 (3.60) 
FEV^ 3.40 
F.R.G. 1.95 (2.67)
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R.V. 1.00 (1.32)
T.L.O. 5-40 (4.92)
Dj^ GO 19.0 (21.9) rnl. CO/min/mm.Hg.
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Patient Mo. 6 .
Mr. M. S.
Age s 29 years.
Occupation; Engineer.
History:
This young man gave a history of atopic eczema, hay fever 
and 8,sthma since early childhood. His attacks of asthma were 
episodic hut tended to he more frequent in summer months. There 
was no history of exercise induced asthma.
Family Historyî
Two brothers - one brother suffers from atopic eczema. 
Therapy:
Salbutamol inhaler - 2 puffs when required.
Investigations:
s 107#.Haemoglobin 
Total WtB.O. count 7,450/mm'
Absolute eosinophil count; 829/mm/. 
Total serum IgE level ; I40 ng/ml. 
Skin tests « House dust 444
Dermatophagoides Pteronyssinus 444
Bg Grasses 444
Pulmonary function tests
Feathers -
V.G. .4.94 (4.96)
FPJV^  1.75
F.R.G. 4.35. (3.74)
R.V. 2.15 (1.87) 
T.L.G. 7.09 (6.83)
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Patient No. 7 »
Mr. I.
Age s 43 years,
/
Occupation; Wages clerk,
History:
I
This patient gave a history of atopic eczema and asthma
/
since early childhood. In the last ten years his asthma had been 
fairly chronic and he required occasional steroid therapy. He 
also gave a history of exercise induced asthma.
Family History:
1 Patient was an adopted child and has no recollection of
parents or siblings.
He has two sons and two daughters - none suffers from an 
atopic disease.
Therapy g
Sodium cromoglycate one spincapsule four times a day, 
Salbutamol inhaler - 2 puffs four to six times a day,
Inve s t i g at ions ;
Haemoglobin s 104#.
Total W.H.O. count s 8,600/mm^.
Absolute eosinophil count: l,069/mm^.
Total serum IgE level : 13,140 ng/ml. (double checked)
Skin tests t House dust 4+
Dermatophagoides Pteronyssinus 44 
Bg Grasses 44
Aspergillus Fumigatus 4 - Arthus 
reaction absent.
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Pulmonary function tests : V.O. 3.00 (4.66)
j FEV^ 1.52
F.R.C. 3.10 (3.74)
R.V. 2.49 (2.02)
T.L.G,. 5'49 (6.68)
DyCO (rest) 11.4 (l9»6) ml, CO/min/
mm,Hg.
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Patient No. 8.
Mrs. J. H. . .
Age « 26 years.
Occupations Housewife.
History:
This patient gave a history of hay fever for the last four
years and this was associated with pollen asthma. She was fairly
free of symptoms in the other times of the year. She also 
suffered from rheumatoid arthritis, however, there were no joint 
deformities and she was fairly mobile.
Family History2
One brother and one sister - sister suffers from fever.
Therapy:
Beolamethasone dipropionate aerosol 200 ugm. four times a 
day from May to September. Indomethacin 25 mgm. four times a day 
for rheumatoid arthritis.
Invest igat ions:
Haemoglobin s 88#.
Total W.B.O. count s 4,650/mm^.
Absolute eosinophil counts 529/mm^.
Total serum IgS level 2 280 ng/ml.
Skin tests s House dust -
Dermatophagoides Pteronyssinus -- 
Bg Grasses ++
Pulmonary function tests s V.O. 2.65,(3..51 )
FW^ 1.95 
F.R.G. 1.95 (2.67)
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R.V. 1.16 (1.37)
T.L.C. 3.80 (4.87)
D^CO (rest) l8.7 (20.2) ml, CO/min/
mm.Eg.
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Patient Ho. 9»
Mrs. E. H.
Age s 25 years.
Occupations Housewife.
History:
This patient gave a history of episodic attacks of asthma 
for two years. Her main problem was exercise induced asthma. 
Family Historys
Ho siblings.
Ho history of atopic disease in the family.
Therapy:
Sodium cromoglycate one spincapsule four times a day 4- 
Salbutamol inhaler when required,
Inve stigat ions:
Haemoglobin 
Total W.B.C, count
92 .^ 
7,620/mm'
Absolute eosinophil counts 605/mm/.
Total serum IgE level s not estimated. 
Skin tests House dust 4-1-
Dermatophagoides Pteronyssinus 44
Bg Grasses -
Pulmonary function tests
Feathers - 
V.O. ,3.70 (2.99) 
FFV^ 2.40 
F.R.O. 3.25.(2.20)
R.V. 2.02 (1.00) 
T.L.G. 5.74 (4.08)
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D^CO (rest) 23.2 (19.8) ml. CO/rnin/
mm.Eg. .
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Patient No. 10.
Miss E*
Age : 16 years.
Occupations School girl.
History:
This girl gave a history of wheezing from early childhood. 
Her attacks were mild and episodic. There was no seasonal 
variation. In the last two years she complained of exercise 
induced asthma and her effort tolerance was limited to going up a 
flight of stairs.
Family History:
Two brothers - one suffers from asthma.
Therapy:
Sodium cromoglycate one soincapsule four times a day + 
Franol tablet when required.
Investigations:
Haemoglobin : 89#.
■
Total H.B.G. count t 4p670/mm .
Absolute eosinophil counts 560/mm^,
Total serum IgE level î 2B0 ng/ml.
Skin tests 2 House dust 44
Derraatophagoides Pteronyssinus 444 
Bg Grasses 4 
Feathers 4
Pulmonary function tests : VAC. 3.60 (3.88)
FIW^ 2.00
F.R.O. 3.15 (2.90)
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R.V. 1.87 (1.44)
T.L.C. 5.47 (5.32)
D^GO (rest) 16.9 (22.2) ml, CO/min/
inm.ïïg.
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Abbreviations
F.R.O. : Functional Residual Capacity.
R.V. : Residual Volume.
T.L.C. s Total Lung Capacity.
D CO £ Carbon Monoxide Transfer Factor.
L
Values in parenthesis are the predicted values for the patient
Interpretation of Prick Tests
Reactions were assessed by the degree of erythema and the 
size of wheal produced (after allowance for any positive response 
to the glycero-saline control);
4-1-4 Very sensitive
44 Moderately sensitive ■
4 Mildly sensitive
Wheal more than 3 mm. diameter.
Flare more than 5 mm. diameter.
Wheal less than 3 mm 0 diameter.
Flare less than 5 mm. diameter.
Wheal insignificant.
Flare less than 3 mm. diameter.
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Mathematical Derivation of Observations on Page 88
l6l
MATHEMATICAL DERIVATION OF OBSERVATIONS ON PAGES 88. AHD 109 
According to Starling’s law of the heart, an increase 
in' the diastolic volume of the ventricle results in a
I
proportional increase in cardiac output, and during isotonic
contraction of a single muscle fibre the degree of
I
contraction is proportional to the initial length of the 
muscle fibre.
Thus, L OC 1 (i)
where L is the initial length and 1 is the 
change in length produced by muscle contraction.
If the muscle fibre surrounds the circumference of a 
flexible tube, it will produce change in radius following 
contraction, and the above equation can be rewritten as
2 ^  R 0C2 /T r (ii)
where R is initial radius, r is change in radius.
.% R 06r e  (iii)
The above relationship also holds true for isolated guinea- 
pig tracheal muscle (Everitt & Gairncross, 1969)^^.
According to Poiseuille's Law, airways resistance
(Raw) o C 8 X L X n (iv)
7 ?  i F
Airways Resistance (Raw) 8 x L x n
7,?' ~
where L is the length of a bronchus 
n is the viscosity of respiratory gases 
and H is the radius of.the bronchus.
In an individual oatient, as the change in the length 
of an airwav during bronchoconstriction is negligible, and 
as the viscosity of the respiratory gases also do not change
162 ■
significantly, the above equation can therefore be rewritten 
as
/ Raw(V k (where 8 x Ln is a constant k)
' Conductance (Caw) which is 1 would bo
Raw
s i  w
k
and change in Caw r^ (vi)
k
where r is change in radius of the bronchus.
As ROC r • (iii)
• ■ • s i  o l  £.1
k k
Initial Gaw OC change in Gaw.
This contention is consistent with observations on 
pages 88 and 109.
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Additional Table;
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Effect of Alpha-receptor Blocking 
Drugs and Disodium Crornoglycate 
on Histamine Hypersensitivity in 
Bronchial Asthma
JAMES W. KERR,* M .D .,  f . r . c . p . g l a s g . ,  m . r . c . p .
M. GOVINDARAJ,t m .b . ,  m . r . c . p . g la s g .
K. R. PATEL4 M . B . ,  B . s .
Summary: Twenty patients with extrinsic type bronchia! astlmia are shown to have a significant fall in 
vital capacity (V.C.) and forced expiratory volume in 1 
second (F.E .V .i) after an intravenous infusion of 50/tg. of 
histamine dihydrochloride. In  10 of these subjects the fall 
in  V.C . and F.E.V.i produced by intravenous histamine is 
inhibited by the alpha-receptor blocldng drugs phentol­
amine and phenoxybcnzamine injected before the hista­
mine test. The inhalation of disodium crornoglycate in 10 
subjects is also shown to inliib it tlie fall in V .C . and 
F.E .V .I produced by the intravenous infusion of hista­
mine. I t  is suggested that bronchial smooth muscle in 
asthmatic subjects has alpha-adrenergic receptor sites, 
and that a possible mechanism for the action of disodium 
crornoglycate is that it stabilizes the cell membrane, 
thereby altering calcium ion transport.
Introduction
In  1929 Weiss, Robb, and Blumgart reported that intxa-
vcnously administered histamine produced a fall in ventilatory
capacity of asthmatic subjects at dosage levels which did not
affect the pulmonary ventilation in normal subjects. This
hypersensitivity to histamine of the airways in asthmatic
* C o n su lta n t Physician.' 
t  F o rm e r M e d ica l R eg istra r.
$ M e d ic a l R eg istra r.
R esp ira to ry Diseases U n it,
H o sp ita l, G lasgow W .3.
C O P Y R I G H T  (ÿ 1970. A ll HiGurs of KEPRonucrioN op this reprint are
  RESERVED IN ALL COUNTRIES OF THE WORLD260/70
W este rn  In f irm a ry  and K n ig h tsw o od
subjects has often been confirmed (Curry, 1946; Dowell, Kerr, 
and Park, 1966) and has been shown to persist for many years 
even in the absence of active asthma (Bouhuys et al., 1960).
Certain animal species develop histamine hypersensitivity 
after an injection of a vaccine prepared from Bordetella  
pertussis organisms (Parfenjcv and Good line, 1948), and while 
investigating this phenomenon in the laboratory Fishcl, 
Szcntivanyi, and Talmagc (1962) observed that in some spe­
cies histamine hypersensitivity could be produced by the 
administration of the beta-adrenergic blocking drug d i- 
chloroisoprotcrenol. These authors went on to suggest that the 
histamine hypersensitivity was the result of a functional 
imbalance between the two types (alpha and beta) of adren­
ergic receptor systems, and Szcntivanyi (1968) developed this 
hypothesis into a general theory to explain the atopic abnor­
mality in bronchial asthma. In  man tlic clinical importance of 
these experimental observations became evident when 
M cN eill (1964) reported that propranolol, a beta-adrenergic 
receptor blocking drug, caused a fall in ventilatory capacity in 
asthmatic subjects which was not reversed by isoprenaline. 
M cN eill and Ingram (1966), using a body pleihysmograph, 
further demonstrated increased airways resistance in normal 
subjects when given propranolol. On the other hand, Zaid and 
Beall (1966) were unable to show increased bronchial sensi­
tivity to histamine in normal subjects with beta-adrenergic 
receptor blockade.
Here we report on an investigation designed to assess the 
relationship of alpha-adrenergic receptors in bronchial 
smooth muscle to histamine hypersensitivity in patients with  
bronchial asthma. In  addition, it is shown that disodium 
crornoglycate inlribits the hypersensitivity to histamine of 
bronchial smooth muscle in patients with asthma.
Patients and Methods
Patients with bronchial astltma of the extrinsic type and 
known to have fully reversible airways obstruction were 
investigated. These patients all had positive skin tests to 
inhalant antigens, such as house dust, the house dust mite, 
and grass pollens. In  addition, they all had a blood eosino- 
philia of at least 700. cclls/cu.mm. The histamine test was 
carried out in each subject at a time when they had minimal 
airways obstruction and had not required an oral broncho­
dilator drug in the preceding 12 hours. Informed consent was 
obtained for these procedures in every case.
H istam ine Test.— The control test was carried out with the 
patients made comfortable in a sitting position during which
baseline levels were determined for the vital capacity (V .C .) 
and the forced expiratory volume in 1 second (F .E .V .i) in 
litres, a dry spirometer (Vitalograph) being used. During tltis 
period an intravenous infusion of normal saline was set up, 
and once steady state readings for the vital capacity and 
F.E.V.I had been obtained the infusion was switched to a 
solution of 50 fig. of histamine dihydrochloride in 200 ml. of 
normal saline. This was administered over a period of 10 to 15 
minutes. The vital capacity and F .E .V .i measurements were 
continued at regular intervals for 40 minutes after the infusion 
of histamine had been completed. For the test infusion the 
procedure was carried out as above but immediately before the 
histamine drip was begun 5 mg. of phentolamine was injected 
intravenously into the arm not being used for the infusion. In  
three patients 10 mg. of phenoxybcnzamine was administered 
in 150 ml. of normal saline intravenously over a period of two 
hours before the histamine drip.
D isodium  Crornoglycate .— Ten patients had a histamine con­
trol test and were then put on disodium crornoglycate (without 
isoprenaline), three 20-mg. capsules being inhaled daily for a 
period of two weeks. Following this the histamine test was 
repeated, each subject inhaling 40 mg. of disodium cromo- 
glycate 30 minutes before the test infusion. The investigation 
was randomized, some patients having the test infusion with 
phentolamine or disodium crornoglycate carried out first and 
having the control test repeated at a later date. Patients on 
disodium crornoglycate were asked to stop this preparation, 
and one week later the histamine test was repeated. In  view of 
the known prolonged action of phcnoxybenzaminc this test 
was always carried out after the control investigation had been 
completed.
R esu lts
A lpha-Adrenerg ic B locking D rugs .— The results of the 
control test in which cases Cases 1 to 10 were given 50 /ig. of 
histamine dihydrochloride intravenously are shown in Table I. 
The fall in V.C. and F.E.V.i was observed in all 10 patients 
and was most pronounced at 10 minutes. There was consider­
able restitution of both V.C. and F.E.V.i by 40 minutes (Fig. 
I). For the test Cases 1 to 8 received 5 mg. of phcijtolamine 
intravenously and Cases 8 to 10 had 10 mg. of phenoxybcnz­
amine intravenously before tire histamine infusion. The results 
are shown in Table I I .  In  these patients the fall in V .C . and 
F.E.V.I due to histamine was completely inhibited (Fig. I). A  
paired t test shows that there was no significant difference in 
the V.C , and F.E.V.i at 0 time and 40 minutes, but at 5, 10, 
and 20 minutes there was a significant difference in both V.C. 
and F.E .V .I when compared with the control test.
T a b i .e  I .— Results in  10 A sth m a tic  Subjects A fte r  SOitf;. H is tam itte  D ih y -
d roch lo rid c  Jn travenously
Case No. Arc
T i m e  in Minute s
0 5
10 20 40
Change in F .C , (in  L itres)
I 22 3 65 2 55 2 45 2 70 3 35
2 20 3 30 3 0 0 2 95 3 00 3 30
3 30 4 55 4 45 4 0 0 3 60 3 75
4 20 3 00 2 75 1 6 0 2 85 2 95
5 34 3 25 2 50 2 50 2 85 3 20
6 19 3 50 3 1 0 2 55 3 40 3 35
7 53 2 50 1 t o 1 5 0 1 6 0 2 1 5
8 23 3 00 2-75 2 60 2 90 2 82
9 28 2 35 2 20 2 00 1-80 2 40
10 26 4 0 0 4 0 5 3 65 3-70 3 90
Change in F.F.. V ., (in L itres)
1 2 25 1 5 5 1 2 0 0 85 2-20
2 2 50 2 30 2 1 0 2 1 5 2-20
3 2 50 2-20 2 05 1 7 5 1 9 0
4 2 30 1 6 0 1 1 5 1 7 0 2 0 0
5 2 40 2 05 2 05 2 25 2 35
6 1 9 0 1 3 5 1 2 0 1 6 0 1 6 0
7 1 5 5 0 45 0 95 1 0 0 1 2 5
8 1 6 5 1 1 5 1 1 5 1 5 0 1 6 5
9 1 30 M O 0 95 0 95 1 0 0
10 3 1 0 2 95 2 55 2-80 2-90
D isod ium  Crornoglycate.— T he results of the control test in 
which Cases 11 to 20 were given 50 pg. of histamine dihydro­
chloride intravenously are shown in Table I I I .  The fall in 
V.C . and F .E .V .i was observed in them all and was most 
pronounced at 20 minutes. There was considerable restitution 
of both V.C . and F.E.V.i by 40 minutes (Fig. 2), For the test. 
Cases 11 to 20 inhaled 40 mg. of disodium crornoglycate 30 
minutes before the intravenous infusion of histamine. The  
results are shown in Table IV . In  these 10 patients tiie fall in 
V.C . and F.E .V .i due to histamine was completely inhibited 
(Fig. 2). A  paired t test shows that at 0 time tlierc was no 
significant difference in the V.C. or F .E .V .i whereas between 
15 and 30 minutes and 10 and 30 minutes for the V .C . and 
F.E .V .i respectively there was a significant difference when 
compared with the control test.
Discussion
The effect of histamine on smoodi muscle may be produced 
by a direct action of the amine on broncliial smootlr muscle or 
by a delayed reflex action (DeKock, Nadel, Zw i, Colebatch,
T ad i .E I I .— Results i t i  10 Subjects w hen  50 H is tam in e
D ih y d io c h lo r id e  is In fu se d  A fte r  P hen to lam ine  5 mg. o r Phenoxybenz- 
am itie  10 m g. In tra ve n o u s ly
T i m e  in Minutes
, 0
10 20 40
Change in  V .C . (in Li'irer)
1 . 3-00 2 95 3-25 2-90 3-15
2 . 3 15 3-10 3 25 3-00 3-10
3 . 4-70 4-35 4-50 4 15 4-50
4 . 2 80 2-95 2 95 3-10 2-95
5 . 3-20 2-95 2 95 2-35 2-90
6 . 3 45 3-35 3 30 3-70 3 80
7 . 2 50 2-25 2 65 2-50 2 55
8 . 3 15 3 1 0 3 1 0 3-20 3-25
•0  . 2 75 2 75 2-60 2-90 2-85
•9  . 2-65 2-65 2 70 2 70 3 0 5
•1 0  . 3-95 3 90 4 05 4-10 4 05
t ■= 0 79 3 11 5-90 2 71 1 1-99
Change in P .P . V . i (in  L itres)
1 . 1 8 5 2-10 2 0 0 2-15 1 9 0
2 . 2 55 2-55 2 35 2 55 2 45
3 . 3-10 2-60 2 75 2-75 3-10
4  . 2 25 2-15 2 30 2-30 2 35
5  . 2-35 1 -SO 1-90 1 7 5 1-90
6 . 1-70 1-80 1-90 1 9 0 1 8 5
7 . 1-60 1-75 2 1 0 1 5 5 1 8 5
8 . 2 45 2 45 2-60 2 90 2-85
*8 . 1 9 5 1 9 0 1 8 0 2-25 2-15
• 9  . 1-85 2 05 1 7 5 1 8 0 1-95
•10 . 2-95 2-90 2 90 3-10 3-15
1-27 3-66 1) 25 — T 3 3 —
•Subjec ts  uiven phenoxybcnzamine.  (0 05 = 2-28. fO O l '=3-169.
•  V .C . H istom ine
H ijta m in c  +  a lp h a -  
o d rc n crq ic  b locking  
d rug
+ 5
- 5
- IO  '
20 -
-2 5  -
-3 0
O 5 to 15 20 25 30 35 40
Minutes
F i g . 1."— M ean fa ll in  V .C . and F .E .V ., in  10 subjects a fte r intravenous 
in fu s io n  o f 50 pg. o f h is tam ine  d ih y d ro c h lo r id c . T h is  fa ll in  V .C . and 
F .E .V .j is com ple te ly  in h ib ite d  by p r io r  in je c tio n  o f phen to lam ine  o r 
phenoxybcnzam ine.
T a b l e  I I I . -R esults VI 10 Asthm a t ic  Subjects A f t e r  50 (ig,
D ih y d ro c h lo r id c  In tra ve n ou s ly
H is tam in e
Case
N o.
Age
T i m e  in M inute s
0 5 10 20 25 30 35
Change in K.C. (in  L itres)
; 11 . . 33 3 20 3 20 3 20 2 90 2 90 2 70 2 80 2 80
I 12 . . 15 3 75 3 10 3 30 3 40 3 50 3 70 3 50 3 70 3 80
13 . . 28 2 70 2 70 2 60 2 60 2 60 2 40 2 30 2 30 2 30
■ 14 . . 20 2 60 2-40 2 30 2 30 2 0 0 1 7 5 2 30 2 20 2 20
15 . . 15 3-10 2 75 2 60 2 30 2 30 2 80 2 95 3 20 3 20
16 . . 31 3 75 3 10 3 20 3 00 2 40 3 30 3 20 3 25 3 35
17 . . 36 4 1 5 4 10 4 20 3 70 3 30 3-40 3 65 3 80 3-75
18 .-. 31 3 25 3 1 0 2 50 2 30 1 9 0 2 45 2 35 2 45 2 45
19 . . 13 2-00 2 00 1 8 0 1 6 0 1 4 0 1 7 5 2 00 2 00 2 00
1 20 . . 14 4 00 3 90 3 60 3 70 3 60 3 60 3 90 4 00 4 00
Chanf, e in F .E .  F . , (in Litres)
i 11 . . 2 25 2 0 0 1 9 0 1 8 0 1-85 1 9 0 • 1 75 1-80
! 12 . . 2 40 1-85 1 9 0 1 2 0 1-25 1 2 0 1 5 0 2 20 2 20
13 . . 1-90 1 9 0 1 -80 1 7 0 1 6 0 1 4 5 1 5 0 1 5 0 1 5 0
1, 14 . . 1 1 0 0 80 0 70 0 90 0 90 1 0 0 1 0 0 1 1 0 1-10
i 15 . . 2 10 1 5 5 1 6 0 1 5 0 1 3 5 1-CO 1-90 2 05 2-00
;* 16 2 0 5 1 9 0 1 9 0 1 8 0 1 4 5 1 8 0 1-90 1 8 0 1 6 5
17 . . 2-45 2 '30 2 30 2 20 2 1 0 1 9 0 2 00 2-10 2 10
18 . . 1 2 5 1 0 0 0-90 0 80 0-80 0 90 0 95 0 90 0 90
19 . . 1-70 1 5 5 1-20 1 2 0 1 2 0 1 3 5 1 6 0 1 7 0 1 7 0
1 20 . . 2 70 2 60 2 20 2 00 1 9 5 2 70 2 70 2 70 2-70
•  V C Hi jfamine
A F.E.V. H tjia m in c  +  dIsodium 
cromoglycQte
u
>
g'
I  -15 •
S’
g
25
-5 0
O 5
M lnuiei
IO 15 20 25 . 30 35 40
F ig . 2.— M ean  fa ll in  V .C . and F .E .V .i in  10 subjects a fte r in travenous 
in fu s io n  o f 50 /tg. o f liis ta m ine  d ih yd ra ch lo rid e . T h is  fa ll in  V .C . and 
F .E .V .I is  com ple te ly  in h ib ite d  by p r io r  in h a la tio n  o f d isod ium  c ro m o-
glycate.
T a b l e  IV .— lie s u l i s  m  10 A ith rn a t ic  S iib /ects when  50 fig. H is tam in e  
D i/ jj 'ffro c / jio n c /e  h iira ven o u s ly  is In fu se d  a fte r In h a fa tio n  o f 40  m g. 
Disodium  Cromoglycate
T im e  in Minute s
10 15 j 20 25 30 40
Change in V.C. (iii Litres')
( 0  05 = 2-26. (0 01 = 3 25.
11 2 55 2 60 2 60 2 60 2 60 2-63 2 65 2 70
12 2 55 2 60 2 35 2 50 2-70 2 70 2 80 2 70 2 70
13 2 80 2 80 2 90 2 80 2 80 2 80 2 85 2 90 2 0 5
14 3 20 3 20 3 30 3 20 3 20 3 30 3 20 3 30 3 30
15 3 20 3 20 3 20 3 20 3 20 3 10 3 20 3 30 3 25
16 3 80 3 80 3 80 3 80 3 85 3 90 3 90 3 90 3 85
17 4 50 4 50 4 60 4 60 4 50 4 60 4 50 4 60 4 60
18 3 40 3 35 3 25 3 25 3 30 3 30 3 30 3 30 3 30
19 2 20 2 20 2 20 2-30 2 30 2 20 2 15 2 20 2 20
20 5 00 5 20 5 1 0 5 20 5 10 5 20 5 20 5 20 5 20
t c 0 1 5 1 5 9 1 7 6 2 62 9-10 2-39 2 54 2 04 l ‘B2
Change in I-.E. y. ("< L it res)
11 1 3 5 I 35 13 5 1-40 1 3 0 1 45 1-30 I 45
12 1 95 1 9 5 2 05 1 9 0 2 00 2 00 2 00 2-00 2 00
13 2 15 2 20 2 20 2 30 2 20 2-20 2 20 2-20 2-20
14 2 20 2 25 2 20 2 20 2-20 2 30 2 30 2 35 2 30
15 1-70 1-70 1 8 0 1 7 5 1-80 1 7 0 1 85 1-85 1 -80
16 IS O 1 8 0 1 8 0 1 8 5 1 7 5 I 90 1 80 18 5 1-90
17 3 00 3 00 3 00 3 00 3 00 3 00 3 00 3 05 3 00
18 1-40 1 3 5 1 25 1 2 5 1 2 5 1 3 0 1 2 5 1 3 0 1 3 0
19 1 7 0 1 7 0 1 8 0 1 80 1 8 0 1 6 5 1 6 5 1 6 5 1 7 0
20 3 60 3 40 3 60 3 60 3 70 3 55 3 70 3 60 3 65
0 96 1 8 1 2 40 3 0 3 3 32 2 89 2 84 1 9 4 2-35
and Olsen, 1966). Our investigation has again confirmed that 
patients with asthma have a bronchial smooth muscle which is 
hypersensitive to histamine. W e have not been able to show a 
similar fall in ventilatory capacity to histamine by this method 
in patients with chronic bronchitis (unpublished observations). 
The mechanism of this histamine hypersensitivity in broncliial 
asthma is not clear.
L ittle  attention has been paid to the possibility that bron­
chial smooth muscle has alpha-adrenergic receptor sites, but 
alpha-receptor sites do exist on the bronchial smooth muscle 
of certain animal species (Castro de la M ata, Penna, and 
Aviado, 1962; Everitt and Caimcross, 1969). Both phentol- 
amine and phenoxybenzamine are classified as alpha-receptor 
blocldng drugs. Phcntolamdne, which is an imidazole (as is 
histamine), has a direct effect on the adrenal medulla, releas­
ing noradrenaline. During the test with phentolamine the 
patients experienced a mild tacliycardia but so long as they 
remained seated during the test there was no fall in blood 
pressure. I t  is unlikely iltat tlie inhibition of the histamine 
effect on ventilatory capacity in these patients was mediated 
via the adrenal medulla. This view would seem to be con­
. h
firmed by the results obtained with phenoxybenzamine. 
Though this drug gave rise to tachycardia, hypotension was 
not a problem during the test period, as the patients remained 
at rest. Further, phenoxybenzamine does not have a direct 
action on tlie adrenal medulla. Phenoxybenzamine has an 
antihistamine effect which cannot be dissociated from its 
alpha-adrenergic blocking activity (Goodman and Gilman, 
1965). I t  is difficult to assess the many pharmacological effects 
which have been reported due to phentclatiiine and 
phenoxybenzamine. Nevertheless, our results suggest that the 
bronchial smooth muscle of patients with asthma have 
alpha-adrenergic receptor sites and that blockade of these 
sites with alpha-receptor antagonists alters the sensitivity of the 
bronchial smooth muscle to histamine.
Disodium cromoglycate was introduced for tlie treatment of 
patients with allergic bronchial asthma by Howell and 
Altotinyan (1967). On inhalation disodium cromoglycate can 
inhibit the fall in V.C. and F.E.V.i in patients with allergic 
asthma when challenged by inltalation of tlte appropriate 
antigen (Pepys, Hargreavc, Chan, and McCarthy, 1968). This  
drug has also been shown to inliibit the fall in V.C, and 
F.E .V .I in exercise-induced asthma (Davies, 1968). On the 
other hand, disodium cromoglycate has been reported not to 
affect the histamine response of human bronchial smooth 
muscle (Cox, 1967). We have investigated the effect of this 
drug on the phenomenon of histamine hypersensitivity in 
patients with bronchial asthma and have found disodium 
cromoglycate is a potent inhibitor of the fall in ventilatory 
capacity produced in tliese subjects by an intravenous infusion 
of histamine.
T h e  mechanism by wltich disodium cromoglycate produces 
its effect in bronchial asthma remains obscure. The drug in­
hibits tlte release of pharmacologically active amines following 
the antigcn-antibody reaction (Cox, 1967). The release of 
these amines after the antigen-antibody reaction in ana­
phylaxis is dependent on three factors : calcium, a heat-Iabilc 
factor, and free sulphydryl groups (Mongar and Scliild, 1957; 
Austen and Humphrey, 1961). Though in some animal species 
intravenous disodium cromoglycate does give rise to profound 
reflex cardiovascular changes (Cox, 1967), it is unlikely that 
disodium cromoglycate acts as an alpha-receptor blocking 
drug as cardiovascular effects have not been reported in man,
T lte  alpha- and beta-adrenergic receptors are believed to 
control the ionized calcium concentration in the enviromnent 
of the contractile protein of tlte myofibrils (Filo, Bohr, and 
Ruegg, 1965; Bohr, 1967), and the histamine response of 
smooth muscle is dependent on the concentration of ionized
calcium (Daniel, 1964). I t  can therefore be postulated that 
beta-reccptor blocking drugs by increasing the ionized cal­
cium of smooth muscle fibrils increase the histamine response, 
and that the alpha-receptor blocking drugs by lowering the 
ionized calcium inhibit the histamine response of bronchial 
smooth muscle. One explanation of our observations is that 
disodium cromoglycate stabilizes the cell membrane and this 
alters calcium ion transport. Such an effect would explain 
both the inliibition of amine release after tlie antigen- 
antibody reaction and the inhibition of histamine hypersensi­
tivity of bronchial smooth muscle affected by this drug. Fur­
ther investigation of the mechanism of action of disodium 
cromoglycate should lead to a better understanding of the 
nature of bronchial asthma.
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The airways response to phenylephrine after 
blockade of alpha and beta receptors in 
extrinsic bronchial asthma
K .  R .  P A T E L  a n d  J A M E S  W .  K E R R
D e p a rtm e n t o f  R e s p ira to ry  M e d ic in e , W este rn  In f irm a ry  a n d  K n ig h ts w o o d  H o s p ita l,  
G la sg o w
Summary
P h en y leph rin e , a p o w e rfu l a lph a  receptor s tim u lan t, has been show n to cause a 
significant fa ll in the F E V ,  and S G a w  in six patients w ith  extrinsic  b ro nch ia l asthm a  
a fte r p r io r  beta b lockade w ith  p ro p ran o lo l. In  contrast, p ro p ra n o lo l o r phenylephrine  
a fte r p r io r  beta  b lockade fa iled  to  elTect a significant change in the  F E V ,  and S G a w  
in  five n o rm a l subjects. T h e  pheny lep hrin e  eflcct can be co m ple te ly  in h ib ile d  by a lph a  
recep to r b lo c k in g  drugs, phenoxybenzam ine and th ym o xam in c . These observations  
suggest th a t the b ro n c h o m o to r tone in  asthm a is largely  con tro lled  by the sym pathetic  
ac tiv ity  and that there are a lph a  receptors in  the hum an  a irw ays w hich  in  the  presence 
o f  beta b lo ckade  can be stim ula ted  to give b ro nchoconstric tion .
Introduction
H y p e r-re a c tiv ity  o f  the a irw ays in  patients w ith  asthm a was first reported  in 1929 
(W eiss , R o b b  &  B lu m g art, 1929). T h is  phenom enon has freq u en tly  been confirm ed  
(C u rry , 1946; D o w e ll, K e rr  &  P a rk , 1966) and has been show n to be present fo r  m an y  
years even in absence o f  active asthm a (B ouhuys et a !., 1960). F ishe l, S zen tivayn i &  
T a m a lg e  (1 9 6 2 ) postu lated  th a t the b ro n ch ia l h yp er-reac tiv ity  in asthm a is due to  the  
fu n c tio n a l im b a lance  in  the neura l con tro l o f  the sm all a irw ays. A s th m a tic  subjects 
m ay develop  b ro ncho con stric tio n  fo llo w in g  beta adrenergic b lo ckade  w ith  p ro p ra n o lo l 
( M c N e i l l ,  1964; R ichardso n  &  S terling , 1969) and contrasts w ith  n o rm a l subjects w here  
beta adrenerg ic  b lo ckade  has fa iled  to effect a significant change in the v e n tila to ry  
capac ity  o r a irw ays resistance (Z a id  &  B eall, 1966; R ichardson  &  S terling , 1969; 
A s tin , 1972). T h e  beta receptor is m em brane bound adenyl cyclase (R o b is o n , 
B utcher &  S u therlan d , 1967) and studies on leucocyte adenyl cyclase in patients w ith  
extrinsic  asthm a have show n a d im in ished  response to s tim u la tio n  w ith  isopro tereno l 
(Lo gsd on , M id d le to n  &  C o fiey , 1972; P arker &  S m ith , 1973).
L itt le  is kno w n  ab o u t a lph a  adrenerg ic  receptors in  the h um an  b ronch ia l tree, 
a lth ou gh  a lp h a  receptors are kno w n  to  be present in the a irw ays o f  an im als  and  give 
rise to  b ro ncho con stric tio n  on s tim u la tio n  (C astro  de la M a ta , Penna &  A v ia d o , 1962 ; 
E v e ritt  &  C a im cross , 1969). H is ta m in e  induced h yp er-reactiv ity  o f  the b ro nch ia l tree 
Correspondence: D r J. W. Kerr, Department of Respiratory Medicine, Western Infirmary, Glasgow.
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is inh ib ited  by a lph a  receptor b lockade (K e rr , G o v in d a ra j &  P a te l, 1970; B ianco et a l., 
1972; G a d d ie  et a l. ,  1972).
W e  have investigated  the ro le  o f  a lph a  and beta receptors in the h u m an  b ro nch ia l 
tree and the p art they p lay  in  the co n tro l o f  b ro nch ia l sm ooth  muscle tone. C hange in  
the a irw ays ca lib re  produced by phenylephrine  a fte r p rio r b lo ckade  w ith  p ro p ra n o lo l, 
and  phenoxybenzam ine  or th ym o xam in e  was m easured by Forced E x p ira to ry  V o lu m e  
in  1 sec ( F E V ] )  and Specific A irw a y s  C onductance (S G a w ) in n o rm a l subjects and  
patien ts  w ith  extrins ic  b ro n c h ia l asthm a.
Table 1. Details of patients with ex­
trinsic bronchial asthma
No. Age Sex
Eosinophil
cells/mm^
IgE
(ng/ml)
1 21 F 893 1110
2 ■ 17 F 792 400
3 15 M 429* 1647
4 23 M 702 150
5 18 M 864 808
6 19 M 694 343
* On steroid therapy. L
Patients and methods
Six patients w ith  extrinsic  b ro n ch ia l asthm a and reversible a irw ays obstruction  were
investigated. These patients h ad  positive skin tests to  in h a la n t allergens, a b lo od
eos in op h ilia  o f  a t least 600 cells/m m ^ and  an Ig E  level above 100 n g /m l (details  in
T a b le  1). D is o d iu m  crom oglycate  therap y  was d iscontinued fo r  7 -1 0  days and  sim ple f
b ro n c h o d ila to r drugs stopped fo r  1 2 -2 4  h r before the tests w ere carried  out. T h e  five i |
n o rm a l subjects w ere volunteers, they  had no resp ira to ry  disease and there was no ;
personal o r fa m ily  h is tory  o f  b ro n c h ia l asthm a or a to p ic  disease. ;
F E V ]  was m easured on a G a rth u r  V ita lo g ra p h  spirom eter. S G a w  was measured i
w ith  a constant vo lum e bod y  p le thysm ograph  as described by D u b o is , B o th e iho  &
C o m ro e  (19 5 6 ). C onductance  was estim ated a t a flow  rate  o f  0-5 litre /sec d u rin g  in ­
sp ira tio n  w hile  subject panted  sha llo w ly  at 2 cycles/sec. A t  the end o f  each run , 
th o rac ic  gas vo lu m e was estim ated by record ing  the m o u th  pressure at the end o f  
ex p ira tio n . T h e  m ean o f  fo u r recordings was calculated to give the S G aw .
Response to p h e n y le p h r in e  b e fo re  a n d  a f te r  p ro p ra n o lo l
A fte r  record ing  the baseline F E V ;  and S G aw , each subject inhaled  0 -7 5 -1 -0 0  m l o f  
0 -5 %  isoton ic so lu tio n  o f  pheny lep hrin e  h ydroch lo ride  th rou gh  a W r ig h t ’s nebu lizer 
using com pressed a ir  a t a  flow  rate o f  8 litres /n iin . F E V ,  and  S G a w  m easurem ents  
w ere repeated 5 m in  a fte r the end o f  the inh a la tio n . A ll  subjects w ere then given  
p ro p ra n o lo l o ra lly . N o rm a l subjects received 120 m g w hile  as thm atic  patients received  
2 0 -3 0  m g. F E V ]  and S G a w  w ere recorded 45 and 60 m in  a fte r p ro p ran o lo l ad m in is tra ­
tio n . A t  60 m in  phenylephrine  in h a la tio n  was repeated and  therea fte r the F E V ]  and  
S G a w  w ere recorded at 2, 5 and 10 m in . A s th m atic  subjects inhaled  80 pg o f iso- 
prena lin e  aerosol at the end o f  the test and F E V ]  and S G a w  w ere recorded 10 m in  
la te r.
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Table 2. ElTect of phenylephrine and isoprenaline on FEV, after prior bela blockade with propranolol 
in six patients with extrinsic asthma
No.
Change in FEV, (litres)
Dose of 
propranolol 
■ (mg)
Baseline Phenylephrine, Propnnolol Phcnylcphrinez Isoprenaline
45 min 60 min 2 min 5 min 10 mill 10 min later
1 20 3-25 3 35 2-40 2-10 1-60 1-50 1-55 1-55
2 20 2-35 2-60 2-25 2-25 1-25 2-05 2-05 2 20
3 30 2-80 3 35 2-00 2-70 1-85 1-90 2-00 2-40
4 30 2-80 2-90 1-45 1-30 1-00 1-05 0-75 —
5 30 2-60 3 00 2-80 2-40 2-35 2-15 2-55 2-95
6 30 3-15 3-40 3-25 3-25 2-90 2-90 3-00 3-25
Mean 2-83 3 10 2-36 2-33 1-83 1-92 1-98 2-47
(S.E.) (0-14) (043) (0-25) (0-26) (0-28) (0-25) (0-32) (0-29)
t 4-28 2-66 2-02 3-84 4-59 3-01
P <0-005 <0-05 =  0-05 < 0  01 <0-005 <0-025
R esponse to  p h e n y le p h r in e  a f te r  be ta  a n d  a lp h a  a d re n e rg ic  b lo cka d e  
T h e  procedure  described above was repeated in the six as thm atic  patients . A t  the tim e  
they  w ere given p ro p ra n o lo l each p atien t inhaled  10 m g o f  pheno xyben zam ine  h y d ro ­
c h lo rid e  dispensed in  a capsule w ith  20 m g  o f  lactose fro m  a sp inhaler (L isons L td ). 
In  patients  2, 3, 4  and 5 the test was repeated a fte r in h a la tio n  o f  LOO m l o f  1 -5%  
so lu tio n  o f  th y m o x a m in e  th ro u g h  a W r ig h t ’s nebulizer. T h y m o x a m in e  was not 
to le ra ted  by tw o  fu rth e r patients  (1 and 6) because o f its b itte r taste and th ro a t i r r i ­
ta t io n , and cou ld  not be given in traven ou s ly  because o f p os tu ra l hypotension  in the  
presence o f  p r io r  beta  b lockade.
Table 3. Effect of phenylephrine and isoprenaline on SGaw after prior beta blockade with 
propranolol in six patients with extrinsic asthma
Change in SGaw (l/cmPLO sec)
No. Baseline Phenylephrine, Propranolol Phenylephrine^ Isoprenaline
45 min 60 min 2 min 5 min 10 min 10 min later
1 0-242 0-315 0-051 0-049 0-025 0-023 0-021 0-021
2 0-083 0-158 0-061 0-062 0-046 0-056 0-055 0-066
3 0-140 0-199 0-103 0-099 0-039 0-041 0-039 0-096
4 0-253 0-265 0-078 0-065 0-039 0-032 0-034 --
5 0-154 0-178 0-155 0-125 0-099 0-081 0-097 0-154
6 0-119 0-137 0-115 0-088 0-065 0-065 0-093 0-132
Mean 0-165 0-209 0-094 0-081 0-052 0-050 0-056 0-094
(S.E.) (0-029) (0-027) (0-015) 03 011) (0-011) (0-009) (0-013) (0-023)
t 4-13 2-18 2-87 5-34 5-26 3-00
P <0-005 <0-05 <0-025 <0-001 <0-001 <0-025
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First phenylephrine Propranolol Second phenylephrine Isoprenaline
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Fig. 1. The cfTcct of phcnylephfine inhalation on the mean FEVi in six patients with asthtna before 
and after beta adrenergic blockade. The first phenylephrine inhalation caused an increase in the FEV,. 
Following propranolol, the FEVi fell by 17% at 45 min and 18%, at 60 min. In the presence of 
propranolol blockade, the second phenylephrine inhalation caused a further fall in the FEV,. There­
after isoprenaline inhalation increased the FEV, by 22%. When phenoxybenzamine or thymoxamine 
is given with propranolol there was a smaller fall in the FEV,. The second phenylephrine inhalation 
produced an 8% increase in the FEV, at 10 min. Thereafter isoprenaline restored the FEV, above the 
baseline recording.
Results
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R esponse to  p h e n y le p h r in e  b e fo re  a n d  a f te r  be ta  b lo cka d e
I I I  the six asth inatic  patients (1 -6 )  the m ean F E V ,  Increased by 10%  and the m ean  
S G a w  by  2 6 %  a fte r the first in h a la tio n  o f phenylephrine. T h e  changes w ere h igh ly  
significant ( F <  0-005). A f te r  p ro p ra n o lo l the m ean F E V j  fe ll by 17%  at 45 m in  and  
1 8 %  at 60 m in and the m ean S G a w  fe ll by 4 3 %  a t 45 m in  and 5 1 %  at 60 m in . T h e  
changes w ere s ign ificant ( F < 0 -0 5 ) .  P h enylephrine  in h a la tio n  was repeated at 60 m in , 
th is caused a fu r th e r fa ll in  the m ean F E V ,  by 17%  and the m ean S G a w  fe ll by 19%  
(Tab les  2 and 3 and F igs. 1 and 2 ). T h e  fa ll in  F E V ,  and S G a w  observed at 2, 5 and  
10 m in  rem ained  significant th ro u g h o u t the test as com pared  to the readings at 60  
m in  befo re  the second phenylephrine  in h a la tio n  ( /^ <  0-001).
F o llo w in g  the in h a la tio n  o f  80 gg o f isoprenaline at the end o f  the investiga tion  the  
m ean F E V ,  increased by 2 2 %  and the m ean S G a w  by 1 7 % , b u t the m ean F E V ,  
was still 1 2 %  and the m ean S G a w  5 3 %  below  the baseline recordings.
In  the  live  n o rm a l subjects (7 -1 1 )  the m ean F E V ,  and S G a w  d id  not change sig­
n ific a n tly  a fte r in h a la tio n  o f  phenylephrine  n o r was there any  s ign ificant change in 
F E V ,  and S G a w  produced  by beta adrenergic  b lockade ( F > 0 -1 0 ) .  In  each subject, 
a fte r 120 m g o f  p ro p ra n o lo l, repeat in h a la tio n  had little  effect on F E V ,  o r S G a w  
( / ’ > 0 -1 0 )  (Tab les  4  and 5 and F ig . 3).
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First phenylephrine Propronolol 
inhalation
4 0 r
20
-2 0
- 4 0
- 6 0
- 8 0
Second phenylephrine isoprenaline 
inhalation
O
Propranolol 
Propranolol and 
phenoxybenzamine 
or thymoxamine
_ l  I___________ L
0 IQ -3 0  6 0  0  5 10 0
Tim e (m in)
Fig. 2. The effect of phenylephrine inhalation on the mean SGaw in six patients with asthtna before 
and after beta adrenergic blockade. The first phenylephrine inhalation caused an increase in the SGaw. 
Following propranolol, the SGaw fell by 43% at 45 min and 51% at 60 min. In the presence of 
propranolol blockade, the second phenylephrine inhalation caused a further fall in the SGaw. 
Thereafter isoprenaline inhalation increased the SGaw by 17%. When phenoxybenzamine or thymox­
amine was given with propranolol there was a smaller fall in the SGaw. The second phenylephrine 
inhalation produced a 14% increase in the SGaw at 10 min. Thereafter isoprenaline restored the 
SGaw above the baseline recording.
Table 4. Effect of phenylephrine on FEV, 
pranolol in five normal subjects
after prior beta adrenergic blockade with pro-
No. Age
(years)
Sex
Change in FEV 1 (litres)
Baseline Phenylephrine 1 Propranolol Phenylephrine^
45 min 60 min 2 min 5 min 10 min
7 26 F 2 55 2-55 ■ 2-55 2-60 2-50 2-45 2-55
8 25 M 4 50 4 50 4-45 4-45 4-50 4-55 4-70
9 26 F 3-30 3-25 3-10 3-00 3-20 3-20 3-00
10 23 M 5-80 5-85 5-70 . 5-65 5 60 5-50 5-60
11 19 F 3-00 2 95 2-90 2-90 2-95 2-90 3-00
Mean 3-83 3 82 3-74 3-72 3-75 3-72 3-77
(S.E.) (0 58) (0-60) (0 58) (0-58) (0-57) (0-57) (0-59)
t 0 60 125 1-37 0-65 0-39 0-98
B N.S. N.S. N.S. N.S. N.S. N.S.
N.S., not significant.
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F irs t plienylephrine  
Inhalation
10 -
Propranolol
'10
Second phenylephrine 
Inhalation
30  
Tim e  (m in)
60 iO
Fig. 3. The effect of phenylephrine inhalation on the mean FEV, (------) and SGaw ( — ) in five
normal subjects before and after beta adrenergic blockade. The first phenylephrine inhalation failed 
to cause a significant change in the FEV, and SGaw. Following propranolol, the FEV, fell by 2% 
at 45 min and 3% at 60 min, and the SGaw fell by 6% at 45 min and 2% at 60 min. In the presence 
of propranolol blockade, the second phenylephrine failed to cflect a significant change either in the 
FEV, or SGaw.
Response io  phenylephrine fo l lo w in g  be ta  a n d  a lp h a  a d re n e rg ic  b lo c k a d e  in  
a s th in a t ic  p a t ie n ts
T h e  first in h a la tio n  o f  pheny lep hrin e  increased the m ean F E V ,  by 9 %  and the m ean  
S G a w  by 2 9 % . A f te r  p ro p ra n o lo l a d m in is tra tio n  and pheno xyben zam ine  or th y m o x ­
am in e  the m ean  F E V ,  fell by 7 %  a t 45 m in  and 10%  at 60 m in  and the m ean S G a w  
fe ll by 1 1 %  a t 45 m in  and  19 %  a t 60 m in . T h e  m ean fa ll in  F E V ,  an d  S G a w  effected  
b y  p ro p ra n o lo l, and  pheno xyben zam ine  o r th y m o x a m in e  was sm a lle r than  tha t 
observed w hen p ro p ra n o lo l was given a lone, a lth ou gh  the d ifference in  the results is
Table 5. Effect of phenylephrine on SGaw after prior adrenergic blockade with 
propranolol in five normal subjects
No.
Change in SGaw (l/cmHjO sec)
Baseline Phenylephrine, Propranolol Phenylephrine^
45 min 60 min 2 min 5 min 10 min
7 0 245 0-248 0-238 0-261 0-256 0-265 0-281
8 0 336 0-358 0-300 0-336 0-306 0-315 0-336
9 0-230 0-244 0-230 0-230 0-213 0-213 0-230
10 0-300 0-316 0-268 0-272 0-277 0-315 0-360
11 0-269 0-253 0-258 0-258 0-258 0-256 0-265
Mean 0-276 0-283 0-259 0-271 0-282 0-272 0-294
(S.E.) (0-019) (0-022) (0-012) (0-017) (0-015) (0-019) (0-023)
t 1-45 0-45 0-62 0-59 0-10 0-94
P N.S. N.S. N.S. N.S. N.S. N.S.
N.S., not significant.
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n o t statistically  s ignificant ( F > 0 -1 0 ) .  A t  60 m in  the second pheny lep hrin e  inh a la tio n  
was given, the rea fte r the m ean  rise in F E V , was 5 %  at 2 m in , 6 %  at 5 m in  and 8 %  
ja t  10 m in , and the m ean rise in  S G a w  was 9 %  a t 2 m in  and 14 %  at 5 and 10 m in . 
'T he .resp on se  to  pheny lephrine  in  the  presence o f  a lph a  and  beta receptor b lockade  
was significant as com pared  to  the efi'ect o f  phenylephrine  in the presence o f  beta  
b lo ckade  a lone < 0  05 ) (Tab les  6 and 7 and Figs. 1 and  2 ),
F o llo w in g  in h a la tio n  o f  80 p g  o f  isoprenaline at the end o f  the investiga tion  the  
m ean  F E V ,  increased by 5 %  and the  m ean S G aw  by 2 2 % . T h e  m ean  F E V ,  was 3 %  
and  the  m ean  S G a w  1 7 %  above baseline recordings.
Table 6. Effect of phenylephrine and isoprenaline on FEV, 
blockade in six patients with extrinsic asthma
after prior alpha and beta adrenergic
No.
Change in FEV, (litres)
Baseline Phenylephrine, Propranolol plus phenoxy* 
benzamine or thymoxamine*
Phenylephrine^ Isopren-
aline
45 min 60 min 2 min 5 min 10 min 10 min later
1 3 00 3-25 3-00 2-65 2-70 2-60 3 20 3 20
2 2-10 2 30 2-00 2-00 2-30 2-20 2-30 2-30
3 3 25 3 70 3-15 2-90 3-35 3 30 3-30 3-40
4 2-00 2 20 1-05 1-50 1-60 1-60 1-50 1-65
5 3 00 3 10 3-25 2-95 3-15 3 20 3-15 3-25
6 3 40 3-40 3-40 3-45 3-20 3 40 3-40 3-45
2* 220 2-25 1-50 1-95 2-05 1-95 2-20 2-25
3* 2 60 3-15 2-80 2-20 2-40 2 50 2-45 3-05
4* 195 2-40 1-30 1-15 1-20 1-35 1-30 1-50
5* 2 90 3-10 3-20 3-05 3-10 3-20 3-20 3-25
Mean 2-64 2 88 2-46 . 2-38 2-50 2-53 2-60 2-73
(S.E.) (0 17) (017) (0-28) (0-23) (0 23) (0 23) (0-24) (0-23)
t
P
1-13
N.S.
0-92
N.S.
6-55 4-41 4-84 
<0001 <0001 <0-001
2 10 
<0-05
N.S., not significant. * Subjects given thymoxamine.
Discussion
T h e  re la tive  a lph a  s tim u la tin g  potencies o f  com pounds acting  on the  a lph a  receptor is 
in  the descending o rd er; p h e n y le p h rin e >  n o ra d re n a lin e >  a d r e n a l in o  isoprenaline  
and is in  the reverse o rd er o f  th e ir beta s tim u la ting  properties (A h lq u is t &  Levy, 1959; 
F u rch g o tt, 1960). P h enylephrine  is a p o w erfu l a lpha receptor s tim u lan t w ith  little  
effect on  the beta receptor. A  d irect action  on the receptor accounts fo r  the greater 
p a rt o f  its effects, o n ly  a sm all p art being due to its a b ility  to  release norad ren a lin e  
(G o o d m a n  &  G ilm a n , 1970). O u r  observations o f  m arked  changes in  the F E V ,  
and S G a w  in  as thm atic  patients fo llo w in g  pharm aco lo g ica lly  induced a lte ra tio n  in the 
sym pathetic  a c tiv ity  confirm s the w e ll-k n o w n  v a ria b ility  in the b ro n ch ia l ca lib re  in  
these subjects, and contrasts w ith  the absence o f  significant change in  the F E V , and  
S G a w  in  n o rm a l subjects fo llo w in g  s im ila r pharm aco log ica l procedures. S tatis tically
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the as th m atic  and n o rm a l subjects belong  to  tw o  d iffe ren t p o p u la tio ns . O u r results  
sup po rt W id d ic o m b e ’s v iew  (1966 ) th a t the sym pathetic  nervous system has a m in o r  
ro le  to  p lay  in  the co n tro l o f  b ro nch ia l ca lib re  in n o rm a l subjects.
In  the as th m atic  subjects sm all doses o f  p ro p ran o lo l caused a s ignificant fa ll in the  
F E V ;  and S G a w , and afte r beta b lockade p henylephrine  gave rise to  fu rth e r b ro ncho ­
con s tric tio n , w hereas i f  these subjects had a com bined  beta and a lph a  b lockade a 
lesser tho ug h  not s ign ificant fa ll in  the F E V ,  and S G a w  occurred. P heny leph rin e  at 
th is stage gave a reversed action  w ith  an increase in the F E V ,  and S G a w . These  
observations suggest th a t in  as thm atic  subjects there arc a lph a  receptors in  the a irw ays  
w h ich  in  the presence o f  beta b lockade can be stim ulated  to give b ro ncho con stric tio n .
Table 7. Effect of phenylephrine and isoprenaline on SGaw after prior alpha and beta adrenergic 
blockade in six patients with extrinsic asthma
No.
Change in SGaw (l/cmHaO sec)
Baseline Phenylephrine; Propranolol plus phenoxy­
benzamine or thymoxaminc*
Phenylephrine^ Isoprcn-
alinc
45 min 60 min 2 min 5 min 10 min 10 min
1 0-248 0-290 0-247 0-226 . 0-223 0-224 0-248 0-257
2 0-138 0-167 0-080 0-105 0-108 0-119 0-105 0-139
3 0-282 0-347 0-274 0-227 0-300 0-300 0-309 0-332
4 0-081 0-113 0-032 0-037 0-040 0-038 0-039 0-048
5 0-104 0-116 0-122 ' 0-101 0-115 0-136 0-123 0-168
6 0-158 0-174 0-124 0-118 0-117 0-124 0-126 0-174
2? 0-080 0-131 0-056 0-073 0-071 0-068 0-067 0-087
3* 0-068 0-128 0-069 0-050 0-067 0-069 0-066 0-135
4* 0-065 0-091 0-027 0-021 0-031 0-037 0-032 0-047
5* 0-085 0-131 0-129 0-111 0-117 0-125 0-125 0-146
Mean 0-131 0-169 0-116 0-106 0-118 0-124 0-124 0-153
(S.E.) (0-025) (0-026) (0-026) (0-022) (0-026) (0-026) (0-028) (0-028)
t
P
0-75
N.S.
1-01
N.S.
2-43 2-33 
<0-025 <0-025
2-92
<0-01
2-45
<0-025
N.S., not significant.
* Subjects given thymoxamine.
B u t u n lik e  P rim e  et a i.  (19 7 2 ) we have been unab le  to  d em on stra te  a lph a  a c tiv ity  in  
n o n -as th m atic  subjects. I t  should be noted th a t isoprenaline  was on ly  able to  over­
com e the  p heny lep hrin e  effect in  the presence o f  beta b lo ckade  whereas isoprenaline  
restored the  F E V ,  and S G a w  above the baseline recordings in the presence o f  beta  
and a lp h a  b lo ckade . A lp h a  recep to r b lock ing  drugs m o d ify  the beta b lockade p ro ­
duced by p ro p ra n o lo l and  th is  observation  could  have a therap eu tic  significance in the  
m an agem en t o f  asthm a.
A lp h a  recep to r b lo ck ing  drugs have been kn o w n  to  in h ib it h is tam in e  h yp er­
re a c tiv ity  o f  the a irw ays in  as th m atic  subjects (K e r r  et a l.,  1970; B ianco e t a l.,  1972; 
G a d d ie  et a i ,  1972) and in  o u r experience h istam ine h yp e r-re a c tiv ity  is consistently
A irw a ys  response io  phenylephrine  447
associated w ith  a lph a  recep to r a c tiv ity  and  contrasts w ith  incthacho line  induced  
bro ncho con stric tio n  w h ich  is n o t inh ib ited  by thym o xam in c  (personal observations).
W e  have no evidence as to  w hether a lph a  receptor ac tiv ity  as reported  here is a 
genetic o r an acqu ired  fu n c tio n  o f  the sm all a irw ays. In  e ith er case the b ro n c h o m o to r  
tone is dependent on the balance c f  a c tiv ity  between the beta and a lpha receptors.
' M e m b ra n e  b ou nd  adeny l cyclasc is now  recognized as the beta receptor (R o b is o n  e l 
a l.,  1967) and shows a subnorm al response to  isopro tereno l d u rin g  active asthm a but 
approaches n o rm a l ac tiv ity  d u rin g  rem ission (P a rk e r &  S m ith , 1973). T h is  suggests 
th a t the  v a r ia b ility  in the b ro nch ia l ca lib re  is due to  changes in the balance o f  sym ­
p ath etic  a c tiv ity . T h e  n o rm a l sym pathetic  n eu ro -tran s m itte r is n o rad ren a lin e  and  
d u rin g  periods o f  d im in ished  adenyl cyclase ac tiv ity , increased n o rad ren a lin e  w ou ld  
be ava ila b le  to  activa te  the a lpha receptors and give rise to  b ro ncho con stric tio n . T h is  
effect has been show n to  be in h ib ite d  by phenoxybenzam ine and th y m o x a m in e . 
F u r th e r  observations on the n a tu re  o f  the a lpha receptor w ill lead to  a b etter u n d er­
standing  o f  the c o n tro l o f  b ro nch ia l ca lib re  in patients w ith  asthm a.
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S u m m a ry
In  six p atien ts  w ith  ex trin s ic  b ro n c h ia l ' as th m a the  
in h a la tio n  o f p ro s tag lan d in  (F G )  Fa a in  a sm a ll dosage 
p roduced s ig n ifican t b roncho co n stric tio n , w hereas PG Ea  
produced b ro n c h o d ila ta tio n . In  these p atien ts  ch o linerg ic  
blockade w ith  a tro p in e  p a r t ia lly  in h ib ite d  the P G F -a -  
induced b ronchoconstriction , b u t the « -rec ep to r-b lo c k in g  
d ru g  th ym o xa m in e  and  sod iu m  crom oglycate  d id  not. 
These results suggest th a t the effect o f  P G F ;«  is m e d ia te d  
th ro u g h  cho linerg ic  receptors in  the a irw ays, and  th is  
effect is grossly exaggerated  in  as th m a. T lie  fa ilu re  to 
in h ib it  P G F ;« -in d u c ed  b ro nchoconstriction  w ith  sod ium  
crom og lycate  and the observation  o f  an  in h ib ito ry  effect 
o f  so d ium  crom oglycate  in  b o th  a lle rg ic  and  exercise  
as th m a  suggest th a t lo c a lly  fo rm e d  PGF%« m a y  n o t be 
th e  m a in  fa c to r in  the pathogenesis o f  b ro n c h ia l as thm a.
In tro d u c tio n
Human lung contains prostaglandins (PG ) of both the E  and F  
series, Eg and Fa® being the most abundant.* * PGFg«, a potent 
bronchoconstrictor to which patients with bronchial asthma are 
highly sensitive,*"® is released from mammalian lungs during 
anaphylactic reactions® and by various chemical and mechanical 
stim uli.’ Recently, a considerable increase in plasma levels of 
P G F j«  metabolites in asthmatic patients after allergen challenge 
was reported.® Based on these observations it was postulated 
that locally formed PGFa« may play an important part in the 
pathogenesis of bronchial asthma.® ® P G E j, on the other hand, 
causes bronchodilatation in man.* *
P G E ; activates adenyl cyclasc, now identified with fi-receptor 
function,*"** and its bronchodilator effect is mediated by an 
increase in cyclic adenosine monophosphate (cyclic A M P ). 
Conversely, PGF^a has been reported to activate guanyl cyclase 
and lead to the formation of cyclic guanosine monophosphate 
(cycUc G M P ).** Guanyl cyclase activity has been found in 
various tissues, including human lung.** Cychc G M P  activates 
cholinergic responses,** *® and guanyl cyclase nuiy also be 
activated by «-stimulation.** Cyclic G M P  has been reported to 
have an opposing influence to cychc A M P  in regulating cell 
function, and according to Haddock et a lM  the relationship of 
cyclic A M P  and cychc G M P  in the lung may influence broncho­
motor tone. In  patients with asthma tlie nonnal balanced 
relationship of P G E j and PGFs« may be altered, giving rise to 
variability in the bronchomotor tone.** In  the light of the 
biochemical observations on prostaglandins I  have studied the 
effects of P G E ; and PG Fz« on forced expiratory volume in one 
second (F E V ;) and specific airways conductance (SGaw) in six 
patients with extrinsic bronchial asthma and tested the effects 
of atropine, the «-receptor-blocking drug thymoxamine, and 
sodium cromoglycate on PGFa «-induced bronchoconstriction 
in these patients.
D ep artm ents  o f R esp irato ry  M edicine, W eotcrn In f irm a ry  and 
I^ lg h tB v/oad  H oapita i, Glasgow  
K . R. P A T E L , M .B ., M .R .C .P ., Senior Registrar
P atients , M a te r ia ls , an d  M ethods
Six patients aged 15 to 37 years with extrinsic bronchial asthma and 
reversible airways obstruction were studied. All reacted to prick tests 
with inhalant allergens and had a blood eosinophilia of over 500 X 
10*/1. Simple bronchodilators such as salbutamol and isoprenaline 
were stopped for at least 24 hours before the tests.
FEV, was recorded on a Garthur Vitalograph spirometer. Airv/ays 
resistance (Raw) was measured in a constant-volume body plethysmo­
graph at a flow rate of 0 5 1/s and a panting frequency of 2/s.** 
Conductance (Gaw), the reciprocal of airways resistance, was divided 
by the thoracic gas volume at which Raw was measured to give SGaw 
(s'* ld?a"*). The mean of four recordings was calculated to give the 
SGaw for each step of the experiment.
Drugs.—A sterile aqueous solution of PGF^a (as a tromethamine 
salt) 5 g/1 was diluted with normal saline to give a concentration of 
50 mg/1. Similarly, a stock solution of PGEj I g/l was diluted with 
normal saline to give a concentration of 50 mg/1. Other drugs used 
were atropine sulphate (600 mg/1 ; Antigen Ltd.), thymoxamine 
hydrochloride (15 g/l ; Warner & Co. Ltd.), and sodium cromoglycate 
(20 mg in powder form dispensed in a Spincapsule; Fisons Ltd.).
Procedure.—After establishing baseline values for FEV, and SGaw 
each patient inhaled about 0 5 ml of a P G I\«  solution through a 
Wright nebulizer using compressed air at a flow rate of 8 1/min, FEV; 
and SGaw were measured two minutes after inhalation and thereafter 
at five-minute intervals for 25 minutes. This test was repeated three 
times in all patients. Ten minutes before inhaling PGFjŒ each patient 
inhaled 12 mg atropine sulphate or 40 mg sodium cromoglycate or 
15 mg thymoxamine hydrochloride. Atropine sulphate and thyrnoxa-, 
mine were inhaled through a Wright nebulizer, and sodium cromo­
glycate was inhaled using a Spinlialcr. In  all six patients the test was 
repeated after inhaling 0 5 ml of a PGE; solution through a Wright 
nebulizer. Placebo inhalations with normal saline were performed on 
each experimental day and the test procedure was carried out only 
when no significant change in FEV, and SGaw v/ith normal saline- 
was observed.
Results
Inhalation of PGF%« produced maximum falls in the mean FEV, and 
SGaw of 27% and 53% respectively (tables I and I I) ,  winch occurred 
five minutes after inhalation. These falls were higlily significant 
(P <  0-001 and P <  0 01). Over the next 25 minutes the values gradually 
returned towards the baseline (figs. 1 and 2).
Inhalation of atropine sulphate increased the mean FEV, and 
SGaw by 9% and 68'!/, respectively, the bronchodilatation produced 
being significant (P <  0-025) (tables 1 and I I) .  PGFj« inhalation 10 
minutes later then reduced the mean F E V , and SGaw by 10% and 
20%  respectively. The maximum falls in FEV, and SGaw produced 
by PGFj« differed significantly from those produced by PGF,« after 
pretreatmcnt with atropine sulphate (P < 0  05). This suggests that 
prior inhalation of atropine sulphate partially inhibited the broncho­
constriction induced by PGFja.
Sodium cromoglycate inhalation did not produce a significant 
change in tire mean FEV, or SGaw, and PGF,a inhalation 10 minutes 
later produced maximum falls of 32% and 55% respectively. There 
was no significant différence between the maximum falls in FEV, and 
SGaw produced by PGF%« alone and those produced after pre- 
treatment with sodium cromoglycate (P >0T 0). This suggests that 
sodium cromoglycate had no effect on PGF,«-induced broncho­
constriction (tables I, I I ;  figs. 1, 2).
Inhalation of thymoxaminc produced no significant change in the 
mean FEV, or SGaw, and PGF^a inhalation 10 minutes later pro­
duced maximum falls of 26% and 55% respectively. There was no 
significant difference between the maximum falls in FEV, and SGaw 
produced by PGF,« alone and those produced by PGF,« after 
pretreatmcnt with thymoxamine (P>0-1G). Tlris suggests that 
thymoxamine had no effect on PGF,«-induced bronchoconstriction
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FIG. 3— E ffec t o f  P G E j in h a la tio n  on mean F E V x and  SGaw 
in  s ix patien ts w ith  ex trins ic  b ro n ch ia l astlim a.
inliibited PGFi?a-iaduced bronchoconstriction in these patients. 
In  contrast, sodium cromoglycate and thymoxamine failed to 
change the mean F E V i and SGaw, and neither of these drugs 
had any effect on the PGFg a-induced bronchoconstriction. 
PGFgct in some patients caused symptoms of upper airway 
irritation— cough, substernal tightness, and increased mucous 
secretion— similar to those experienced after methacholine 
inhalation.
P G F ja  is released from guinea-pig and rat limgs during 
anaphylactic reactions® and by various chemical and mechanical 
stim uli.’ The release of PGF^a during type 1 allergic reactions 
and. the observation of increased sensitivity of asthmatic 
patients to inhaled PGF^a led M athé et al,^ to postulate that 
endogenous, locally formed PGF^a may play an important part 
in tlie pathogenesis of bronchial asthma. This view was sup­
ported by a report of about an eightfold increase in plasma 
levels of 15“keto-13,14-dihydroprostaglandin F^a, the main 
metabolite of P G F j« , in asthmatic patients after allergen 
challenge.® Local PGF%« release in the lung has been suggested 
as tlie mechanism of exercise-induced asthma,’ ® and the 
demonstration of tliis release in guinea-pig Itmgs in response 
to minor mechanical stimuli supports this view. The resiilts of 
the present investigation, however, suggest that sodium 
cromoglycate does not inliibit PGFj«-induced bronchocon­
striction in asthmatic patients.
This effect of sodium cromoglycate on PGF^«-induced 
bronchoconstriction together w itli tlie observations of its 
inliibitory effect in allergen-provoked*® and exercise-provoked*’ 
asthma suggest that the release of prostaglandins locally in the ' 
lung may not be tlie primai-y factor in the pathogenesis of 
asthma. In  addition, indoraethacin administration, which 
considerably reduces tlie total body production of FGFscc, does 
not completely inliibit allergen-provoked astlima in man or 
anaphylactic reactions in guinea-pigs.®*
T he studies on cyclic nucleotide systems suggest. tliat the 
effects of PGEa are mediated through p-adrenergic receptors, 
whereas PGF^a may activate cholinergic receptors. T he partial
inliibition o f PGF^ «-induced bronchoconstriction by atropine 
as reported here is consistent with this hypothesis. «-Blockade 
with thymoxamine failed to inliibit the PGF« «-induced 
bronchoconstriction in these patients with astlima, which 
suggests that P G F ja  does not stimulate «-receptors in the lung. 
In  man, cholinergic or vagal stimulation causes bronchocon­
striction, which is grossly exaggerated in astlima.*® The evidence 
so far suggests that PGFg« together with other chemical 
mediators such as histamine, bradykinin, serotonin, and SRS-A  
are released during the type I  allergic reaction. P G F ,«  is a 
potent bronchoconstrictor to which asthmatic patients are 
highly sensitive, and it may act by stimulating cholinergic 
receptors. Airways hyperreactivity to chemical mediators 
released in the type I  allergic reaction is now well recognized 
in patients with asthma. Though Szentivayni** suggested that 
this hyperreactivity in asthma may result from an imbalance 
between the «- and p-adrenergic receptors in the lung, the 
evidence to support this theory is not conclusive.*® I t  would be 
wrong to consider PGFaa as the main factor in the pathogenesis 
of asthma until we further clarify the cause of airways hyper­
reactivity, which appears to be the primary defect in astlunatic 
patients.
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Effect of alpha receptor blocking drug, thymoxamine, 
on allergen induced bronchoconstriction in extrinsic 
asthma
K. R. PA TEL and J. W. KERR
Department of Respiratory Medicine, Western Infirmary & Knightswood Hospital, 
Glasgow (713 2XG
Summary
In ten patients with extrinsic bronchial asthma, allergen provoked bronchospasm was 
significantly inhibited by the alpha receptor blocking drug thymoxamine given intra­
venously. In two of these patients thymoxamine by inhalation also effectively inhibited 
allergen induced bronchoconstriction. It is suggested that thymoxamine may be acting 
either by increasing intracellular levels of cyclic AMP and thus inhibiting mediator 
release following allergen challenge or by modifying the airways response to these 
mediators by altering the bronchomotor tone. The variable responses recorded after 
allergen challenge in presence of alpha blockade with thymoxamine suggests that the 
dominant eftect is on the bronchomotor tone rather than the mediator release.
Introduction
It has recently been shown that the reagin mediated release of histamine and SRS-A 
can be inhibited by catecholamines which activate the membrane bound adenyl 
cyclase (now identified with beta receptor function) and lead to an increase in the 
cyclic adenosine monophosphate (cyclic AMP) formation (Lichtenstein & De 
Bernado, 1971 ; Orange, Austen & Austen, 1971\ In acute asthma, it has been shown 
that the diminished leucocyte adenyl cyclase response to isoprenaline can be restored 
towards normal by alpha receptor blocking drugs, phentolamine and thymoxamine 
(Logsdon et al., 1973; Alston, Patel & Kerr, 1974b Further, it has been reported that 
alpha adrenergic stimulation augment histamine and SRS-A release from human 
lung and isolated rat mast cells (Kaliner, Orange & Austen, 1972; Coffey & Middleton, 
1973), The above observations have lead us to study the effect of thymoxamine, the 
most specific alpha receptor blocking drug available, on allergen induced broncho­
constriction in ten patients with extrinsic asthma.
Patients and methods
Ten patients, aged between 18 and 46 years, with extrinsic bronchial asthma and 
reversible airways obstruction were investigated. All patients had positive prick tests 
to inhalant allergens and a blood eosinophil count of over 500 cells/mm .^ Sodium
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cromoglycate therapy was discontinued for 7-10 days and simple bronchodilator 
drugs stopped 12-24 hr before the tests.
Airways resistance (Raw) was measured with the help of a constant volume body 
plethysmograph (Dubois, Bothelho & Comroe, 1956) at a flow rate of 0 5 1/sec while 
the patient panted shallowly at 2 cycles/sec. Conductance, the reciprocal of Raw, 
was divided by the thoracic gas volume at which Raw was measured to give the 
Specific Airways Conductance (SGaw). The mean of four recordings was calculated to 
give the SGaw.
Allergen inhalation test
Standard solutions of house dust or pollen extract (500 protein nitrogen u/ml) were 
used. After recording the baseline SGaw, each patient inhaled an appropriate allergen 
solution through a Wright’s nebulizer until he developed symptoms of airways 
obstruction. SGaw was recorded 5 min after the inhalation and thereafter at regular 
intervals for 60 min. On a different day (allowing at least 3 days between the tests), 
the allergen inhalation test was repeated in each patient after intravenous administra­
tion of thymoxamine (0 1 mgm/kg body weight). In two patients (nos 3 and 10'' 
allergen challenge was repeated after inhalation of 15 mgm of thymoxamine (1-5%) 
through a Wright's nebulizer. In one patient (no. 10) the dose of allergen inhaled after 
thymoxamine was doubled.
Results
Allergen inhalation produced a significant fall in the mean SGaw in ten patients with 
extrinsic bronchial asthma (P<0-01). The maximal fall in the mean SGaw was 59% 
at 15 min and thereafter there was a gradual restitution in the SGaw (Table 1 and 
Fig. I).
Following intravenous thymoxamine, a smaller fall in the mean SGaw was ob­
served. The maximal fall in the mean SGaw was 35% at 25 min. The overall inhibition
Tabic 1. Efi’ect of allergen challenge on SGaw in ten patients with extrinsic bronchial asthma
Change in SGaw (l/cmHzO sec. 1)
No. Age Sex Allergen inhalation
Basel i tie 5 min 10 min 15 min 25 min 35 min 45 min 60 min
1 19 M 0-235 0-142 0-129 0-114 0-091 0-081 0-116 0-132
2 23 M 0-189 0-122 O -lIl 0-094 0-087 0-081 0-101 0-120
3 21 F 0-144 0-034 0-030 0-029 0-042 0-045 0-054 0-140
4 18 F 0-213 0-122 0-149 0-097 0-096 0-106 0-167 0-258
5 46 F 0-109 0-063 0-060 0-063 0-066 0-063 0-063 0-093
6 18 F 0-132 0-088 0-089 0-091 0-114 0-110 0-120 0-114
7 23 F 0-227 0-066 0-038 0-068 0-060 0-127 0-145 0-146
8 18 M 0-066 0-022 0-017 0-011 0-011 0-023 0-026 0-045
9 27 M 0-105 0-024 0-014 0-022 0-019 0-029 0-047 0-094
10 28 M 0-082 0-021 0-024 0-019 0-023 0-025 0-078 0-088
Mean 0-150 0-070 0 066 0-061 0-061 0-069 0-092 0-123
s.e. mean 0-020 0-014 0-015 0-012 0-011 0-012 0-014 0-018
y/-.Ü.v
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Fig. 1, The cfTect of intravenous thymoxamine on allergen induced fall in the SGaw in ten patients 
with extrinsic bronchial asthma. The fall in SGaw was partially inhibited by thymoxamine.
Allergen; allergen + thymoxamine,
obtained with thymoxamine in these ten patients was statistically significant (/’<0-025, 
Tables 1 and 2, Fig. I). However the elTect of intravenous thymoxamine on allergen 
induced bronchoconstriction varied greatly in individual patients. In three patients 
(nos 2, 5 and 7), the allergen provoked bronchospasm was completely inhibited where­
as in four patients (nos 4, 6, 8 and 9) thymoxamine had no efi'ect in this respect. In 
the remaining three patients (nos 1, 3 and 10) thymoxamine partially inhibited allergen 
induced bronchoconstriction.
Thymoxamine given by inhalation also inhibited allergen provoked broncho­
constriction in two patients (nos 3 and 10) and in one of these patients (no. 10) this
Table 2. Eflcct of allergen challenge on SGaw after prior bela blockade with 
thymoxamine in ten patients with extrinsic bronchial asthma
Change in SGaw (l/cmHzO sec. 1)
No. Allergen inhalation
Baseline 5 min 10 min 15 min 25 min 35 min 45 min 60 min
I 0-245 0-237 0-179 0-178 0-t07 0-10! 0-133 0-202
2 0-193 0-195 0-169 0-189 0-189 0-212 0-225 0-238
3 0-183 0-207 0-188 0-147 0-104 0-105 0-126 0-122
4 0-177 0-174 0-069 0-043 0-051 0-059 0-083 0-076
5 0-079 0-081 0-088 0-095 0-095 0-101 0-098 0-097
6 0-124 0-037 0-052 0-064 0-071 0-080 0-080 0-085
7 0-179 0-204 0-179 0-200 0-200 0-220 0-221 0-231
8 0-087 0-023 0-019 0-021 0-019 ' 0-025 0-028 0-045
9 0-067 0-020 0-027 0-026 0-022 0-026 0-027 0-035
10 0-082 0-051 0-044 0-048 0-057 0-052 0-052 0-076
Mean 0-142 0-123 0-101 0-101 0-092 0-098 0-107 0-120
s.e. mean 0-019 0-028 0-022 0-022 0-020 0-022 .. 0-022 0-024
/ test 2-44 2-63 1-83 1-97 2-46 0-08 0 00
0-025 0-025 0-05 0-05 0-025 N.S. N.S.
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protection was maintained even when the dose of allergen inhaled was doubled 
(Figs 2 and 3).
Thymoxamine given intravenously did not cause a significant fail in blood pressure 
in any of the patients and none complained of any side effects. However, thymox­
amine by inhalation precipitates transient bronchospasm in some patients due to its 
local irritant elTect on .the airways.
0-200 r
0-150
0-100
0-050
•o.
20 40 60
Time (min)
Fig. 2. The ciTcct of thymoxamine by inhalation on allergen induced fall in the SGaw in patient no. 3.
Thymoxamine cn’ectively inhibited allergen induced bronctioconstriclion. © Allergen; o O,
allergen +  thymoxamine.
0-150
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Fig. 3, The efiect of thymoxamine by inhalation on allergen induced fall in the SGaw in patient no. 10. 
Thymoxamine effectively inhibited allergen induced bronchoconstriction. This protection was
maintained even when the dose of allergen inhaled was doubled. 3  o, Thymoxamine + allérgen;
•  o, allergen; a ------ a , thymoxaminc +  allergen (x  2).
Discussion
It is now generally accepted that cyclic AMP functions as a second messenger for many 
hormonal actions including catecholamines (Robison, Butcher & Sutherland, 1971). 
The catecholamines activate membrane bound adenyl cyclase leading to accum­
ulation of intracellular cyclic AMP. Cyclic AMP inhibits mediator release (hist­
amine and SRS-A) from mast cells and is active in the first stage of type 1 allergic 
reaction which is not calcium dependent (Lichtenstein & Dc Bernado, 1971). Alpha 
receptor agonists have been shown to increase the release of histamine and SRS-A
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ill the type I allergic reaction (Kaliner et a i ,  1972; Colley & Middleton, 1973). 
These observations suggest that thymoxamine is acting by cyclic AMP formation 
(Logsdon et al., 1973; Alston et a l ,  1974) and in our experiments leading to inhibition 
• of mediator release following allergen challenge.
Although the results are statistically significant, the wide variation in the responses 
following allergen challenge suggest that the action of thymoxamine may not be to 
inhibit the release of pharmacologically active substances but rather to modify the 
airways response to mediators released by altering bronchomotor tone. Patients with 
extrinsic asthma are hyper-reactive to chemical mediators released in the type I 
allergic reaction (Curry, 1946; Tiffeneau, 1955; Varonier & Panzani, 1968; Mathe 
et a l ,  1973). This hyper-reactivity remains constant in individual patients (Cade & 
Pain, 1971) and persists for many years even in the absence of active asthma (Bouhuys 
et a l ,  1970). It has been postulated that bronchial hyper-reactivity is due to a functional 
imbalance between the alpha and beta adrenergic receptors and results from a 
diminished beta receptor function in the lung (Szentivayni, 1968). Alpha adrenergic 
receptors have been demonstrated in human lung and stimulation of these receptors 
can cause bronchoconstriction (Prime et a l ,  1972; Patel & Kerr, 1973). it. lias recently 
been shown that alpha receptor blocking drugs, including thymoxamine, inhibit 
histamine induced bronchoconstriction in patients with asthma (Kerr, Govindaraj & 
Patel, 1970; Bianco et a l ,  1972). The type I allergic reaction is now known to release 
significant quantities of Prostaglandin Fzcc (Green, Hcdqvist & Svanborg, 1974), in 
addition to histamine, SRS-A, bradykinins and 5-hydroxytryptamine. The variable 
responses recorded after allergen challenge in presence of alpha blockade with thymo­
xamine could be accounted for by the observation that thymoxamine does not inhibit 
the effect of Prostaglandin F,a on the airways (Patel, 1975) suggesting that the 
dominant effect of thymoxamine is on bronchomotor tone rather than on the mediator 
release. The effect of thymoxamine in the management of patients with extrinsic 
asthma requires further investigations to define its place in the treatment of asthma.
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SÜMIÆARY
Of the 22 patients with extrinsic bronchial asthma, 13 patients 
developed post-exercise bronohooonstriotion after treadmiUl exercise 
whereas in 9 patients treadmill exercise had no effect on the ventilatory 
capacity. No statistical difference in the resting lung volumes and CO 
transfer factor was found between the ti70 groups. A significmit inhibition 
of post«exercise bronchoconstriction was observed in 12 out of 13 patients 
follovd.ng thymoxamine or sodium ci'omoglycate inhalation.
In some asthmatic patients who show diminished beta receptor 
responsiveness to catecholamines, noradrenaline released during exercise 
could have a marked alpha agonistic effect giving rise to bronchoconstriction, 
Inhibition of post-exeroiso bronchoconstriction by alpha blockade with 
thymoxamine suggests that increased alpha adrenergic activity in the 
presence of diminished beta receptor funotion could bo the mechanism of 
post-exercise bronchoconstriction in those patients. Sodium oromoglyoato, 
with its cyclic phosphodiesterase inhibiting action, may act by increasing 
the levels of cyclic jUîP and restox’ing the beta receptor responsiveness 
to oat c chclaminos.
INTRODUCTION
».-mewpiiiewûHWoiteeCvss4eaaii,Tkfa*-Mi
I Exercise induced, bronohocoustriotiou is a woll recognised phenomenon 
in bronohial asthma (Jones et al, 1963), and in some patients exorcise may 
act as the.predominant or even the only px*eoipitating stimulus of broncho­
constriction. Using more sensitive methods it has been sho^m that
vigorous exercise can cause a small but significant reduction in bronchial
/ '
calibré of normal subjects (McNeill et al, 1966; Fisher et al, 1970» 
Anderson et al, 1971; Lefcoe et al, 1971)» Inhibition of post-exercise 
airways obstruction by sympathomimetic amines (Jones et al, 1963»
McNeill et alj> 1966; Hebuck & Read, 1968; Crompton, I968) suggests that 
it results from contraction of bronchial smooth muscle.
Recently there has been an increasing interest In the presence of 
alpha adrenergic receptors in the human bronchial tree and their role in 
the control of bronchomotor tone. Alijha adrenergic stJjnulation has been 
reported to cause bi'onchoconstriotion in animals and man (Castro de la 
Mata et al, 1962; Everitt & Caimcross, 1969» Simonsson et al, 1971 »
Prime et al, 1972; Patel & Kerr, 1973)» The hyper-reactivity of airways 
in patients with bronchial asthma may be due to increased alpha adrenergic 
activity (Faillers et al, 1971» Patel & Kerr, 1973)« Noradrenaline, a 
powerful alpha receptor agonist, is released by strenuous exeroise 
(Vendsalu, I96O; Kozlowski et al, 1973) and this release is enhanced if 
there is hypoxia and metabolic acidosis. In patients with bronchi^ 
asthma there is evidence of diminished beta receptor responsiveness to 
catecholamines (inoue, 1967; Middleton & F^ jiko, 1968; Parker & Smith, 1973» 
Alston et al, 1974). In this situation, post«exorcise release of 
noradrenaline may give rise to alpha stimulation and lead to broncho­
constriction. However, Sly et al (196?) have shown that alpha adrenergic 
blockade with phentolamine has no effect on post-exercise broncho­
constriction. Phentolamino is a short acting alpha rocoptor blocking 
drug and it may produce inadequate blockade F/hon given intravenously. 
Although sodium cromoglycate has been reported to be effective in 
preventing post-exercise bronohooonstriotion (Muittari & Kreus, 1'969)» its 
mode of action in exorcise induced bronchospasm still remains imcortain.
?/0 have investigated the effect of thymoxamine, a specific alpha 
receptor blockijig drug, on post-exoroiso bronchooonstrietion in 13 
patients with bronchial asthma. The effect of thymoxamine is compared 
to sodium cromoglycate in those patients, and the possible mode of action 
of both these drugs is discussed.
PATIÉEPS M D  METHODS
Twenty two patients with extrinsic bronchial asthma and reversible
airways obstruction who complained of dyspnoea or wheezing after moderate
exertion were investigated. All patients had positive aldjn tests to .
inhalant allergens and a blood eosinophil count of over 500 cello per 
3ram . Three patients were on sodium cromoglycate and others used simple 
bronohodilator drugs like salbutainol aerosol f w  relief of acute symptoms, 
Sodium cromoglycato was discontinued for 7-10 days and simple broncho** 
dilator drugs stopped at least hours before the tests* 
pulmonary Function Assessment
Total lung capacity (TLC) and Residual Volume (rv) wore measured 
by helium dilution method in a closed circuit using a Godart Pulmotost. 
Vital Capacity (VC) and Forced Expiratory Volume 1 sec. (FEV^) were 
measured with the help of a Gart bur Vitalograph spirometer. All lung 
volumes were corrected for body temperature^ pressure and saturated with 
water vapour (BTPS)« Predicted values of lung volumes for adults were 
taken from Bates et al (1971) and those for children from Cotes (1965)» 
The resting gas transfer factor (Dj^ CO) was measured by the steady 
state method using carbon monoxide and an end tidal sampler (Bates et al, 
1962). Predicted values for D^GO at rest were token from Bates et al 
(1971) and Cotea (1965)*
Exercise test
Exercise tes^s were carried out in symptom free periods and after 
the preliminary pulmonary assessment had been completed. Each test 
consisted of steady state exorcise of running on an incJJjned treadmill 
(10°) for up to 8 minutes. The speed of treadmill was adjusted so that 
the patient's pulse rate at the end of exercise was at least I80 per rain. 
FEV^ was recorded at 2 minutes after exorcise and thereafter at regular 
intervals for the next 30 minutes.
In thirteen patients (1 - 13) who developed post-exox'ciss broncho- 
constriction, the test was repeated after inhalation of saline, 
thymoxaraine and sodiim cromoglyoato* The order of drug treatment was
randomised and the observer (A3#) recording the FEV^ after exorcise was
unaware of the drug treatment. In the control test, the patient inhaled 
normal saline through a Wright’s nebulizer using compressed air at a flow 
rate of 8 litres per minute. On a different day, the exercise test was 
repeated after inlialation of 15 mgm, of thymoxaraine hydrochloride solution 
( 1 ,5 ^  aqueous solution) through a Wright's nebulizer. Thymoxaraine has a 
bitter taste and causes transient bronchooonstriotion in some patients 
which usually settles within 5“10 minutes. At a lator date, the 
exorcise test was repeated in each patient after inhalation of 40 mgm. 
of sodium cromoglycate through a spinhaler 15 minutes before the exorcise. 
KBSULTS
The anthropometric and lung function data are given in table 1• 
Although all patients with bronchial asthma complained of dyspnoea on 
moderate exertion, only thiiteen patients (1 “ 13) developed a significant 
fall in after treadmill exercise. There was no statistical
difference in the resting lung volumes and transfer factor (D^  CO) at rest 
between the patients who. developed post-exoroise bronchooonstriotion and 
those patients in whom treadmill exercise had no effect on the ventilatory 
capacity.
In thirteen patients (1 - 13) the maximal fall in the mean FEV^ 
after treadmill exercise was 35^ and occurred at 5 minutes. Thereafter 
there was a gradual restitution in PEV^ over the next 25 m^jiutes (Pig, 1)« 
The fall in PEV^ was highly signifieejit (P<*001).
When the patients were pretreated with thymoxaraine, th© maximal 
fall in mean PEV^ was 5^ end occurred 5 minutes after exercise.
Thereafter the FEV^ returned to the baseline value over the next 25 
minutes. The fall in mean FEV^ was statistically significant ( P < .05), 
However, when the falls iui FEV^ induced by exercise in the control test 
and after thymoxaraine treatment were compared, the inîiibitory effect of 
thymoxaraine on post-exercise bronchooonstriotion was found to be highly 
significant (t test = 2.80, P <[.01 ) «
When the exercise test was repeated after inhalation of sodium 
cromoglycate, the maximal fall in mean FEF^ was IC^ o and occurred 5 
raj.nutes after exercise « Thereafter the mean FEV. returned to the
. fL C
minutes was significant (P<d025)« However^ when the falls in PEV^ 
induced by exercise in the control tost and after sodium cromoglycate 
treatment were compared, the inhibitory effect of sodium cromoglycate 
on post-exercise bronchooonstriotion was found to be higlily significant 
(t test :: 3*0, P<*01).
The inliibitory effect of thymoxamine and sodium cromoglycate on 
post-exercise bronchooonstriotion In patients with bronchial asthma m s  
comparable and no atat:lstioal diff eronoe was found botwoon. the two drug 
treatments (t tost = 0*3* P^.IO),
DISCUSSION • • .
Recently it has been shown that form, intensity and duration of 
exercise, and time intervals at which observations are made, are critical 
in assessing the effect of exercise on ainvays obstruction. It has boen 
reported that high efficiency negative work, namely running at near 
maximal work loads for eight minutes, provides a more potent stimulus 
for bronchooonstriotion than other jmtterns of exercise tests (Anderson 
et al, 19711 Fitch & Morton, I97I)» Although all the patients with 
asthma in the present investigation complained of dyspnoea on moderato 
exertion, only 13 patients developed a significant fall in FEV^ after 
treadmill exercise. Nine of the patients oxaminod did not develop 
pbst-exercise bronchooonstriotion, although in on© patient (No, 19) post-
I
exercise bronchooonstriotion was demonstrated two years previously.
There was no statistical difference in the resting lung volumes and CO 
transfer factor between the patients who developed post-exercise broncho- 
constriction and those patients in whom treadmill exercise had no effect. 
Exorcise response was measured by a fall in FEV^, and if more sensitive 
method of measuring airways obstruction had been used, suoh as mid- 
expiratory flow rate, a higher incidence of post-exercise broncho- 
constriction may have been obtained (MoFadden & Linden, 1972; Paterson 
et al, 1973).
A significant inhibition of post-exercise bronchooonstriotion was 
observed in 12 out of 13 patients following thymoxamine inhalation, and 
in these 12 patients a statistically comparable inhibition of post-exorciso 
bronchooonstriotion was also obtained with sodium cromoglycate. However, 
in one patient (No. 10) neither drug had any effect on post-exercise 
bronchooonstriotion. Further, atropine sulphate given by inhalation also 
failod to inhibit exercise induced bronchospasra in this patient.
The mechanism of exercise ijtiduced bronchooonstriotion in asthma
remains uncertain, A wide variety of humoral mediators have been
suggested. Histamine levels have beon found to be normal or unre3.atod
to the degree of post-oxerois© bronchooonstriotion (&ranerus ©t a'l, 1971Î 
I
Mathews & Pan, 1970)' Further, antiliistaininio drugs have failed to
.inlilbit post-exeroise ‘bronchooonstriotion (McNeill et al, I9665 Sly et al, 
1967)* The role of serotonin as a bronchoconstriotor in man is disputed 
(Miohelson et al, 1958) and its antagonist, methyaergide, does not alter 
the exercise response (Quanjer et al, 1971)* Local prostaglandin 
release in the lung has been suggested, and the demonstration of this 
release in guinea-pig lungs in response to minor mechanical stimuli 
(Piper & ‘Vane, 1971) would support this view. However, sodium 
cromoglycate does not inhibit prostaglandin induced bronchospasm in 
asthmatic patients (Smith, 1974; personal observations). The effect of 
sodium cromoglycate on prostaglandin induced bronchooonstriotion, 
together with the observation of its beneficial effect in exercise 
induced asthma, would suggest that the release of prostaglandin locally 
in the lung may not be the primary factor in exercise induced broncho- 
spasm.
Noradrenaline and adrenaline are released during strenuous exercise, 
and this release of catecholamines is greatly enhanced by prior adrenergic 
blockade with propranolol or oxprenolol (Inking et al, 1974)« A similar 
enhanced release of catecholamines may also occur in asthmatic patients 
who show diminished beta responsiveness to catecholamines. Of the 13 
patients with exercise induced airways obstruction, 12 showed a significant 
inliibition of post-exercise bronchooonstriotion following thymoxaraine 
inhalation. These observations suggest that increased alpha adrenergic 
activity in the presence of diminished beta receptor responsiveness could 
be the mechanism of post-exercise bronchooonstriotion in these patients.
The report by Jones (1972) that a proportion of normal subjects develop 
post-exercise bronchooonstriotion in the presence prior beta blockade
with propranolol would further suggest that alpha adrenergic stimulation
I
by catecholamines could b© the cause of post-exerois© bx*onchoconstrictioa 
in these subjects. Recently, work on adenyl cyclase (identified with 
beta receptor function) has shorn n diminished responsiveness of this 
enzymo system to catecholamines in some patients with asthma (Parker & 
Smith, 1973; Alston ot al, 1974). In this situation, noradrenaline and 
adrenaline would have a marked alpha agonistic effect giving rise to
bronohoGonstriotion (Patel & Xerr, 1973)* It has recently been suggested 
that sodium cromoglycate acts by inhibition of cyclic phosphodiesterase 
(Taylor et e,l, 1974), and leads to an djacreaso in the levels of cyclic 
adenosine monophosphate (cyclic MP). These observations are 
consistent with the hypothesis that post-oxercise bronchooonstriotion is 
caused by alpha adrenergic activity in the airwaya, and can be iiiiibited 
by alpha receptor blocking drugs and sodium cromoglycate.
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SUMMARY
In normal subjects inhalation of produced two
qualitatively different airways responses. In five subjects 
tiiere was a significant fall in SGaw without change in maximum
I
expiratory flow rates, FEV^ or CV. In contrast, the remaining 
three subjects showed a significant fall in flow rates and FEV^ 
together with a significant increase in CV while their SGaw was 
unaffected, PGF^a inhalation in six asthmatic patients produced 
a significant fall in maximum expiratory flow rates, FEV and
1  A
SGaw. These patients shov/ed a dual response with individual 
variability in magnitudes of changes. It is suggested that 
differing responses may reflect the balance between the 
sympathetic and parasympathetic nervous controls of the airways, 
and that the diminished beta receptor activity in asthmatic patients 
may account for heightened bronchoconstrictor response to inhaled 
both centrally and peripherally in the bronchial tree.
Prostaglandin (PGF^a), a potent bronchoconstrictor,
is released from guinea-pig and rat lungs during anaphylactic 
reaction and by various chemical and mechanical stimuli (Edmonds,
Berry & Wyllie, 1969; Piper & Vane, 1969). This local release
!
of PGF„a together with the exquisite sensitivity of asthmatic
!
patients has led Mathe, Hedqvist, Holmgren & Svanborg (1973) to
I
postulate that endogenous, locally formed PGF^a'may play an im­
portant part in the pathogenesis of bronchial asthma. This 
hypothesis is further supported by the report of Green, Hedgvist.
& Svanborg (1974) who have shown an eight fold rise in the plasma 
levels of PGF^G metabolites in asthmatic patients following 
allergen challenge. In addition, local release of PGF^g has 
been suggested as the mechanism of exercise induced asthma 
(Paterson, Ahmad & Lefcoe, 1973).
Despite the importance of PGF^u in asthma, most previous 
studies of its effect in the human lung have been limited to 
the measurement of FEV^ and airways conductance (Mathe et al, 1973; 
Patel, 1975). In order to obtain additional information on the 
effect of PGF^G on lung mechanics, dyiicunic and static lung 
volumes, specific airways conductance and closing volume were 
measured before and after PGF^u inhalation in eight normal subjects 
and seven patients with extrinsic asthma.
PATIENTS AND .METHODS
Seven patients aged between 15 and 3o years with 'extrinsic
asthma and reversible airways obstruction were studied. All
patients had positive prick tests to inhalant allergens and a
blood eosinophilia of over 500 cells mm. Simple bronohodilator
drugs like ealbutamol and isoprenaline were stopped for at least
24 hours before the tests.
The control group consisted of eight volunteers aged
between 18 and 30 years. They had no respiratory disease and
there was no personal or family history of bronchial asthma or
atopic disease. Five subjects in this group (1,2,5,7 & E) were 
1
light smokers. Informed consent was obtained in each case.
I - ■
I The static lung volumes were measured by helium dilution
method in a closed circuit using Godart Pulmotest. Forced
Expiratory Volume in 1 second (FEV^), Maximum Mid-expiratory Plow
Rate (MMFR) and Vital Capacity (VC) were recorded on a Godart
Expirograph. All lung volumes were corrected to body temperature,
pressure, saturated with water vapour (BTPS).
 Airways resistance (Raw) was measured with a constant volume
body plethysraograph (Dubois, Bothelho & Comroe, 1956) at a flow
-1rate of 0.5 litre sec and a panting frequency of 2 Hz. Conductance, 
the reciprocal of Raw, was divided by the thoracic gas volume at 
which Raw was measured to give specific airways conductance (SGaw). 
The mean of four recordings was calculated to give SGaw for the 
event.
Closing volume (CV) was measured by a single breatli nitrogen
test as modified by Anthonisen, Danson, Robertson & Ross (1969).
The equipment circuit and procedure has been described previously
by Buist & Ross (1973). Both the inspiratory and expiratory flow
_]
rates were kept under 0,5 litre sec by close observation of the 
rate of movement of the pen recording the volume trace on spirometer
spirometer/
chart. Throughout the expiration, gas was sampled at the mouth 
and nitrogen concentration was estimated using a nitrogen meter 
(Godart Nitrograph). The volume change was recorded using a 
potentiometer connected to the spirometer pulley. The nitrogen 
concentration in the expired gas and the VC were recorded on Y 
and X axis respectively of an X-Y plotter. The volume at which 
■ the nitrogen concentration rose sharply from the alveolar plateau 
(or Phase III) has been termed the closing volume (or Phase IV) and
A-
is expressed as the fraction of VC. The term closing capacity (CC) 
is used for the sum of CV and RV and is expressed as the fraction 
of Total Lung Capacity (TLC).
DRUGS ' .
A sterile stock solution of PGF^ (as a tromethamine salt) , 
5mgm/ml., was diluted with normal saline to give a final concentration 
of 50ugm/ml.
PROCEDURE
After measuring static lung volumes, FEV^, MMFR, SGaw and CV 
each subject inhaled 0.5 ml. of PGF^a solution through a Wrights 
nebulizer using compressed air at a flow rate of 8 litres per minute. 
The measurements were repeated five minutes after inhalation. The 
whole procedure in each subject took thirty minutes to carry out.
The test procedure was similar in astlimatic patients, however, 
— satisfactory CV tracings could not be obtained in those patients 
— because of marked bronchoconstrictor response to 3?GF^ a.
PGF^G inhalation produced coughing, retrosternal tightness 
in five normal subjects (1-5) whereas the remaining three subjects 
(6 - 8) complained of dyspnoea and wheezing. In contrast, all 
patients with asthma developed more marked and prolonged broncho­
constrictor response following PGF^G inhalation.
Lung function .changes before and after PGF^g inhalation in 
normal subjects are given in Table I and*11. Two qualitatively 
different responses could be distinguished in these subjects
depending on the symptoms. In five subjects (1 - 5) with coughing
d
and retrosternal tightness there was a highly significant fall in
& J
^Gaw, 38%, (P<.00l) whereas FEV^, MMFR, CV/TLC% were unaffected.
The second group of subjects (6-8) showed a significant, fall in
i
FEV^, MMFR, together with a significant increase in both CV/VC% and 
CC/TLC%. The mean fall in FEV^ and MMFR was 8.3% (P<.01) and 
15% (P<.025) respectively; and the mean CV/VC% and CC/TLC% increased 
by 152.0% (P<.01) and 27.6% (P<.01) respectively from the baseline 
values. However, PGF^u did not cause a significant change in the 
mean SGaw in these subjects (Table III). These differing airways 
responses did not relate to the smoking habits of the subjects, 
and time-course experiments in four of these subjects failed to show 
any relationship to the duration of PGF^a effect on the bronchial 
tree.
PGF„a inhalation in all asthmatic patients but one (9)
2
produced a marked fall in FEV^, MMFR and SGaw with a significant 
increase in RV(Table II)., The mean fall in FEVi, MMFR and SGaw 
was 17.5% (P<.05), 19.7% (P<.05) and 62.0% (P<.001) respectively.
The mean RV increased by 37.0% (P<.05) after PGF^u
inhalation. Apart from one patient (9) who showed a conductance 
response, all other patients showed a dual response with ind.i vidual 
variability in magnitudes of changes.
DISCUSSION (cont.) ■ . . - . '
In contrast, airways resistance assesses airflow obstruction 
in central airways, there being little contribution from the peripheral 
airways to total resistance. Thus, conductance-response would 
seem to reflect PGF^a induced smooth muscle contraction in 
relatively large airways whereas as flow rate response to reflect 
smooth muscle contraction in the peripheral airways. This hypothesis 
is further supported by observation of a significant increase in the 
CV in the flow-rate responders suggesting airways closure and air 
trapping. i
Bouhuys and Woestijne (1970) have postulated that individual 
variations in airways response to histamine or hemp dust is 
principally determined by variations of sympathetic tone of the 
airvjuys. According to this hypothesis a subject witli flow rate 
response may have relatively few sympathetic fibres in peripheral 
airways so that the g adrenergic activity might be insufficient to 
counteract the bronchoconstriefive effect of histamine or hemp dust 
in these airways. Conversely, in a subject with conductance response, 
-the sympathetic distribution might be predominantly to the smaller 
airwaysl Similarly in dogs, vagal stimulation has been shown to 
cause bronchooonstriotion either centrally or peripherally (Bates, 
Macklem & Christie, 1971). Reed (1974) has suggested that broncho- 
motor tone in man is dependent on the balance between the cholinergic 
and sympathetic divisions of the autonomic nervous system. The 
observations in man and in dog suggest that the autonomic balance 
'between the sympathetic and parasympathetic system may vary in the 
different parts of bronchial tree and hence account for differing 
airways response to histamine, hemp dust, PGF^a or vagal stimulation.
It is now well recognised that patients with asthma show a diminished 
3 receptor response to catecholamines (Cookson & Reed, 1963;
Middleton & Finke, 1968; Alston, Patel & Kerr, 1974). Hence, a 
diminished g receptor function in both tho central and peripheral
DISCUSSION (cont.)
peripheral/
airways in asthmatic patients would explain the marked broncho­
constrictor effect of PGF^G at both these sites. In addition, 
the diminished beta adrenergic responsiveness reflects a failing 
counter-regulating mechanism against bronchoconstricing mechanism 
and probably accounts for airways hyper-reactivity in asthma 
(Patel, Alston & Kerr, 1974). In such a situation, PGF^o released 
locally by specific and non specific stimuli would cause marked 
bronchoconstriction both in the central and peripheral airways in ■ 
asthmatic patients with significant air trapping. i
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